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ABSTRACT 
 
Contribution to the Study of Experimentally-Simulated  
Toxic and Metabolic Encephalopathies 
 
PhD Thesis (by published work / retrospective) in Neuroscience by 
Apostolos Ch. Zarros 
University of Bolton, Bolton 2014 
 
This current PhD Thesis (by published work / retrospective) in Neuroscience focuses on per-
formed studies of three crucial brain enzyme activities under seven categories of experimen-
tally-simulated toxic and metabolic encephalopathies. The studied enzymes were: (a) acetyl-
cholinesterase (AChE, EC 3.1.1.7), (b) sodium-potassium adenosine triphosphatase (Na+,K+-
ATPase, EC 3.6.3.9, formerly EC 3.6.1.3), and (c) magnesium adenosine triphosphatase (Mg2+-
ATPase, EC 3.6.3.2, formerly EC 3.6.1.3). The studied experimentally-simulated toxic and 
metabolic encephalopathies were: (a) thyroid-hormone-related brain dysfunctions (as a re-
sult of hyper- or hypothyroidism), (b) thioacetamide-induced fulminant hepatic encephalopa-
thy, (c) streptozotocin-induced diabetic encephalopathy, (d) experimentally-simulated Wer-
nicke’s encephalopathy (arising from chronic ethanol consumption, dietary thiamine-
deprivation and pyrithiamine-administration), (e) manganese-induced neurotoxicity, (f) lan-
thanum-induced neurotoxicity, and (g) nickel-induced neurotoxicity. Enzymatic activities 
were determined spectrophotometrically on albino Wistar rat brain homogenates. Assess-
ments of brain homogenates’ antioxidant status, in vivo antioxidant administrations, in vitro 
experiments, brain homogenates’ enzymatic activity determinations, as well as pure enzyme 
activity determinations (under various conditions), were performed (wherever required) in 
order to elucidate the nature of some of the observed in vivo findings, to evaluate the poten-
tial limitations of the experimental-simulation techniques and / or to study the potential use 
of known antioxidants as neuroprotective agents. All experiments were performed at the 
Medical School of the National and Kapodistrian University of Athens. The current PhD Thesis 
condenses and presents the significance of the aforementioned contribution to the study of 
experimentally-simulated toxic and metabolic encephalopathies, based on published work. 
 
Keywords: Neuroscience; toxic encephalopathy; metabolic encephalopathy; enzyme; enzy-
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PREFACE 
 
Contribution to the Study of Experimentally-Simulated  
Toxic and Metabolic Encephalopathies 
 
Aristotle’s contribution to science is of colossal importance. Amongst his surviving works (as 
indexed in “Corpus Aristotelicum”), “Parva Naturalia” includes the following excerpt: 
“… περὶ δὲ ὑγιείας καὶ νόσου οὐ μόνον ἐστὶν ἰατροῦ ἀλλὰ καὶ τοῦ φυσικοῦ μέχρι 
του τὰς αἰτίας εἰπεῖν. ᾗ δὲ διαφέρουσι καὶ ᾗ διαφέροντα θεωροῦσιν͵ οὐ δεῖ λαν-
θάνειν͵ ἐπεὶ ὅτι γε σύνορος ἡ πραγματεία μέχρι τινός ἐστι͵ μαρτυρεῖ τὸ γινόμε-
νον· τῶν τε γὰρ ἰατρῶν ὅσοι κομψοὶ καὶ περίεργοι λέγουσί τι περὶ φύσεως καὶ 
τὰς ἀρχὰς ἐκεῖθεν ἀξιοῦσι λαμβάνειν͵ καὶ τῶν περὶ φύσεως πραγματευθέντων 
οἱ χαριέστατοι σχεδὸν τελευτῶσιν εἰς τὰς ἀρχὰς τὰς ἰατρικάς”, 
which can be translated as follows (Zarros, 2014): 
“… but health and disease also claim the attention of the scientist, and not mere-
ly of the physician, in so far as an account of their causes is concerned. The ex-
tent to which these two differ and investigate diverse provinces must not escape 
us, since facts show that their inquiries are, to a certain extent, at least conter-
minous; for physicians of culture and refinement make some mention of natural 
science, and claim to derive their principles from it, while the most accom-
plished investigators into nature generally push their studies so far as to con-
clude with an account of medical principles”. 
This fundamental scientific truth that has been written sometime between 384 BC and 322 
BC, is now verified and evident through the existence and excellence of multiple interdiscipli-
nary scientific fields serving Medicine with the assistance of tools acquired through the study 
of Natural Sciences.  
Neuroscience is amongst the most rapidly evolving of these interdisciplinary fields, 
aiming to serve Medicine through an understanding of brain disease pathophysiology-related 
mechanisms and the discovery of efficient therapeutic approaches. The current PhD Thesis 
(by published work / retrospective) focuses on the performed studies of three crucial brain 
enzyme activities under seven different categories of experimentally-simulated toxic and 
metabolic encephalopathies. Encephalopathies compromise a large chapter in human brain 
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pathology, and their study maintains a high-priority research objective for Neuroscience, 
since a better understanding of their pathophysiology might reveal sites of potential neuro-
protective and eventually therapeutic intervention. 
The current PhD Thesis condenses and presents the significance of a part of my contri-
bution to the study of experimentally-simulated toxic and metabolic encephalopathies, based 
on published work. The studied experimentally-simulated toxic and metabolic encephalopa-
thies were: (a) thyroid-hormone-related brain dysfunctions (as a result of hyper- or hypothy-
roidism), (b) thioacetamide-induced fulminant hepatic encephalopathy, (c) streptozotocin-
induced diabetic encephalopathy, (d) experimentally-simulated Wernicke’s encephalopathy 
(arising from chronic ethanol consumption, dietary thiamine-deprivation and pyrithiamine-
administration), (e) manganese-induced neurotoxicity, (f) lanthanum-induced neurotoxicity, 
and (g) nickel-induced neurotoxicity. The studied crucial brain enzyme activities were those 
of: (a) acetylcholinesterase (AChE, EC 3.1.1.7), (b) sodium-potassium adenosine triphospha-
tase (Na+,K+-ATPase, EC 3.6.3.9, formerly EC 3.6.1.3), and (c) magnesium adenosine triphos-
phatase (Mg2+-ATPase, EC 3.6.3.2, formerly EC 3.6.1.3). These enzymatic activities were de-
termined spectrophotometrically on albino Wistar rat brain homogenates. Assessments of 
brain homogenates’ antioxidant status, in vivo antioxidant administrations, in vitro experi-
ments, brain homogenates’ enzymatic activity determinations, as well as pure enzyme activi-
ty determinations (under various conditions), were performed (wherever required) in order 
to elucidate the nature of some of the observed in vivo findings, to evaluate the potential limi-
tations of the experimental-simulation techniques and / or to study the potential use of 
known antioxidants as neuroprotective agents. 
I am grateful to Dr Stylianos Tsakiris (Assoc. Professor of Physiology) for his mentor-
ship and continuous support, as well as to Dr Charis Liapi (Assoc. Professor of Pharmacology) 
and to Dr Haris Carageorgiou (Assoc. Professor of Pharmacology, retired) for their trust and 
help towards the completion of the works described in this PhD Thesis. All described experi-
ments were performed in their laboratories at the Medical School of the National and Ka-
podistrian University of Athens. 
At this point, I feel that I should make clear to all readers that I am fully aware that this 
PhD Thesis contains grammatical and syntactical errors. I am sure that the readers will ex-
cuse me for the existence of such errors, since I am not a native speaker of English. However, I 
feel that I should indeed apologize for the existence of the significant number of scientific 
speculations employed in order to discuss the presented experimental findings. The readers 
are asked to bear in mind that these speculations are a result of the ignorance and / or the 
technical and financial “inadequacies” that accompanied the performance and analysis of the 
described experiments. I hope that the readers (including, hopefully, scientists of the days to 
come) will understand this point, look upon this PhD Thesis with sympathy, and forgive me 
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for my share of ignorance and impotence. 
 
Bolton, December 2014 
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PART A 
 
Overview of the published work 
 
 
 
 
 
 
  
CHAPTER I 
 
Contribution to the study of thyroid-hormone-related  
brain dysfunctions* 
 
Thyroid hormones (THs) are recognised as key metabolic hormones stimulating the catabo-
lism of glucose, fats and proteins by increasing the levels of many enzymes that catalyse these 
metabolic reactions (e.g. liver hexokinase), as well as of those mitochondrial enzymes in-
volved in oxidative phosphorylation (Lodish et al., 1995; Smith et al., 2002). A characteristic 
response of the homeothermic animals to THs is increased oxygen consumption; however, 
several organs, including the brain, are unresponsive to the calorigenic effects of the THs 
(Hardman et al., 2001; Silva, 1995). Since the demonstration of the existence and the descrip-
tion of the distribution patterns of TH receptors in the rat brain at both developmental and 
adult stages, many recent studies have focused on the activity of THs within the central nerv-
ous system (CNS). It is now well-established that THs play a critical role in brain develop-
ment, mediating important effects within the CNS throughout life (Bernal and Nunez, 1995; 
Bradley et al., 1989; Cook et al., 1992; Gullo et al., 1987; Koromilas et al., 2010; Mellström et 
al., 1991; Oppenheimer and Schwartz, 1997; Rastogi et al., 1977). Metabolic effects such as 
those affecting mitochondrial respiratory chain enzyme activities and acetate metabolism, 
have been shown to occur in the brain after TH administration (Chapa et al., 1995; Dembri et 
al., 1983).  
It should be noted that oxygen-derived free radical species (reactive oxygen species - 
ROS) can develop during several steps of normal metabolic events, such as the mitochondrial 
electron transport chain, the microsomal electron transport chain, the reactions of oxidant 
enzymes, and autoxidation reactions (Freeman and Crapo, 1982; Hauck and Bartke, 2000; 
Matés et al., 1999). Variations of the TH levels can be one of the main physiological modula-
tors of in vivo cellular “oxidative stress”, in view of their known effects on mitochondrial res-
piration (Guerrero et al., 1999). In particular, it has been suggested that the increase in ROS 
induced by THs can lead to an oxidative stress state in several organs, such as the liver, the 
myocardium, the skeletal muscles and the brain, with a consequent lipid peroxidative re-
                                                 
* modified-version of the article by Carageorgiou et al., entitled: “Changes in antioxidant status, protein 
concentration, acetylcholinesterase, (Na+,K+)-, and Mg2+-ATPase activities in the brain of hyper- and 
hypothyroid adult rats”, published in Metabolic Brain Disease 2005; 20(2): 129-139. 
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sponse (Asayama and Kato, 1990; Fernandez and Videla, 1989; Mano et al., 1995; Pasquini 
and Adamo, 1994). Superoxide and hydrogen peroxide (H2O2), generated as by-products of 
oxidative metabolism in mitochondria, can be removed by so-called “free radical-scavenging 
enzymes”, such as superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase 
(CAT), and glucose-6-phosphate dehydrogenase (G-6-PD) (Bilmen et al., 2001; Cheeseman 
and Slater, 1993; Lombardi et al., 2000; Sies, 1993).  
Adult-onset thyroid dysfunction is associated with both neurological and behavioural 
abnormalities (Aminoff et al., 2005; DeGroot et al., 1984), emphasising the importance of THs 
for normal brain function. Hypothyroidism (HypoT) has been associated with loss of the al-
pha-rhythm during electroencephalography (EEG) examination, cerebellar ataxia, confusion, 
delusions, memory impairment, hallucinations and psychotic behaviour (Adams and Rosman, 
1971; Hall et al., 1986). On the contrary, in the case of hyperthyroidism (HyperT), symptoms 
include irritability, nervousness, anxiety, sleep disturbances, tremulousness and increased 
frequency of the alpha-rhythm during EEG examination, even delirium, stupor and coma (Hall 
et al., 1986). An overview of important neuropsychiatric effects of HyperT and HypoT, in 
terms of observed symptoms and pathological states occurring in clinical practice, is provid-
ed in Table A.1. 
Acetylcholinesterase (AChE, EC 3.1.1.7) is a cholinergic enzyme, the role of which is 
very important in the acetylcholine (ACh) cycle, including the release of ACh (Kouniniotou-
Krontiri and Tsakiris, 1989). It is the enzyme which degrades ACh to choline (Ch) and an ace-
tate. This cholinergic enzyme is characterized by a very high catalytic activity, and its activity 
serves to terminate synaptic transmission and enhance Ch recycling. In addition, AChE has 
been reported to be co-released from the dopaminergic neurons, implying an interaction be-
tween these two molecules (a phenomenon which is important for the dopaminergic func-
tion) (Klegeris et al., 1995).  
Sodium-potassium adenosine triphosphatase (Na+,K+-ATPase, EC 3.6.3.9, formerly EC 
3.6.1.3) is a transmembrane enzyme implicated in neuronal excitability (Sastry and Phillis, 
1977), metabolic energy production (Mata et al., 1980), as well as the uptake and release of 
catecholamines (Bogdanski et al., 1968; Swann, 1984) and serotonin (5-HT) (Hernández, 
1987). It is responsible for the maintenance of the neuronal membrane potential, since it 
pumps three sodium ions (Na+) out of the cell for every two potassium ions (K+) pumped in, 
via the consumption of adenosine triphosphate (ATP); indeed, the functioning of Na+,K+-
ATPase is responsible for a very large component of neuronal energy expenditure. Magnesi-
um adenosine triphosphatase (Mg2+-ATPase, EC 3.6.3.2, formerly EC 3.6.1.3) is also an ATP-
consuming enzyme that functions in order to maintain high brain intracellular magnesium 
ion (Mg2+) levels, changes of which can control the rates of protein synthesis and cell growth 
(Sanui and Rubin, 1982). 
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The aim of the work described and discussed in this chapter was to assess the total an-
tioxidant status (TAS), the protein concentration and the activities of AChE, Na+,K+-ATPase 
and Mg2+-ATPase in the brain of adult rats with experimentally-induced HyperT and HypoT. 
Male albino Wistar adult rats (six-month-old) were used in all experiments. The rats 
were housed at a maximum of four in a cage, at a constant room temperature (22 ± 1oC) un-
der a 12 h light : 12 h dark (light 08:00 - 20:00 h) cycle. Food and water were provided ad 
libitum. Animals were cared for in accordance with the principles of the “Guide to the Care 
and Use of Experimental Animals” (Committee on the Care and Use of Laboratory Animals, 
1985). 
Experimental simulation of HyperT was induced in rats by thyroxine (T4, Figure A.1.a) 
administration. Firstly, T4 (Sigma, St. Louis MO) was dissolved in 99% (v / v) ethanol (EtOH) 
by adding a small volume (20 μL) of 25% sodium hydroxide (NaOH) and diluted 33 times by 
adding 0.9% sodium chloride (NaCl) to obtain a stock solution of 1 mg / mL. Before each in-
jection, a fresh solution was made in 0.9% NaCl in order to obtain a concentration of T4 of 50 
μg / mL. In the current study, T4 at a dose of 25 μg / 100 g of body weight was given subcuta-
neously, once daily for 14 days.  
Conversely, HypoT was induced in rats by administration of 6-n-propyl-2-thiouracil 
(PTU, Figure A.1.b) in drinking water at a final concentration of 0.05% for 21 days. Each 
treatment results in a long-term moderate HyperT (Pantos et al., 1999) or HypoT (Pantos et 
al., 2003). Two controls were used: (a) saline controls (SC) that were treated with subcutane-
ous injections of normal saline given once daily for a period of 14 days (control of HyperT 
rats), and (b) controls without any treatment (NTC) for 21 days (control for HypoT rats). 
The animals were killed by decapitation and their whole brains were rapidly removed. 
The tissue was homogenised in 10 volumes of ice-cold (0-4oC) medium containing 50 mM 
Tris (hydroxymethyl) aminomethane-hydrochloride (Tris-HCl), pH 7.4 and 300 mM sucrose, 
using an ice-chilled glass-homogenising vessel at 900 rpm (4-5 strokes). Subsequently, the 
homogenate was centrifuged at 1,000 × g for 10 min in order to remove nuclei and debris 
(Tsakiris, 2001; Tsakiris et al., 2000). In the resulting supernatant, the protein content was 
determined according to the method of Lowry et al. (1951), and then the enzyme activities as 
well as the TAS were measured. 
The TAS was evaluated in each fresh homogenised rat brain. It was measured spectro-
photometrically by a commercial kit (Randox Laboratories Ltd., Cat No NX2332), as previous-
ly reported (Carageorgiou et al., 2004; Tsakiris et al., 2000). 2,2'-Azino-di-[3-
ethylbenzthiazoline sulphonate (ABTS) was incubated with a peroxidase (metmyoglobin) and 
H2O2 in order to produce the radical cation ABTS•+. The latter has a relatively stable blue-
green colour, which was monitored at a wavelength of 600 nm. This determination took place 
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in order to estimate the possible free-radical production (low TAS) or the possible protective 
role of free-radical-scavenging enzymes (high TAS value) in the brain. 
The activity of AChE was determined by monitoring the hydrolysis of acetylthiocholine 
according to the method of Ellman et al. (1961), as described by Tsakiris (2001). The incuba-
tion mixture (1 mL) contained 50 mM Tris-HCl, pH 8, 240 mM sucrose, and 120 mM NaCl. The 
protein concentration of the incubation mixture was 80-100 μg / mL. The reaction was initi-
ated after addition of 0.03 mL of 5,5'-dithionitrobenzoic acid (DTNB), and 0.05 mL of 
acetylthiocholine iodide, which was used as a substrate. The final concentration of DTNB and 
substrate were 0.125 and 0.5 mM, respectively. The reaction was followed spectrophotomet-
rically by the increase in absorbance (ΔOD) at 412 nm over a period of 120 sec. 
The activity of Na+,K+-ATPase was calculated from the difference between total ATPase 
activity (Na+,K+,Mg2+-dependent ATPase) and Mg2+-dependent ATPase activity. Total ATPase 
activity was assayed in an incubation medium consisting of 50 mM Tris-HCl, pH 7.4, 120 mM 
NaCl, 20 mM potassium chloride (KCl), 4 mM magnesium chloride (MgCl2), 240 mM sucrose, 1 
mM ethylenediamine tetraacetic acid dipotassium-salt (K+-EDTA), 3 mM disodium ATP, and 
80-100 μg protein of the homogenate in a final volume of 1 mL. Ouabain (1 mM) was added in 
order to determine the activity of Mg2+-ATPase. The reaction was initiated by adding ATP, and 
stopped after an incubation period of 20 min by the addition of a 2 mL mixture of 1% lubrol 
and 1% ammonium molybdate in 0.9 M sulphuric acid (H2SO4) (Bowler and Tirri, 1974; Tsa-
kiris, 2001). The yellow colour which developed was read at a wavelength of 390 nm. 
Data acquired were analyzed by a two-tailed Student’s t-test; p values of <0.05 were 
considered statistically significant. 
The effects of experimentally-simulated HyperT and HypoT on rats' body weight are 
summarised in Table A.2. The rats belonging to the HyperT group showed a non-statistically-
significant decrease in their body weight (-9%, p>0.05) when compared with their respective 
controls (SC group). However, the rats belonging to the HypoT group underwent a statistical-
ly-significant decrease in their body weight (-38%, p<0.001) when compared with their re-
spective controls (NTC group). Table A.3 summarises the effects of experimentally-simulated 
HyperT and HypoT on the rats' brain weight, where no significant differences were observed. 
Figure A.2 presents brain TAS values of control groups’ rats, and those of the HyperT 
and HypoT groups. There were no statistically-significant changes observed in the brain TAS 
of the HyperT group animals, whilst a 20% increase (p<0.001) was observed in those under-
going experimental simulation of HypoT (when compared with their respective controls). 
Figure A.3 illustrates the total brain protein concentration values observed in the above 
treatment groups. Protein concentration was found unaltered (p>0.05) in the HyperT rat 
brain samples, whilst it was found inhibited by 35% (p<0.001) in HypoT ones (when com-
pared with their respective controls). 
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Tables A.4, A.5 and A.6 synopsise the effects of experimentally-simulated HyperT and 
HypoT on the adult rat brain AChE, Na+,K+-ATPase and Mg2+-ATPase activities, respectively. 
Indeed, decreased brain AChE activity was observed in both HyperT (-25%, p<0.001) and 
HypoT (-24%, p<0.001) animals. In addition, Na+,K+-ATPase activity was found decreased by 
27% (p<0.01) in the HyperT group and increased by 33% (p<0.001) in the HypoT group rat 
brains. Adult rat brain Mg2+-ATPase activity was found to be unaffected by the experimental 
induction of HyperT (p>0.05), and also to be statistically-significantly activated by HypoT 
(+21%, p<0.001). 
A strong relationship appears to exist between the CNS and THs. Certain metabolic re-
actions increase in parallel with the development of HyperT, such as those affecting the mito-
chondrial respiratory enzyme activities (Dembri et al., 1983) and acetate metabolism (Chapa 
et al., 1995). Laboratory animals that develop HyperT appear to have a shorter lifespan and, 
at an advanced age, present a myelin deficit. This may be attributable to the damage pro-
duced by the oxidative stress generated from an excess of THs (Pasquini and Adamo, 1994). 
However, this brain oxidative stress (inhibited TAS) was not found in the HyperT group of the 
current study (Figure A.2). It is likely that free-radical production is counteracted by the in-
creased activities of brain radical scavenging enzymes, such as CAT, SOD and GSH-Px (Mano 
et al., 1995) as part of an adaptive mechanism, or may be ascribable to the fact that the brain 
does not respond to the calorigenic effect of THs (Hardman et al., 2001; Silva, 1995) under 
the experimental conditions employed. 
In HypoT, brain TAS was found to be enhanced (Figure A.2). This may be attributable 
to decreased metabolic reactions and the subsequent low generation of free radicals 
(Swaroop and Ramasarma, 1985), as well as to the stimulated activity of total SOD and GSH-
Px (Mano et al., 1995) and / or the high activity of G-6-PD (Yilmaz et al., 2003). In addition, it 
has been proposed that HypoT provides in vivo protection against free radical-induced dam-
age, as well as that this cellular defence mechanism may be acting differently from antioxi-
dant defence systems (Venditti et al., 1997). However, Yilmaz et al. (2003) have concluded 
that HypoT, produced via intraperitoneal administration of PTU for 15 days, may cause pe-
roxidation in the tissues of 1- and 2-month-old female rats. It should be noted that in the cur-
rent experiments, adult male rats were used and received 0.05% PTU for a period of 3 weeks. 
In the study of Yilmaz et al. (2003), G-6-PD activities did not change in the brain of 30-day-old 
rats, but increased in the 60-day-old animals. It seems likely that antioxidant enzyme activi-
ties in experimentally-simulated HypoT depend on several factors such as sex, age and tissue 
class, as well as on the severity of the induced HypoT. Hence, this subject certainly requires 
further study. 
Brain protein concentration remained unaltered under our employed conditions of ex-
perimentally-simulated HyperT (Figure A.3), an observation possibly attributable to the unaf-
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fected TAS. In contrast, the observed diminished protein concentration arising in HypoT 
could be a result of a diminished protein synthesis during the lower metabolic rate expected 
in this condition. 
The effects induced by alterations of the thyroid state on rat brain AChE remain largely 
unknown. Virgili et al. (1991) have reported a decreased AChE activity in the prefrontal cor-
tex and in the striatum of HypoT rats. A decreased AChE activity was also found in the current 
study (Table A.4), but in the whole brain of adult rats. In HyperT, a decrease in the whole 
brain AChE activity was observed (Table A.4), whilst Almeida and Santos (1993) found no 
change in AChE activity in T3-treated rats. In addition, Smith et al. (2002), who employed a 
different treatment protocol of T4 administration (2.5 mg / kg daily for 4 days and 5 or 10 mg 
/ kg every third day for 28 days, intraperitoneally), found an increased AChE activity in both 
the frontal cortex and the hippocampus in the first dosage regiment (4 days). However, this 
enzyme activity was shown to be increased only in the hippocampus in the second dosage 
regimen (28 days). In our current experimental study, a different dose and way of admin-
istration of T4 (0.25 mg / kg daily for 14 days, subcutaneously) was used and produced mod-
erate HyperT, whilst AChE activity was measured in the whole rat brain homogenate. Provid-
ing that AChE is the degrading enzyme of ACh, one could speculate that T4 improves learning 
and memory in view of the inhibition of AChE, via the increase in ACh levels in the synaptic 
cleft. However, this cannot explain the decreased AChE activity in the HypoT group rat brains, 
to which diminished learning and memory functions are expected (Gerges et al., 2004). Not-
withstanding, Smith et al. (2002) suggested that the increased cholinergic activity by T4 ad-
ministration improves cognitive performance. In this case, the degree of HyperT may be re-
lated to the nature of the changes occurring in the examined enzyme activities. The observed 
inactivated AChE in HypoT rat brains may arise from the decreased protein concentration, 
possibly inducing a long-term diminution of the number of the active enzyme molecules in 
the membrane. In contrast, the observed inhibited AChE activity in the HyperT rat brains 
(Table A.4) might result from a T4-induced increase of intracellular calcium ions (Ca2+) (Ern-
est, 1989), which results in synaptosomal membrane changes and modulation of the lipid(s)-
protein interaction(s). 
The observed inhibition of brain Na+,K+-ATPase by HyperT (Table A.5) may also be as-
cribable to the increase of intracellular Ca2+ by T4 (Ernest, 1989). In contrast, the increased 
activity of Na+,K+-ATPase in HypoT could be related to the observed increase in TAS (Tsakiris 
et al., 2000). Changes in brain Na+,K+-ATPase activity have been associated with modulations 
of brain electrical activity (EEG) (Abdel-Latif et al., 1967). Therefore, the opposing changes of 
Na+,K+-ATPase activity observed with the above treatments might be related to the reported 
increased frequency of the alpha-rhythm of EEG in HyperT, and the loss of the alpha-rhythm 
in HypoT (Adams and Rosman, 1971; Hall et al., 1986). Additionally, the opposing changes of 
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Na+,K+-ATPase activity may differentially modulate the brain neural excitability (Sastry and 
Phillis, 1977), metabolic energy production (Mata et al., 1980), as well as the uptake and re-
lease of catecholamines (Bogdanski et al., 1968; Swann, 1984) and 5-HT (Hernández, 1987). 
The observed changes in brain Mg2+-ATPase activity (Table A.6) may be related to 
those observed in TAS (Figure A.2). The increased activity of Mg2+-ATPase in HypoT could be 
an adaptive mechanism that serves to maintain the brain intracellular Mg2+ at high levels, 
changes of which may modulate rates of protein synthesis and cell growth (Sanui and Rubin, 
1982). 
In conclusion, TAS, protein concentration and Mg2+-ATPase activity were found to be 
unaffected in the brain of adult male rats suffering from HyperT, whilst AChE and Na+,K+-
ATPase activities were found to be reduced. In contrast, TAS and the activities of Na+,K+-
ATPase and Mg2+-ATPase were found to be increased in the brains of adult rats suffering from 
HypoT, whilst AChE activity and protein concentration were shown to be decreased. These 
effects could be attributable to differences in metabolism and TAS values, as well as to differ-
ences in the intracellular Ca2+ and Mg2+ concentrations. Such changes in the enzyme activities 
may differentially modulate the brain neural excitability, as well as the uptake and release of 
biogenic amines. 
 
>> Tables A.1, A.2 and A.3: page 9 
>> Tables A.4, A.5 and A.6: page 10 
>> Figures A.1.a, A.1.b and A.2: page 11 
>> Figure A.3: page 12 
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Table A.1: Overview of the major neuropsychiatric effects of HyperT and HypoT in terms of 
observed symptoms and pathological states occurring in clinical practice. 
 
  
HyperT HypoT 
  
  
- agitation (in activated crisis) 
- apathy (in apathetic crisis) 
- coma (in thyrotoxic crisis) 
- confusional state (in thyrotoxic crisis) 
- death (in thyrotoxic crisis) 
- depression (in apathetic crisis) 
- exaggerated physiologic (action) tremor 
- hallucinations (in activated crisis) 
- hyperreflexia 
- psychosis (in activated crisis) 
- seizures 
 
- agitation  
- ataxia 
- coma (in myxedema or untreated HypoT) 
- confusional state (in myxedema) 
- deafness  
- delayed relaxation of the tendon reflexes 
- dementia (in myxedema) 
- dysarthria 
- flat affect 
- psychomotor retardation 
- psychosis  
- seizures (in untreated HypoT) 
  
 
Note: presented in alphabetical order. Data acquired by Aminoff et al. (2005). 
 
 
Table A.2: Effects of experimentally-simulated HyperT and HypoT on rat body weight. 
 
  
Experimental group Body weight (g) 
  
  
Saline control (SC)  353 ± 35   |   --- 
Hyperthyroid (HyperT)  320 ± 26   |   -9% (NS) vs SC 
Non-treated control (NTC)  340 ± 30   |   --- 
Hypothyroid (HypoT)  210 ± 11   |   -38% (***) vs NTC 
  
 
Note: each value indicates the mean ± standard deviation (SD) of eight independent experiments (eight rats, n = 
8). NS: non-statistically-significant; ***: p<0.001. There is no statistically-significant difference between the two 
control groups (SC and NTC). 
 
 
Table A.3: Effects of experimentally-simulated HyperT and HypoT on rat brain weight. 
 
  
Experimental group Brain weight (g) 
  
  
Saline control (SC)  1.761 ± 0.098   |   --- 
Hyperthyroid (HyperT)  1.819 ± 0.082   |   +3% (NS) vs SC 
Non-treated control (NTC)  1.819 ± 0.082   |   --- 
Hypothyroid (HypoT)  1.816 ± 0.100   |   -0% (NS) vs NTC 
  
 
Note: each value indicates the mean ± SD of eight independent experiments (eight rats, n = 8). NS: non-
statistically-significant. There is no statistically-significant difference between the two control groups (SC and 
NTC). 
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Table A.4: Effects of experimentally-simulated HyperT and HypoT on rat brain AChE activity. 
 
  
Experimental group AChE activity (ΔOD / min x mg protein) 
  
  
Saline control (SC)  1.108 ± 0.036   |   --- 
Hyperthyroid (HyperT)  0.831 ± 0.042   |   -25% (***) vs SC 
Non-treated control (NTC)  1.126 ± 0.030   |   --- 
Hypothyroid (HypoT)  0.853 ± 0.051   |   -24% (***) vs NTC 
  
 
Note: each value indicates the mean ± SD of eight independent experiments (eight rats, n = 8). The average of each 
experiment arose from three evaluations in the homogenised brain tissue of each animal. ***: p<0.001. There is no 
statistically-significant difference between the two control groups (SC and NTC). 
 
 
Table A.5: Effects of experimentally-simulated HyperT and HypoT on the activity of rat brain 
Na+,K+-ATPase. 
 
  
Experimental group Na+,K+-ATPase activity (μmol Pi / h x mg protein) 
  
  
Saline control (SC)  6.32 ± 0.38   |   --- 
Hyperthyroid (HyperT)  4.61 ± 0.41   |   -27% (***) vs SC 
Non-treated control (NTC)  6.17 ± 0.30   |   --- 
Hypothyroid (HypoT)  8.22 ± 0.66   |   +33% (***) vs NTC 
  
 
Note: each value indicates the mean ± SD of eight independent experiments (eight rats, n = 8). The average of each 
experiment arose from three evaluations in the homogenised brain tissue of each animal. ***: p<0.001. There is no 
statistically-significant difference between the two control groups (SC and NTC). 
 
 
Table A.6: Effects of experimentally-simulated HyperT and HypoT on rat brain Mg2+-ATPase 
activity. 
 
  
Experimental group Mg2+-ATPase activity (μmol Pi / h x mg protein) 
  
  
Saline control (SC)  08.31 ± 0.66   |   --- 
Hyperthyroid (HyperT)  07.98 ± 0.79   |   -4% (NS) vs SC 
Non-treated control (NTC)  08.65 ± 0.50   |   --- 
Hypothyroid (HypoT)  10.47 ± 0.84   |   +21% (***) vs NTC 
  
 
Note: each value indicates the mean ± SD of eight independent experiments (eight rats, n = 8). The average of each 
experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-statistically-
significant; ***: p<0.001. There is no statistically-significant difference between the two control groups (SC and 
NTC).  
 
 
Zarros AC | PhD Thesis (by published work / retrospective) in Neuroscience  11
 
Figure A.1.a: Chemical structure of T4, used for the experimental simulation of HyperT. 
 
 
 
 
 
Note: T4 is a prohormone and a reservoir for the active TH, triiodothyronine (T3), which is about four times more 
potent; T4 is involved in controlling the rate of metabolic processes in the body and influencing physical develop-
ment. 
 
Figure A.1.b: Chemical structure of PTU, used for the experimental simulation of HypoT. 
 
 
 
 
 
Note: PTU inhibits thyroperoxidase (which normally acts in thyroid hormone synthesis by oxidising the anion 
iodide to iodine, facilitating iodine’s addition to tyrosine residues on thyroglobulin; this being one of the essential 
steps in the formation of T4) and also inhibits 5'-deiodinase (which converts T4 to the active T3). PTU is a thioam-
ide drug used to treat HyperT, by decreasing the amount of THs produced by the thyroid gland. 
 
 
Figure A.2: Effects of experimentally-simulated HyperT and HypoT on rat brain TAS. 
 
 
 
 
 
Note: each value indicates the mean ± SD of eight independent experiments (eight rats, n = 8). The average of each 
experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-statistically-
significant; ***: p<0.001; when compared with their respective control values. There is no statistically-significant 
difference between the two control groups (SC and NTC). 
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Figure A.3: Effects of experimentally-simulated HyperT and HypoT on rat brain protein con-
centration. 
 
 
 
 
 
Note: each value indicates the mean ± SD of eight independent experiments (eight rats, n = 8). The average of each 
experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-statistically-
significant; ***: p<0.001; when compared with their respective control values. There is no statistically-significant 
difference between the two control groups (SC and NTC). 
  
CHAPTER II 
 
Contribution to the study of thioacetamide-induced  
fulminant hepatic encephalopathy* 
 
Fulminant hepatic failure is a rare condition characterised by a sudden onset of hepatocyte 
necrosis, generally occurring within hours or days (O’Grady et al., 1993), and is attributable 
to viral hepatitis, or drug- or chemical-induced liver injury (Lee, 1993). This condition is ac-
companied by a neuropsychiatric multi-staged disorder, known as “hepatic encephalopathy” 
(Albrecht and Jones, 1999). In its acute (due to fulminant hepatic failure) form, hepatic en-
cephalopathy can cause a wide spectrum of phenomena (from altered mental status, delirium 
to stupor and coma), and can rapidly lead to the development of brain edema (with high in-
tracranial pressure, often resulting in brain herniation) and death (Hazell and Butterworth, 
1999). 
There are a variety of experimental methods used for the induction of fulminant hepat-
ic failure in rats; one of the most commonly utilised is by the administration of large doses of 
the hepatotoxicant thioacetamide (TAA; Figure A.4) (Chilakapati et al., 2007). Following TAA-
administration, metabolites derived therefrom induce hepatic necrosis (Porter and Neal, 
1978), hyperammonemia (Hilgier and Olson, 1994) and oxidative stress (Reddy et al., 2004). 
Moreover, the TAA-induced fulminant hepatic failure in rats serves as a good experimental 
model for the study of fulminant hepatic encephalopathy (since it produces crucial cerebral 
metabolic changes encountered in clinical practice) (Sathyasaikumar et al., 2007). 
Ammonia is considered to be the main causative factor of hepatic encephalopathy 
(Cooper and Plum, 1987), since its excessive accumulation in the brain is known to cause a 
wide variety of toxic effects on both excitatory and inhibitory neurotransmission (Szerb and 
Butterworth, 1992; Zielińska et al., 2002). However, it is not the only factor involved in the 
pathophysiological mechanisms that are responsible for the clinical signs of hepatic encepha-
lopathy: false neurotransmitters, altered aromatic amino acid metabolism, and oxidative 
phenomena are also implicated in this enigmatic and life-threatening state (Butterworth, 
                                                 
* modified-version of the article by Zarros et al., entitled: “Effects of fulminant hepatic encephalopathy 
on the adult rat brain antioxidant status and the activities of acetylcholinesterase, (Na+,K+)- and Mg2+-
ATPase: comparison of the enzymes’ response to in vitro treatment with ammonia”, published in Meta-
bolic Brain Disease 2008; 23(3): 255-264. 
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2002). In view of this, a significant amount of research has focused on the effects of fulminant 
hepatic encephalopathy on crucial neuromodulating factors, neurotransmission systems and 
membrane-bound enzyme activities (Felipo and Butterworth, 2002; Swapna et al., 2007; 
Zielińska et al., 2002; Zimmermann et al., 1989). 
The aim of the work described and discussed in this chapter was to shed more light on 
the effects of TAA-induced fulminant hepatic encephalopathy on: (a) the adult rat brain TAS 
and (b) the activities of AChE and two important adenosine triphosphatases (Na+,K+-ATPase 
and Mg2+-ATPase). Moreover, an attempt has been made to evaluate the possible role of am-
monia in the observed effects of TAA-induced fulminant hepatic encephalopathy on the 
above-mentioned adult rat brain enzyme activities (via the performance further in vitro ex-
periments). 
Albino Wistar adult male rats (four-month-old) were used in all experiments. The rats 
were housed at a maximum of four in a cage, at a constant room temperature (22 ± 1oC) un-
der a 12 h light : 12 h dark (light 08:00 - 20:00 h) cycle. Food and water were provided ad 
libitum. Animals were cared for in accordance with the principles of the “Guide to the Care 
and Use of Experimental Animals” (Committee on the Care and Use of Laboratory Animals, 
1985), under Institutional approval. 
For the induction of fulminant hepatic encephalopathy, intraperitoneal injections of 
TAA at a dosage of 400 mg / kg of body weight at three consecutive time intervals of 24 h 
were used (Larsen et al., 1994; Zimmermann et al., 1989). The stage of hepatic encephalopa-
thy of the TAA-treated rats was determined 1 h after the third injection of TAA (right before 
decapitation), by a neurobehavioral scale: stage 1 (lethargy), stage 2 (mild ataxia), stage 3 
(lack of spontaneous movement and loss of righting reflex, but still responsive) or stage 4 
(coma and lack of response to pain) (Margeli et al., 2003; Mullen, 1988). 
The animals were killed by decapitation and their whole brains were rapidly removed. 
The tissue was homogenised in 10 volumes of ice-cold (0-4oC) medium containing 50 mM 
Tris-HCl, pH 7.4 and 300 mM sucrose, using an ice-chilled glass-homogenising vessel at 900 
rpm (4-5 strokes). Subsequently, the homogenate was centrifuged at 1,000 × g for 10 min in 
order to remove nuclei and debris (Tsakiris, 2001; Tsakiris et al., 2000). In the resulting su-
pernatant, the protein content was determined according to the method of Lowry et al. 
(1951), and then the enzyme activities as well as the TAS were measured (following the same 
methodology described in Chapter I). 
In the in vitro experiments, the enzymatic activity measurements were performed on 
homogenised rat whole brains. The activities were determined after incubation of 0.1 mg of 
homogenised brain protein (acquired from control rats) with ammonium chloride (NH4Cl; 3 
mM) for 3 h. This in vitro concentration of NH4Cl is considered as toxic (Faff-Michalak and 
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Albrecht, 1991; 1993b), and is used in order to simulate the increased brain ammonia levels 
in hepatic encephalopathy.  
Obtained data were analyzed by a two-tailed Student’s t-test; p values of <0.05 were 
considered statistically significant. 
The induction of fulminant hepatic encephalopathy was considered as successful 
through the previously described approach, as all TAA-treated rats (n = 7) presented the he-
patic encephalopathy symptoms, scaled as stage 2 (n = 1), stage 3 (n = 3) and stage 4 (n = 3).  
Figure A.5 presents the TAS values observed in the brain homogenates of the two ex-
perimental groups. The TAS values were significantly reduced in the TAA-treated rat brain 
homogenates (-22%, p<0.001). Moreover, TAA-induced fulminant hepatic encephalopathy 
caused a significant decrease in the activity of Na+,K+-ATPase (-26%, p<0.001), but had non-
significant effects on the whole brain AChE and Mg2+-ATPase activities (Table A.7). A slight 
but insignificant reduction (-5%, p>0.05) was recorded regarding the protein concentration 
of the TAA-treated rat brain homogenates (results not shown). 
The in vitro experiments (conducted through a 3 h incubation with ammonia) showed 
no significant alterations in any of the examined parameters (Table A.8). However, the TAA-
treated rat brain samples that were also incubated for the same time-period, re-established 
our in vivo findings (Table A.8). 
Our experimental findings confirmed the induction of oxidative stress by TAA-induced 
fulminant hepatic failure in the rat brain (Figure A.5); ROS are thought to play a vital role in 
the pathogenesis of hepatic encephalopathy (Slater, 1984), where CAT and GSH-Px activities 
have been recently found decreased in rat brain region experiments (Sathyasaikumar et al., 
2007). This inhibition in the antioxidant defense system is accompanied by a higher rate of 
lipid peroxidation (Sathyasaikumar et al., 2007), an increase of SOD-induced H2O2 production 
(Reddy et al., 2004), and a vulnerability to ROS in view of a high iron ion accumulation (Hal-
liwell, 1992; Sathyasaikumar et al., 2007). The overall effect of these oxidative phenomena is 
to provoke cellular deregulation and cell-membrane-protein degradation (García et al., 1997), 
thus affecting the activity of several membrane-bound enzymes (involved in crucial metabolic 
and / or neuroregulating pathways). 
Although several effects on important neuroregulating factors have been reported as 
being ascribable to TAA-induced hepatic encephalopathy (Felipo and Butterworth, 2002; 
Swapna et al., 2007; Zielińska et al., 2002; Zimmermann et al., 1989), few studies have ad-
dressed the cholinergic system of neurotransmission. Experimental animals that underwent 
hyperammonemic convulsions revealed diminished concentrations of brain ACh (Takahashi 
et al., 1961; Ulshafer, 1958). However, acute hyperammonemia and postcaval shunting did 
not provoke any changes in rat brain ACh levels (Parker et al., 1977; Walker et al., 1971). 
Such contradictory findings are also reported regarding membrane-bound AChE activity. The 
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latter has been shown to be decreased (Kosenko et al., 1994; Swapna et al., 2007), increased 
(Devi and Murthy, 1993; Sadasivudu et al., 1983) and unaltered (Faff-Michalak and Albrecht, 
1993a; Rao et al., 1994). The above studies are characterised by a wide heterogeny as con-
cerns: (a) the samples used, (b) the brain regions or sub-regions studied, (c) the in vivo exper-
imental procedures followed for the simulation of hepatic encephalopathy, and (d) the bio-
chemical determinations and methodological procedures followed. 
In order to shed more light on what really happens in rat brains undergoing fulminant 
hepatic encephalopathy, both in vivo (TAA-induced) and in vitro (NH4Cl-induced) simulation 
studies were conducted. Both studies (Tables A.7 and A.8) have shown that no significant 
modifications are taking place regarding the activity of whole rat brain AChE. These findings 
are in accordance with those of Rao et al. (1994) (conducted on frontal and temporal cortex, 
cerebellum and caudate nucleus obtained from alcoholic cirrhotic patients who died in hepat-
ic coma), as well as with those of Faff-Michalak and Albrecht (1993a) (conducted on rat cere-
bral homogenates that underwent repeated treatment with ammonium acetate or TAA-
induced hepatic failure). However, our findings are not in accordance with the decreased 
AChE activity reported by Kosenko et al. (1994) (since their findings refer to acute exposure 
to ammonium acetate and very high in vitro concentrations of ammonia), nor with the de-
creased cerebral cortex AChE activity reported by Swapna et al. (2007) (since a different ex-
perimental protocol was applied and their results relate to a time-dependent variation of 
AChE activity). 
Although our experimental data are supportive of the view that the cholinergic brain 
function remains intact in fulminant hepatic encephalopathy, we should not neglect the fact 
that the cholinergic system is only a part of the total neurotransmission complex that consti-
tutes our CNS and serves our basic and higher functions. The unaltered rat brain AChE activi-
ty cannot exclude a possible deregulation of the cholinergic function ascribable to edema, 
metabolic changes, neuroregulating interactions and / or excitation dysfunction as a result of 
the effects of ammonia and hepatic failure on other systems of neurotransmission. 
The decreased activity of whole rat brain Na+,K+-ATPase found in vivo (Table A.7) but 
not in vitro (Table A.8), is indicative of a non-ammonia-dependent effect of fulminant hepatic 
failure that may be implicated in rat brain excitability (Sastry and Phillis, 1977), metabolic 
energy production (Mata et al., 1980) and the uptake and release of catecholamines (Bogdan-
ski et al., 1968; Swann, 1984), 5-HT (Hernández, 1987) and glutamate (Lees et al., 1990). This 
finding is not in accordance with that of Albrecht et al. (1985) suggesting an increased Na+,K+-
ATPase activity in astroglial fractions and a stable (when compared with controls) Na+,K+-
ATPase activity in synaptosomes of early-stage TAA-induced hepatic encephalopathy. It is, 
however, a finding that is compatible with the reports on the inhibitory properties of the sera 
acquired by patients with fulminant hepatic failure on the activity of this crucial enzyme 
Zarros AC | PhD Thesis (by published work / retrospective) in Neuroscience  17
(Seda et al., 1984a; 1984b; 1984c). Moreover, Na+,K+-ATPase activity is also found decreased 
in the rat forebrain and hindbrain regions after D-galactosamine-induced hepatic failure (Ede 
et al., 1987), as well in rat liver plasma membrane preparations following TAA-
administration (Dwivedi et al., 1993; Nikolaev et al., 1988). One cannot exclude a possible 
stimulation of Na+,K+-ATPase in certain cell types, such as astrocytes (where ammonia substi-
tution for K+ could provoke increased cytoplasmic osmolarity, resulting in a swollen cellular 
appearance) (Pilbeam et al., 1983; Wall and Koger, 1994). However, the observed whole rat 
brain Na+,K+-ATPase inhibition attributable to fulminant hepatic encephalopathy should not 
arise from brain ammonia accumulation (Table A.8), but a possible result of (a) oxidative 
stress (Tsakiris et al., 2000), (b) neurotransmission deregulation (Butterworth, 2002), and / 
or (c) other hepatogenic factors spread through serum and reaching the brain (thus provok-
ing direct or indirect Na+,K+-ATPase inhibition) (Ede et al., 1987). 
With regard to the activity of Mg2+-ATPase, no statistically-significant changes were 
observed in either in vivo or in vitro (Tables A.7 and A.8, respectively) conditions. An experi-
mental simulation of hepatic failure causes a decrease in liver Mg2+-ATPase activity (Dwivedi 
et al., 1993; Nikolaev et al., 1988), but does not seem to affect the brain Mg2+-ATPase activity 
(Rozhanets et al., 1979). Since Mg2+-ATPase is an enzyme functioning in order to maintain 
high brain intracellular Mg2+, and thus possibly controlling the rate of protein synthesis and 
cell growth (Sanui and Rubin, 1982), its intact function under the examined experimental 
conditions might be a reason for the maintenance of a stable brain protein concentration, as 
observed in our experiment (data not shown). 
In conclusion, the herein presented in vivo and in vitro findings suggest that alterations 
in AChE and Mg2+-ATPase activities are not involved in the pathophysiology of the adult-onset 
fulminant hepatic encephalopathy, while the observed Na+,K+-ATPase inhibition could arise 
as a result of the observed TAA-induced oxidative stress, neurotransmission deregulation, 
and / or of the presence of other toxic substances (that appear to act as direct or indirect in-
hibitors of the enzyme) and not ascribable to the excess accumulation of ammonia in the rat 
brain. 
 
>> Tables A.7 and A.8: page 18 
>> Figures A.4 and A.5: page 19 
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Table A.7: Effects of TAA-induced fulminant hepatic encephalopathy on adult rat brain en-
zyme activities. 
 
   
 Experimental group 
  
  
 Control (C) TAA-treated 
   
   
AChE activity  
(ΔOD / min x mg protein) 
0.587 ± 0.037 
--- 
0.633 ± 0.044 
+8% (NS) vs C 
   
   
Na+,K+-ATPase activity 
(μmol Pi / h x mg protein) 
1.51 ± 0.12 
--- 
1.12 ± 0.07 
-26% (***) vs C 
   
   
Mg2+-ATPase activity 
(μmol Pi / h x mg protein) 
5.74 ± 0.57 
--- 
6.25 ± 0.60 
+9% (NS) vs C 
   
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-
statistically-significant; ***: p<0.001. 
 
 
Table A.8: Effects of a 3 h in vitro incubation with NH4Cl (3 mM) on adult rat brain enzyme 
activities: correlation with those of the TAA-treated adult rats. 
 
                      
 Incubation group 
  
  
 Control (C) C + [NH4Cl] TAA-treated 
    
    
AChE activity  
(ΔOD / min x mg protein) 
0.609 ± 0.030 
--- 
0.658 ± 0.036 
+8% (NS) vs C 
0.665 ± 0.038 
+9% (NS) vs C 
    
    
Na+,K+-ATPase activity 
(μmol Pi / h x mg protein) 
1.72 ± 0.12 
--- 
1.57 ± 0.11 
-9% (NS) vs C 
1.20 ± 0.09 
-30% (***) vs C 
    
    
Mg2+-ATPase activity 
(μmol Pi / h x mg protein) 
3.22 ± 0.41 
--- 
3.47 ± 0.35 
+8% (NS) vs C 
3.71 ± 0.43 
+15% (NS) vs C 
    
 
Note: each value indicates the mean ± SD of four different experiments. NS: non-statistically-significant; ***: 
p<0.001. 
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Figure A.4: Chemical structure of TAA, used for the experimental induction of fulminant he-
patic encephalopathy. 
 
 
 
 
 
Note: TAA is a water-soluble organosulfur compund that serves as a source of sulfide ions in the synthesis of or-
ganic and inorganic compounds. It is a carcinogen class 2B, known to produce marked hepatotoxicity in exposed 
animals (a property for which it is currently widely used for the experimental simulation of hepatic diseases). 
 
 
Figure A.5: Effects of TAA-induced fulminant hepatic encephalopathy on adult rat brain TAS. 
 
 
 
 
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. ***: p<0.001; when 
compared with control (C) values.  
 
 
 
 
 
  
CHAPTER III 
 
Contribution to the study of streptozotocin-induced  
diabetic encephalopathy* 
 
Diabetes mellitus is a very common and heterogenous metabolic disorder, that is known to 
cause a variety of complications such as renal failure, blindness, limb amputation, neurologi-
cal complications, vascular complications of coronary artery disease, cerebrovascular disease 
and / or premature death (Cohen et al., 2007; Harati, 1996; Rolo and Palmeira, 2006). Un-
treated diabetes is not only a known and major risk factor for cerebral vascular diseases, but 
also the presence of hyperglycemia at the time of a cerebrovascular event may adversely in-
fluence the outcome (Harati, 1996). Moreover, diabetes mellitus is associated with moderate 
cognitive deficits and neurophysiological and structural changes in the brain, a condition that 
may be referred to as “diabetic encephalopathy” (Brands et al., 2003; Mijnhout et al., 2006). 
The multifactorial pathogenesis of diabetic encephalopathy is not yet completely un-
derstood, but clearly shares features with brain ageing and the pathogenesis of diabetic neu-
ropathy (Biessels et al., 2002; Gispen and Biessels, 2000), since it: (a) involves some (thought 
to be) direct neurotoxic effects of hyperglycemia, such as the generation of oxidative stress 
(Kumar and Menon, 1993), the enhanced formation of advanced glycation end-products (Ryle 
et al., 1997), as well as the disturbance of Ca2+ homeostasis (Levy et al., 1994), (b) includes 
vascular and cerebral blood flow alterations (Jakobsen et al., 1990), and (c) requires neu-
rotrophic and neuromodulatory changes (Gispen and Biessels, 2000; Wuarin et al., 1996). 
However, experimental approaches of this state have led to interesting but often contradicto-
ry findings (Gispen and Biessels, 2000); phenomena providing difficulties in revealing the 
exact pathophysiological background of diabetic encephalopathy. 
Experimental diabetes is usually produced in animals by high-dose beta-cytotoxic 
drug-administration, using drugs such as streptozotocin (STZ) or alloxan (AL) (Szkudelski, 
2001). Animal models have been widely used in order to study the effects of uncontrolled di-
abetes on brain physiology, and have already led to the conclusion that diabetes: (a) decreas-
es the rat brain antioxidant capacity (Tahirovic et al., 2007), (b) provokes extensive neuro-
                                                 
* modified-version of the article by Zarros et al., entitled: “Effects of adult-onset streptozotocin-induced 
diabetes on the rat brain antioxidant status and the activities of acetylcholinesterase, (Na+,K+)- and 
Mg2+-ATPase: modulation by L-cysteine”, published in Metabolic Brain Disease 2009; 24(2): 337-348. 
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chemical and structural changes (Brands et al., 2003; Chu et al., 1986; Wahba and Soliman, 
1988), while, (c) causes learning and memory deficits that are preventable by the administra-
tion of certain antioxidants (Kamboj et al., 2008; Kuhad and Chopra, 2007). 
The aim of the work described and discussed in this chapter was to shed more light on 
the effects of adult-onset STZ-induced diabetes on: (a) the adult rat brain TAS and (b) the ac-
tivities of AChE and two important adenosine triphosphatases (Na+,K+-ATPase and Mg2+-
ATPase). Moreover, since L-cysteine (Cys) is a well-known antioxidant and chelating agent 
(Carageorgiou et al., 2004), it was administered in diabetic rats in order to evaluate its effica-
cy on protecting the rat brain against the STZ-induced effects on the above parameters. In 
addition, in vitro experiments were considered as necessary, and were conducted in order to 
provide a clear view of the effects of Cys or STZ on the examined enzymes. 
Albino Wistar adult male rats (three-month-old, weighting 263 ± 28 g) were used in all 
experiments. The rats were housed at a maximum of four in a cage, at a constant room tem-
perature (22 ± 1oC) under a 12 h light : 12 h dark (light 08:00 - 20:00 h) cycle. Food and water 
were provided ad libitum. Animals were cared for in accordance with the principles for the 
care, use and protection of experimental animals as set by the European Economic Communi-
ty (EEC) Council Directive 86/609/EEC (EEC Council, 1986) and aligned according to the Euro-
pean Union (EU) Recommendation 2007/526/EU. 
Rats were divided into two main groups (C: control and D: diabetic). The rats belong-
ing to group D were injected with a single intraperitoneal dose of STZ (50 mg / kg of body 
weight, diluted in a 0.1 mol / L citrate solution, pH 4.5; Figure A.6.a) to induce diabetes (Bilg-
inoglu et al., 2007), while those belonging to group C were injected with the citrate buffer 
medium. Figure A.7 presents the in vivo experimental protocol that was followed. Rats were 
killed 8 weeks after the injection of STZ or buffer (groups DA and CA, respectively), while oth-
ers (presented in Figure A.7) were killed 9 weeks after the injection of STZ or buffer. The 9-
week groups were injected intraperitoneally with saline (groups CB and DB) or Cys (groups 
C+Cys and D+Cys), once daily, during the 9th week. The administration of Cys (Figure A.6.b) 
was performed at a dosage of 7 mg / kg of body weight (Carageorgiou et al., 2005b). It should 
be noted that the diabetic status of the STZ-treated rats was systematically confirmed 
through the monitoring of 24 h urine volumes and glucose levels, as well as of 24 h food and 
water consumption (performed over all rat groups in metabolic cages, once every 2 weeks, at 
the end of the 2nd, 4th and 6th week following STZ-administration). 
The animals were killed by decapitation and their whole brains were rapidly removed. 
The tissue was homogenised in 10 volumes of ice-cold (0-4oC) medium containing 50 mM 
Tris-HCl, pH 7.4 and 300 mM sucrose, using an ice-chilled glass-homogenising vessel at 900 
rpm (4-5 strokes). Subsequently, the homogenate was centrifuged at 1,000 × g for 10 min in 
order to remove nuclei and debris (Tsakiris, 2001; Tsakiris et al., 2000). In the resulting su-
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pernatant, the protein content was determined according to the method of Lowry et al. 
(1951), and then the enzyme activities as well as the TAS were measured (following the same 
methodology described in Chapter I). 
In the in vitro experiments, the enzymatic activity measurements were performed on 
homogenised rat whole brains. The activities were determined after incubation of 0.1 mg of 
homogenised brain protein (acquired from control or diabetic rats; see Figure A.7) with STZ 
(10 mM) (Vesely et al., 1977) or Cys (0.83 mM) (Carageorgiou et al., 2004) for 3 h.  
Obtained data were analyzed by one-way analysis of variance (ANOVA), followed by 
Bonferroni’s post-hoc test, when required; p values of <0.05 were considered statistically sig-
nificant. All analyses were performed by SPSS for Windows Software. 
Table A.9 presents the effects of adult-onset STZ-induced diabetes on the brain TAS, as 
well as the changes produced by Cys administration. Table A.10 presents the respective ef-
fects regarding AChE activity. Diabetic rats exhibited a statistically-significant reduction in 
brain TAS (-28%, p<0.001, DA vs CA; -30%, p<0.001, DB vs CB) that was reversed after 1-week 
Cys-administration into basal levels (Table A.9). Diabetes caused a significant increase in 
AChE activity (+27%, p<0.001, DA vs CA; +15%, p<0.001, DB vs CB), that was further enhanced 
by Cys-administration (+57%, p<0.001, D+Cys vs CB) (Table A.10). The C+Cys group exhibited 
no significant difference compared with the CB group in TAS (+2%, p>0.05) (Table A.9), but 
showed a significantly increased AChE activity (+66%, p<0.001, C+Cys vs CB) (Table A.10). 
Tables A.11 and A.12 present the effects of adult-onset STZ-induced diabetes on the rat 
brain Na+,K+- and Mg2+-ATPase activities (respectively), as well as the modifications produced 
by Cys administration. Diabetic rats exhibited a significant reduction in the activity of Na+,K+-
ATPase (-36%, p<0.001, DA vs CA; -48%, p<0.001, DB vs CB) that was not reversed after 1-week 
of Cys administration (Table A.11). Mg2+-ATPase activity was not affected by STZ-induced 
diabetes, whilst Cys caused a significant inhibition of the enzyme (-14%, p<0.001, C+Cys vs 
CB; -17%, p<0.001, D+Cys vs CB) (Table A.12). 
The conducted in vitro experiments revealed that STZ (following a 3 h incubation) had 
no effect on the homogenised rat brain AChE (-2%, p>0.05, CB + [STZ] vs CB; results not 
shown), (Na+,K+)-ATPase (-3%, p>0.05, CB + [STZ] vs CB; Table A.13) or Mg2+-ATPase activities 
(+7%, p>0.05, CB + [STZ] vs CB; Table A.14). However, incubation with Cys partly reversed the 
diabetes-induced Na+,K+-ATPase inhibition (+33%, p<0.05, DB + [Cys] vs DB; Table A.13), 
whilst it caused a significant inhibition of Mg2+-ATPase (-16%, p<0.05, DB + [Cys] vs CB; Table 
A.14). 
Our experimental findings confirmed that adult-onset diabetes is an oxidative state 
that causes a statistically significant decrease of the rat brain TAS (Table A.9). Hyperglycemia 
is known to induce a disruption of the mitochondrial membrane potential and an increase in 
the formation of ROS (Tahirovic et al., 2007). This diabetes-induced oxidative stress has been 
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demonstrated to play an important role in the brain damage arising from diabetes, in both 
humans and animals suffering from this disease (Biessels et al., 2002). This damage is mainly 
caused by: (a) increased ROS formation, (b) increased lipid oxidation products’ levels, as well 
as (c) decreased CAT and SOD activities (Kumar and Menon, 1993; Ohkuwa et al., 1995). Our 
data revealed that Cys-administration can be a protective treatment against the diabetes-
induced oxidative stress occurring in the adult rat brain (Table A.9), since it can efficiently 
reverse the decreased (by diabetes) TAS levels back to those of the control group (CB). 
This is not the first study that evaluates the use of an antioxidant towards the oxidative 
effects induced by diabetes on the nervous system. Sesamol (3,4-methylenedioxyphenol) 
(Kuhad and Chopra, 2008), curcumin (Kuhad and Chopra, 2007), tetrahydrocurcumin (Pari 
and Murugan, 2007) and resveratrol (Ates et al., 2007) are agents that were recently success-
fully employed in order to modify oxidative stress in the brain of diabetic animal models. 
Such substances (along with Cys, that was used in our study) could serve as part of a potential 
neuroprotective treatment against diabetic neuropathy and / or encephalopathy, if their cen-
tral actions are studied in greater detail and are proved to be safe for other functional brain 
parameters. 
However, things are not so clear regarding the activity of brain AChE. A background of 
contradictory findings (mainly attributable to differing experimental protocols followed) has 
been reported in the literature, concerning the behaviour of this crucial cholinergic enzyme 
under (experimental) diabetic simulation. Some studies suggest that rat brain AChE activity is 
not significantly altered by STZ- (Leong and Leung, 1991; Ueyama et al., 2007) and AL-
induced diabetes (Mansour et al., 2002), while some reports refer to a reduced rat brain AChE 
activity due to diabetes (Ashokkumar et al., 2006; Ramkumar et al., 2005). Other authors re-
port an increase of rat brain region AChE activity (Wahba and Soliman, 1988), which is re-
cently reported to even reach a +80% increase in the cerebral cortex of diabetic rats (Kuhad 
and Chopra, 2007; 2008). These findings do not agree with those of a recent study by Kamboj 
et al. (2008), who report decreased AChE activity in the cerebral cortex, the cerebellum and 
the brain stem of STZ-induced diabetic rats. 
The induction of adult-onset STZ-induced diabetes in our study caused a statistically-
significant increase in rat brain AChE activity (Table A.10), 8 and 9 weeks after the induction 
of diabetes (Figure A.7). This increase (that was significantly altered by saline-treatment as 
noted in Table A.10, and that was not connected to the presence of STZ in the brain as proved 
by our in vitro experiments) did not simply revert to the control levels by Cys-administration. 
On the contrary, Cys further enhanced the diabetes-induced enzyme’s activation (Table A.10). 
Could the latter be a neuroprotective alteration? 
At this stage we cannot discern whether or not this Cys-induced effect is neuroprotec-
tive. Previous studies have linked aged rat brain AChE activation with an increased learning 
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performance (Carageorgiou et al., 2003), whilst others have recorded an increase in adult rat 
brain AChE by both toxic and antioxidant parameters (Carageorgiou et al., 2005b). The esti-
mation of the nature of this alteration can only be made if past and future studies can provide 
evidence that the diabetes-induced cholinergic dysfunction is well-linked to the reported 
cognitive and neurochemical changes, and if more light is shed on the effects of Cys-
administration on a wide range of further neurochemical parameters (altered by untreated 
diabetes). 
The activity of rat brain Na+,K+-ATPase was found to be significantly decreased by 
adult-onset STZ-induced diabetes (Table A.11), an observation that seems to be in accordance 
with the literature (Franzon et al., 2005; Leong and Leung, 1991). Moreover, 1-week saline-
administration caused a significant further decrease of the enzyme’s activity in diabetic rats 
(Table A.11), indicating a vulnerability of this brain parameter (as well as of that of AChE ac-
tivity) to the administration of saline and / or to the induction of a daily-performed injection-
al stress. This diabetes-induced brain Na+,K+-ATPase inhibition may reflect a possible means 
through which untreated diabetes could affect neuronal excitability, metabolic energy pro-
duction and certain systems of neurotransmission (Bogdanski et al., 1968; Hernández, 1987; 
Lees et al., 1990; Mata et al., 1980; Sastry and Phillis, 1977; Swann, 1984), thus contributing 
to the disease’s multifactorial neuropsychiatric phenotype. We should also not neglect the 
fact that several studies have linked diabetic encephalopathy to severe mitochondrial dys-
function (Mastrocola et al., 2005) and a purinergic signaling modification (Duarte et al., 
2007), both processes linked to decreased ATP availability. 
The administration of Cys could not reverse the diabetes-induced Na+,K+-ATPase inhi-
bition in vivo (Table A.11), as expected (Carageorgiou et al., 2004). However, the in vitro in-
cubation of diabetic brain protein with Cys (Table A.13) caused a significant increase in 
Na+,K+-ATPase activity, underlying a potential protective role of Cys under different in vivo 
experimental conditions. 
Finally, the activity of rat brain Mg2+-ATPase was not altered by the conducted STZ-
induced diabetes (Table A.12), in contrast to a previous report referring to an AL-induced 
diabetic brain region Mg2+-ATPase activation (Mayanil et al., 1982). Since Mg2+-ATPase is an 
enzyme functioning in order to maintain high brain intracellular Mg2+, and thus possibly con-
trolling the rate of protein synthesis and cell growth (Sanui and Rubin, 1982), its intact func-
tion under the examined experimental conditions may provide a reason for the maintenance 
of a stable brain protein concentration, as observed in our experiments (data not shown). 
Moreover, the in vitro incubation with Cys and STZ (Table A.14) had no effect on Mg2+-ATPase 
activity in either diabetic or control brain homogenates (respectively), while in vivo Cys sig-
nificantly decreased the enzyme’s activity in both diabetic and control rat brains (Table A.12). 
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In conclusion, our study revealed a protective role for Cys towards the oxidative effect 
of untreated diabetes on the adult rat brain. Moreover, an increase in whole brain AChE activ-
ity ascribable to diabetes was recorded (not repeatedly established in the literature, since 
contradictory findings exist), that was further increased by Cys. In addition, it was estab-
lished that Mg2+-ATPase activity cannot be affected by diabetes, whilst the observed inhibi-
tion of Na+,K+-ATPase reflects a possible mechanism through which untreated diabetes could 
affect neuronal excitability, metabolic energy production, and certain systems of neuro-
transmission. With regard to the use of Cys as a neuroprotective agent against diabetes, our 
in vitro findings could be indicative of a possible protective role of Cys under different in vivo 
experimental conditions. 
 
>> Tables A.9, A.10 and A.11: page 26 
>> Tables A.12, A.13 and A.14: page 27 
>> Figures A.6.a and A.6.b: page 28 
>> Figure A.7: page 29 
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Table A.9: Effects of adult-onset STZ-induced diabetic encephalopathy on rat brain TAS. 
 
  
Treatment TAS (mmol / L) 
  
  
CA  50.83 ± 4.07   |   --- 
DA  36.35 ± 2.94   |   -28% (***) vs CA 
CB  48.25 ± 3.47   |   -5% (NS) vs CA 
DB  33.60 ± 2.34   |   -30% (***) vs CB; -8% (NS) vs DA 
C+Cys 49.42 ± 1.82   |   +2% (NS) vs CB 
D+Cys 49.68 ± 2.06   |   +3% (NS) vs CB; +48% (***) vs DB; +1% (NS) vs C+Cys 
  
 
Note: each value indicates the mean ± SD of five independent experiments (five rats, n = 5) in the case of treat-
ments CA and DA and of seven independent experiments (seven rats, n = 7) in the case of treatments CB, DB, C+Cys 
and D+Cys. The average of each experiment arose from three evaluations in the homogenised brain tissue of each 
animal. NS: non-statistically-significant; ***: p<0.001. For details regarding the treatments, see Figure A.7. 
 
 
Table A.10: Effects of adult-onset diabetic encephalopathy on rat brain AChE activity. 
 
  
Treatment AChE activity (ΔOD / min x mg protein) 
  
  
CA  0.466 ± 0.009   |   --- 
DA  0.590 ± 0.014   |   +27% (***) vs CA 
CB  0.470 ± 0.012   |   +1% (NS) vs CA 
DB  0.541 ± 0.029   |   +15% (***) vs CB; -8% (**) vs DA 
C+Cys 0.780 ± 0.032   |   +66% (***) vs CB 
D+Cys 0.738 ± 0.029   |   +57% (***) vs CB; +36% (***) vs DB; -5% (*) vs C+Cys 
  
 
Note: each value indicates the mean ± SD of five independent experiments (five rats, n = 5) in the case of treat-
ments CA and DA and of seven independent experiments (seven rats, n = 7) in the case of treatments CB, DB, C+Cys 
and D+Cys. The average of each experiment arose from three evaluations in the homogenised brain tissue of each 
animal. NS: non-statistically-significant; *: p<0.05; **: p<0.01; ***: p<0.001. For details regarding the treatments, 
see Figure A.7. 
 
 
Table A.11: Effects of adult-onset STZ-induced diabetic encephalopathy on the activity of rat 
brain Na+,K+-ATPase. 
 
  
Treatment Na+,K+-ATPase activity (μmol Pi / h x mg protein) 
  
  
CA  3.53 ± 0.26   |   --- 
DA  2.26 ± 0.13   |   -36% (***) vs CA 
CB  3.67 ± 0.31   |   +4% (NS) vs CA 
DB  1.92 ± 0.22   |   -48% (***) vs CB; -15% (**) vs DA 
C+Cys 2.14 ± 0.16   |   -42% (***) vs CB 
D+Cys 1.95 ± 0.19   |   -47% (***) vs CB; +2% (NS) vs DB; -9% (NS) vs C+Cys 
  
 
Note: each value indicates the mean ± SD of five independent experiments (five rats, n = 5) in the case of treat-
ments CA and DA and of seven independent experiments (seven rats, n = 7) in the case of treatments CB, DB, C+Cys 
and D+Cys. The average of each experiment arose from three evaluations in the homogenised brain tissue of each 
animal. NS: non-statistically-significant; **: p<0.01; ***: p<0.001. For details regarding the treatments, see Figure 
A.7. 
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Table A.12: Effects of adult-onset STZ-induced diabetic encephalopathy on the activity of rat 
brain Mg2+-ATPase. 
 
  
Treatment Mg2+-ATPase activity (μmol Pi / h x mg protein) 
  
  
CA  5.35 ± 0.37   |   --- 
DA  4.82 ± 0.39   |   -10% (NS) vs CA 
CB  5.49 ± 0.29   |   +3% (NS) vs CA 
DB  5.23 ± 0.41   |   -5% (NS) vs CB; +9% (NS) vs DA 
C+Cys 4.73 ± 0.24   |   -14% (***) vs CB 
D+Cys 4.55 ± 0.27   |   -17% (***) vs CB; -13% (**) vs DB; -4% (NS) vs C+Cys 
  
 
Note: each value indicates the mean ± SD of five independent experiments (five rats, n = 5) in the case of treat-
ments CA and DA and of seven independent experiments (seven rats, n = 7) in the case of treatments CB, DB, C+Cys 
and D+Cys. The average of each experiment arose from three evaluations in the homogenised brain tissue of each 
animal. NS: non-statistically-significant; **: p<0.01; ***: p<0.001. For details regarding the treatments, see Figure 
A.7. 
 
 
Table A.13: Effects of a 3 h in vitro incubation of rat brain homogenates with STZ (10 mM) or 
with Cys (0.83 mM) on Na+,K+-ATPase activity.  
 
  
Incubation group Na+,K+-ATPase activity (μmol Pi / h x mg protein) 
  
  
CB 2.58 ± 0.35   |   --- 
CB + [STZ] 2.49 ± 0.23   |   -3% (NS) vs CB 
DB 1.45 ± 0.26   |   -44% (**) vs CB 
DB + [Cys] 1.93 ± 0.29   |   -25% (*) vs CB; +33% (*) vs DB 
  
 
Note: each value indicates the mean ± SD of four independent experiments. NS: non-statistically-significant; *: 
p<0.05; **: p<0.01.  
 
 
Table A.14: Effects of a 3 h in vitro incubation of rat brain homogenates with STZ (10 mM) or 
with Cys (0.83 mM) on Mg2+-ATPase activity.  
 
  
Incubation group Mg2+-ATPase activity (μmol Pi / h x mg protein) 
  
  
CB 3.73 ± 0.31   |   --- 
CB + [STZ] 3.98 ± 0.26   |   +7% (NS) vs CB 
DB 3.34 ± 0.26   |   -10% (NS) vs CB 
DB + [Cys] 3.13 ± 0.25   |   -16% (*) vs CB; -6% (NS) vs DB 
  
 
Note: each value indicates the mean ± SD of four independent experiments. NS: non-statistically-significant; *: 
p<0.05.  
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Figure A.6.a: Chemical structure of STZ, used for the experimental induction of diabetes. 
 
 
 
 
 
Note: STZ was originally identified as an antibiotic. However, it was found to be selectively toxic to the beta cells of 
the pancreatic islets, a fact that has defined its use as a valuable compound for the experimental induction of dia-
betes, as well as a drug for pancreatic islet cell cancer (insulinoma). 
 
Figure A.6.b: Chemical structure of Cys, used in the experiments described. 
 
 
 
 
 
Note: Cys is a well-known antioxidant, in view of the ability of thiols to undergo redox reactions. It is a precursor 
of glutathione (GSH) and a metal-binding amino acid; proteins that contain Cys (such as metallotheionin) maintain 
a high-affinity for heavy metals. 
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Figure A.7: Schematic overview of the experimental protocol followed for the induction of 
adult-onset diabetic encephalopathy and the investigation of the potential neuroprotective 
effects of Cys administration. 
 
 
 
 
 
Note: rats were divided into two main groups (C: control and D: diabetic). The rats belonging to group D were in-
jected with a single intraperitoneal dose of STZ (50 mg / kg of body weight, diluted in a 0.1 mol / L citrate buffer 
solution, pH 4.5) to induce diabetes, while the rats belonging to group C were injected with the citrate buffer. Rats 
were killed 8 weeks after the injection of STZ or buffer (groups DA and CA, respectively), whilst others were killed 
9 weeks after the injection of STZ or buffer. The 9-week groups were injected intraperitoneally with saline (groups 
CB and DB) or Cys (groups C+Cys and D+Cys), once daily, during the 9th week. The administration of Cys was per-
formed at a dosage of 7 mg / kg of body weight. For the in vitro experiments, brain homogenates from groups CB 
and DB were incubated with STZ and Cys, respectively. 
 
 
  
CHAPTER IV 
 
Contribution to the study of experimentally-simulated  
Wernicke’s encephalopathy* 
 
Wernicke’s encephalopathy (or Wernicke encephalopathy; WE) is a serious acute neuropsy-
chiatric syndrome, resulting from thiamine (vitamin B1; T) deficiency (TD), and associated 
with a significant level of morbidity and mortality (Sechi and Serra, 2007). Prolonged alcohol 
consumption and grossly impaired nutritional status are thought to be the main causes of WE 
(Martin et al., 2003). Indeed, chronic alcohol consumption can result in TD by causing: (a) 
inadequate nutritional T intake, (b) decreased absorption of T from the gastrointestinal tract, 
and (c) impaired T utilisation in cells (Martin et al., 2003). Chronic exposure to EtOH along 
with TD cause small necrotic lesions, symmetrically distributed in the walls and the floor of 
the third ventricle, in the gray matter surrounding the Sylvian aqueduct, and in the floor of 
the fourth ventricle (Victor et al., 1989). These lesions appear to result in the main sympto-
matology of WE, which includes oculomotor disturbances, mental status changes and im-
paired ability to coordinate movements (particularly of the lower extremities) (Harper et al., 
1986; Wernicke, 1881). However, many WE patients do not exhibit all three of the pre-
mentioned symptoms: post-mortem neuropathological studies have indicated that numerous 
cases of TD-related encephalopathy may not be diagnosed in life, since not all symptoms are 
present or recognised (Martin et al., 2003). In adults, autopsy studies have revealed a higher 
prevalence of WE lesions than those predicted by clinical studies (0.8-2.8% instead of 0.04-
0.13%, respectively) (Harper et al., 1986; Sechi and Serra, 2007; Victor et al., 1971). The es-
timated mortality of WE is 17% (Victor et al., 1971), whilst 80% of the patients who survive 
develop Korsakoff’s syndrome (Sechi and Serra, 2007); the latter is a dense amnestic disorder 
in which patients, in addition to the severe anterograde amnesia, exhibit a frontal lobe syn-
drome, affective disorders, and visuoperceptual disturbances (Homewood and Bond, 1999). 
In WE, several genetic defects (Thomson and Marshall, 2006) may combine with envi-
ronmental factors (i.e. alcoholism and diet abnormalities) in order to provoke TD. The latter 
                                                 
* modified-version of the article by Zarros et al., entitled: “Experimentally-induced Wernicke’s en-
cephalopathy modifies crucial rat brain parameters: the importance of Na+,K+-ATPase and a potentially 
neuroprotective role for antioxidant supplementation”, published in Metabolic Brain Disease 2013; 
28(3): 387-396. 
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leads to brain lesions (restricted to the pre-mentioned vulnerable brain regions) within 2-3 
weeks (Schenker et al., 1980). Once the body’s stores of T are depleted (a process that usually 
takes place within 18 days at maximum) (Tanphaichitr, 1999), the blood levels of T fall, lead-
ing to impaired function of the enzymes requiring T-pyrophosphate as a coenzyme (Sechi and 
Serra, 2007). This coenzyme is involved in a large number of biochemical pathways in the 
brain, and hence plays an important role in intermediate carbohydrate metabolism, lipid me-
tabolism and neurotransmission (Iwata, 1982; Manzo et al., 1994). Moreover, the earliest bi-
ochemical changes occurring at the cellular level due to TD include: (a) a decrease in alpha-
ketoglutarate-dehydrogenase (α-KGDH) activity in astrocytes (occurring after about 4 days of 
TD and leading to cytotoxic edema and astrocyte volume increase) (Butterworth, 1986; Ha-
zell et al., 2003), (b) a decrease in transketolase activity (occurring after 7-10 days of TD and 
leading to a diffuse decrease in the use of glucose with consequent severe impairment of sev-
eral astrocyte-related functions, such as the control of extracellular and intracellular gluta-
mate concentrations, the maintenance of ionic gradients across the cell membrane, and 
blood-brain barrier permeability) (Hakim and Pappius, 1983; Hazell et al., 1998), and (c) an 
increase in nitric oxide (NO) production attributable to endothelial cell dysfunction (leading 
to the development of vasogenic edema in parallel to a breakdown of the blood-brain barrier) 
(Sechi and Serra, 2007). If the TD state is not reversed, increased lactate production by both 
astrocytes and neurons, reductions in pH and focal acidosis are notable (Navarro et al., 2005). 
These modifications are usually accompanied by mitochondrial dysfunction, oxidative stress 
and DNA fragmentation, resulting in apoptotic cell death (Desjardins and Butterworth, 2005; 
Matsushima et al., 1997). 
The aim of the work described and discussed in this chapter was to shed more light on 
the pathophysiology of WE, by introducing a modified in vivo experimental model of WE, and 
also by focusing on changes provoked in the TAS and three crucial brain enzyme activities in 
adult rats. The examined enzymatic activities were those of AChE, Na+,K+-ATPase and Mg2+-
ATPase. The study was also designed in order to: (a) examine the causes of the expected ef-
fects upon the above-mentioned crucial brain parameters ascribable to WE, (b) study any 
changes in these parameters following a therapeutic scheme of T-administration, as well as 
(c) provide more evidence of their potential direct involvement in WE pathophysiology and 
their potential role as targets for therapeutic intervention and / or neuroprotection. In vitro 
incubation of brain homogenates or pure enzymes with T or neuromodulatory antioxidants 
(Cys and L-carnitine; Carn) was also conducted. 
Fifty (50) albino Wistar adult male rats (three-month-old, weighting 163 ± 19 g) were 
used in all experiments. The rats were housed at a maximum of five in a cage, at a constant 
room temperature (22 ± 1oC) under a 12 h light : 12 h dark (light 08:00 - 20:00 h) cycle. Food 
and water were provided ad libitum. Animals were cared for in accordance with the princi-
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ples for the care, use and protection of experimental animals as set by the EEC Council Di-
rective 86/609/EEC (EEC Council, 1986), and aligned according to the EU Recommendation 
2007/526/EU. 
Rats were divided into four primary groups and six secondary groups as presented in 
Table A.15. Our study’s experimental design was based on the ones followed by Langlais and 
Zhang (1997), as well as by Pires et al. (2005), with modifications. The induction of WE was 
performed in rats placed on EtOH (20% v / v) consumption for a total of 5 weeks, who by the 
end of the 3rd week were also fed a T-deficient diet (TDD; see Figure A.8.a), and were treated 
with daily intraperitoneal injections of pyrithiamine (PT; 0.25 mg / kg of body weight; see 
Figure A.8.b) for the remaining 2 weeks. Half of these rats were treated with T immediately 
after the onset of the WE-indicative neurological signs (ataxia, onset of seizures and impaired 
righting reflex), which in all cases occurred at the 14th (last-scheduled) day of PT administra-
tion. Treatment with T was performed via three consecutive intraperitoneal injections (100 
mg / kg of body weight), once every 8 h. Rats of all primary and secondary groups that did 
not receive PT and / or T, were treated with equivalent volumes of saline. Dosage and treat-
ment routes were the same for both the primary and secondary group rats (Table A.15). 
During the experiment, body weight and chow consumption were monitored on a 
weekly basis, whilst liquid consumption was monitored on a daily basis. Neurological exami-
nation was performed once daily since the beginning of TDD and / or PT administration, and 
twice daily after the 8th day of TDD and / or PT administration in all rats of all groups. Signif-
icant amelioration of the neurological symptomatology was observed in the WE (+T) group of 
rats following the administration of T, when compared to the WE (-T) group. 
The animals were killed by decapitation and their whole brains were rapidly removed. 
The tissue was homogenised in 10 volumes of ice-cold (0-4oC) medium containing 50 mM 
Tris-HCl, pH 7.4 and 300 mM sucrose, using an ice-chilled glass-homogenising vessel at 900 
rpm (4-5 strokes). Subsequently, the homogenate was centrifuged at 1,000 × g for 10 min in 
order to remove nuclei and debris (Tsakiris, 2001; Tsakiris et al., 2000). In the resulting su-
pernatant, the protein content was determined according to the method of Lowry et al. 
(1951), and then the enzyme activities as well as the TAS were measured (following the same 
methodology described in Chapter I). 
In the in vitro experiments, the enzymatic activity measurements were performed on 
homogenised rat whole brains of the Control (-T) and the WE (-T) groups (Table A.15), as 
well as on pure enzymes. As pure enzymes, eel E. electricus AChE and porcine cerebral cortex 
Na+,K+-ATPase were used. The activities were determined after incubation with T (1 mM) 
(Tallaksen and Taubøll, 2000), Carn (5 mM) (Tsakiris et al., 2008) or Cys (0.83 mM) (Car-
ageorgiou et al., 2004) for 3 h at 37oC.  
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Obtained data were analyzed by one-way ANOVA; p values of <0.05 were considered 
statistically significant. All analyses were performed by SPSS for Windows Software. 
Rats that underwent an experimental simulation of WE but received saline as a treat-
ment [WE (-T)] (Table A.15) demonstrated a decrease in their brain TAS (-19%, p<0.001) 
when compared with their respective controls [Control (-T)] (Figure A.9). This brain TAS de-
crease was partially ameliorated by treatment with T in the WE (+T) group (+15%, p<0.001) 
when compared with the saline-treated WE (-T) group, and reached the TAS values of the 
Control (+T) group (-1%, p>0.05), but did not attain the mean value of the Control (-T) group 
TAS (-7%, p<0.05; Figure A.9). It was also revealed that T administration itself caused a slight 
but significant decrease in the brain TAS of the Control (+T) group (-6%, p<0.05) when com-
pared with the Control (-T) group (Figure A.9). The evaluation of TAS in all secondary groups’ 
brain homogenates revealed a constant decrease in this oxidative stress-related marker when 
expressed relative to the Control (-T) values (ranging from -7% to -18%, significances varied; 
Figure A.9). However, all the secondary groups’ brain TAS values were significantly higher 
than that of the WE (-T) group (ranging from +8% to +15%, significances varied; Figure A.9), 
with the exemption of the WE-5 group (the group treated with PT and TDD for 2 weeks; Ta-
ble A.15) that did not significantly differ from WE (-T) (+2%, p>0.05; Figure A.9). 
The induction of WE in rats not treated with T [WE (-T)] caused inhibition of brain 
AChE (-14%, p<0.001) when compared with the respective control group [Control (-T)] 
(Table A.16). In vivo treatment with T not only failed to ameliorate this inhibition, but further 
decreased brain AChE activity in both the WE (+T) and the Control (+T) groups [-20%, 
p<0.001 and -23%, p<0.001, respectively, when compared with Control (-T); Table A.16]. The 
study of the brain AChE activity of the secondary groups indicated that the WE-5 (PT- and 
TDD-treated) group was once again that most closely resembling that of the WE (-T) group 
(their AChE activity levels almost matched; Table A.16). In order to further study the effect of 
T on AChE activity, and also evaluate the potential neuroprotective application of Carn, brain 
homogenates of the Control (-T) and the WE (-T) groups were incubated (for 3 h at 37oC) 
with T (1 mM) and Carn (5 mM); T had no effect in vitro upon the brain homogenate AChE 
activities of either studied groups, while Carn significantly increased AChE activity in the 
Control (-T) + [Carn] and the WE (-T) + [Carn] groups (+5%, p<0.05 and +15%, p<0.001) 
when compared with their respective controls [Control (-T) and WE (-T), respectively; Figure 
A.10]. Further incubation of these substances (at the same concentrations) with pure (eel E. 
electricus-derived) AChE revealed that T inhibited pure AChE activity (-34%, p<0.001), while 
Carn was found not to directly interact with AChE (Table A.17). 
The induction of WE in rats untreated with T [WE (-T)] caused activation of brain 
Na+,K+-ATPase (+92%, p<0.001) when compared with the respective control group [Control 
(-T)] (Table A.18). In vivo treatment with T ameliorated this activation in the WE (+T) group 
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(-55%, p<0.001) when expressed relative to the WE (-T) group (Table A.18). The study of the 
brain Na+,K+-ATPase activity of the secondary groups indicated that the WE-4 (PT-treated), 
the WE-5 (PT- and TDD-treated) and the WE-6 (TDD-treated) groups were the only groups 
resembling the WE (-T) group (their Na+,K+-ATPase activity levels were very high; Table 
A.18). In order to further study the effect of T on Na+,K+-ATPase activity, and also to evaluate 
the potential neuroprotective application of Carn and Cys, brain homogenates of the Control 
(-T) and the WE (-T) groups were incubated (for 3 h at 37oC) with T (1 mM), Carn (5 mM) and 
Cys (0.83 mM); both T and Cys provoked a significant inhibition on the brain homogenate 
Na+,K+-ATPase of both groups, whilst Carn significantly increased the Na+,K+-ATPase activity 
of the Control (-T) + [Carn] group, but not of the WE (-T) + [Carn] group (+46%, p<0.001 and 
-7%, p>0.05) when compared with their respective controls [Control (-T) and WE (-T), re-
spectively; Figure A.11]. Further incubation of these substances (at the same concentrations) 
with pure (porcine cerebral cortex-derived) Na+,K+-ATPase revealed that all of them had the 
capacity to inhibit pure Na+,K+-ATPase activity (T: -35%, p<0.001; Carn: -32%, p<0.01; Cys: -
40%, p<0.001; Table A.19). 
The in vivo induction of WE, whether treated with T or not, had no effect on brain Mg2+-
ATPase activity (Table A.20). In vivo treatment with T also had no effect on the activity of 
Mg2+-ATPase in the Control (+T) group (Table A.20). Amongst the studied secondary groups, 
only the WE-1 (which was the EtOH-treated) group (see Table A.15) presented with a signifi-
cant decrease in Mg2+-ATPase activity (-14%, p<0.05) when compared with the Control (-T) 
group (Table A.20). Further in vitro studies of the effects of T, Carn and Cys on brain homoge-
nate Mg2+-ATPase activity in the Control (-T) and the WE (-T) groups led to no significant 
findings (Figure A.12). 
Oxidative stress is considered a significant element of WE pathophysiology, linked to 
ROS production, lipid peroxidation, cellular energy failure, focal lactic acidosis and excitotoxi-
city (Desjardins and Butterworth, 2005; Hazell and Butterworth, 2009). Our study confirmed 
the enhanced “activity” of oxidative stress in the brains of rats undergoing experimental-
induction of WE, as reflected by the reduced TAS found in brain homogenates (Figure A.9). 
According to our findings, this oxidative stress could also be attributed to the synergistic oxi-
dative effect of PT and TDD, and only partially to EtOH (Figure A.9). Moreover, the in vivo T 
administration scheme followed appears to partially ameliorate the WE-induced decrease in 
brain TAS; this is in accordance with studies indicating a partial and site-directed antioxidant 
role for T (Gibson and Zhang, 2002; Huang et al., 2010), but cannot clarify the reasons why T 
administration still provoked a small but significant decrease in TAS when compared with 
saline administration in the control groups. 
Our study has therefore demonstrated that the untreated (with T) induction of WE 
caused an inhibition of brain AChE, whilst the in vivo treatment with T not only did not ame-
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liorate this inhibition, but further decreased brain AChE activity in both the WE (+T) and the 
Control (+T) groups (Table A.16). Cholinergic dysfunction is a well-studied effect of TD: one 
of the first studies on the matter revealed significantly reduced ACh levels in the rat medulla-
pons, the midbrain, the diencephalon, the corpus striatum and the hippocampus, whilst ACh 
utilisation was found significantly reduced in the midbrain, the corpus striatum and the hip-
pocampus of rats treated with PT and fed with TDD for a period of 10-12 days (Vorhees et al., 
1978). The PT-induced TD-related amnesic model has been recently reported to cause a de-
crease in ACh efflux in the hippocampus, the medial frontal cortex and the retrosplenial cor-
tex of rats, accompanied by (but not always correlated to) significant reductions in choliner-
gic innervation (in terms of fiber density) (Anzalone et al., 2010). In agreement with our find-
ings and also indicating that no matter the extent of TD, an inhibition of brain AChE should be 
expected after exposure to either PT and / or TDD (Table A.16), Pires et al. (2005) have re-
ported that TD provoked reduced AChE activity in both the rat hippocampus and the neocor-
tex; the latter was correlated with decreased behavioural performance (in terms of spatial 
memory) in pre-trained rats (Pires et al., 2005). This decrease in AChE activity could arise 
from a down-regulation of the enzyme following adaptation to low ACh levels and / or dis-
rupted cholinergic innervation. In fact, the PT-induced suppression of synaptoplasmic acetyl-
CoA (attributable to mitochondrial dysfunction leading to an inhibited acetyl-CoA transport 
to the synaptoplasmic compartment through the ATP / citrate lyase pathway) has been corre-
lated with an inhibition of quantal ACh release, but caused no change in the activity of cho-
line-acetyltransferase (ChAT) in rat brain nerve terminals (Jankowska-Kulawy et al., 2010). 
However, unbiased stereological assessment of neuronal populations in the septohippocam-
pal pathway revealed that ChAT-positive neurons were significantly reduced in a PT-treated 
rat model of WE (Roland and Savage, 2009), suggesting a disruption of cholinergic innerva-
tion.  
Whatever the case, EtOH appeared to have no participation in the inhibition of AChE, 
at least under the examined in vivo experimental conditions (Table A.16). A single dose of 
EtOH (intraperitoneally at 1 g / kg of body weight) has been reported to cause no change in 
AChE mRNA levels (as studied at 40 and 240 min after EtOH administration) in the rat frontal 
cortex and hippocampus (Jamal et al., 2007). Moreover, acute EtOH-intoxicated rats demon-
strated no changes in AChE activity (when compared with controls) (Oner et al., 2002), and 
so they did following a chonic EtOH exposure scheme (Ruano et al., 2000). Husain and Soma-
ni (1998) are amongst those who have managed to detect changes in AChE activity ascribable 
to EtOH, following an exposure scheme of 6.5 weeks (very close to our own 5-week scheme), 
but these modifications were limited to the hypothalamus and were correlated with an in-
creased level of lipid peroxidation. However, one should definitely not exclude a major role of 
alcoholism in the induction of cholinergic-dysfunction as part of the pathophysiology of WE, 
Zarros AC | PhD Thesis (by published work / retrospective) in Neuroscience  36
since a much longer period of experimental exposure (28 weeks) to 20% (v / v) EtOH has 
been reported to cause profound reductions in the ACh content and the activities of AChE and 
ChAT in the cortex, the hippocampus, the substantia innominata, and the striatum of Sprague-
Dawley rats (when compared with tap-water-receiving controls) (Arendt et al., 1990). 
Through the in vitro study of the effects of T and Carn on AChE activity, T was shown to 
have no effect on brain homogenate AChE of either studied groups, whilst Carn was shown to 
significantly increase AChE activity in both the examined groups (Figure A.10). Further incu-
bation of these substances (at the same concentrations) with pure (eel E. electricus-derived) 
AChE revealed that T inhibited pure AChE activity, whilst Carn was found not to directly in-
teract with AChE (Table A.17). These findings: (a) partially explain the in vivo findings of re-
duced AChE activity ascribable to T-administration, (b) suggest that the WE-induced cholin-
ergic deregulation (to the extent that this can be represented by changes in rat brain homog-
enate AChE activity) might be of a complex nature and not directly linked to T availability, as 
well as (c) suggest that Carn-administration could represent a manner of restoring AChE ac-
tivity to control levels (despite the fact that Carn did not seem to interact with AChE directly). 
The most significant finding of this study was the significantly stimulated brain Na+,K+-
ATPase found in untreated WE (Table A.18), and that was ameliorated both in vivo (Table 
A.18) as well as in vitro (Figure A.11, Table A.19) by T. This is the second in vivo study corre-
lating the increase of Na+,K+-ATPase activity with TD, and follows that of Mousseau et al. 
(1996), where Na+,K+-ATPase was found to be selectively increased by 200% in the thalamus 
of PT-treated rats, prior to the appearance of symptoms. Taking into consideration the above 
findings, as well as the fact that, as far as Na+,K+-ATPase activity is concerned, the WE-4 (PT-
treated), the WE-5 (PT- and TDD-treated) and the WE-6 (TDD-treated) groups were the only 
groups resembling the WE (-T) group (their Na+,K+-ATPase activity levels were very high; Ta-
ble A.18), one could assume that: (a) the absence of T stimulated Na+,K+-ATPase in the stud-
ied model of WE, (b) T ameliorated this stimulation and may have caused an inhibition of 
Na+,K+-ATPase, and (c) (co)exposure to EtOH did not allow for any change in brain Na+,K+-
ATPase activity, at least not under the examined experimental conditions. 
Although T is considered to be an integral component of the brain synaptosomal mem-
branes (Matsuda and Cooper, 1981), very little is known about its relationship with crucial 
brain enzymes such as Na+,K+-ATPase. Matsuda and Iwata (1987) reported a decrease in 
high-affinity ouabain-binding in the cerebellum and the hypothalamus of rats undergoing TD; 
an observation very likely to indicate a potential involvement of T in ouabain- and ouabain-
like substance-binding regulation of brain Na+,K+-ATPase activity. Moreover, considering the 
fact that T seems to directly inhibit pure Na+,K+-ATPase in vitro (Table A.19), one could sug-
gest that: (a) brain Na+,K+-ATPase activity could act as a marker for TD in WE, and (b) Na+,K+-
ATPase could represent a significant part of the WE pathophysiology, since changes in its ac-
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tivity could reflect changes in the maintenance of the neuronal membrane potential, neuronal 
excitability, metabolic energy production, as well as in the uptake and release of catechola-
mines and 5-HT. Moreover, one should not neglect the fact that the functioning of Na+,K+-
ATPase is responsible for a very large part of the neuronal energy expenditure and that it has 
been shown to be implicated in the pathophysiology of a number of experimentally-simulated 
brain disorders (Bimpis et al., 2013; Zarros et al., 2008; 2009).  
The amelioration of the WE-induced Na+,K+-ATPase stimulation could also be achieved 
through the (co)administration of Cys, but not of Carn, as suggested by the conducted in vitro 
experiments (Figure A.11). Further incubation of these substances with pure (porcine cere-
bral cortex-derived) Na+,K+-ATPase revealed that all of them had the capacity to inhibit its 
activity (Table A.19). 
Finally, of all the studied brain parameters, Mg2+-ATPase was the only one not to be 
modified by the in vivo induction of WE, whether treated with T or not (Table A.20). Amongst 
the studied secondary groups, only the WE-1 (EtOH-treated) group presented with a signifi-
cant decrease in Mg2+-ATPase activity, which is in accordance with the in vitro findings of 
Syapin et al. (1985) (linking this decrease to EtOH in a dose-dependent manner), as well as 
with the in vivo findings of Moloney and Leonard (1984) (who observed a similar decrease in 
the brain of rat offspring following an exposure to EtOH during weaning). A further in vitro 
study of the effects of T, Carn and Cys on brain homogenate Mg2+-ATPase activity led to no 
significant findings (Figure A.12), indicating that all three agents could be used as neuropro-
tectants in vivo, with a limited likelihood of causing any undesirable changes in Mg2+-ATPase 
activity. 
In conclusion, our data suggest that the administration of T inhibits AChE, which is also 
found inhibited in WE. Moreover, increased brain Na+,K+-ATPase activity could serve as a 
marker of T deficiency in WE, whilst combined T and antioxidant co-supplementation of Cys 
and / or Carn could exert neuroprotective effects in terms of restoring the examined crucial 
brain enzyme activities back to control levels. 
 
>> Tables A.15 and A.16: page 38 
>> Tables A.17, A.18 and A.19: page 39 
>> Table A.20, Figures A.8.a and A.8.b: page 40 
>> Figure A.9: page 41 
>> Figure A.10: page 42 
>> Figure A.11: page 43 
>> Figure A.12: page 44 
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Table A.15: Presentation of the experimental groups’ treatments. 
 
      
Treatment EtOH PT TDD T n 
      
      
Primary groups      
      
Control (-T) - - - - 5 
WE (-T) + + + - 5 
Control (+T) - - - + 5 
WE (+T) + + + + 5 
      
Secondary groups      
      
WE-1 + - - - 5 
WE-2 + + - - 5 
WE-3 + - + - 5 
WE-4 - + - - 5 
WE-5 - + + - 5 
WE-6 - - + - 5 
      
 
Note: “n” stands for the number of rats used in each group. 
 
 
Table A.16: Effects of experimentally-induced WE on adult rat brain AChE activity, and the 
role of in vivo T administration. 
 
  
Treatment AChE activity (ΔOD / min x mg protein) 
  
  
Control (-T) 0.699 ± 0.029   |   --- 
WE (-T) 0.604 ± 0.019   |   -14% (***) vs Control (-T) 
Control (+T) 0.539 ± 0.025   |   -23% (***) vs Control (-T) 
WE (+T) 0.561 ± 0.022   |   -20% (***) vs Control (-T); -7% (*) vs WE (-T) 
  
WE-1 0.724 ± 0.034   |   +4% (NS) vs Control (-T); +20% (***) vs WE (-T) 
WE-2 0.673 ± 0.019   |   -4% (NS) vs Control (-T); +11% (***) vs WE (-T) 
WE-3 0.645 ± 0.020   |   -8% (**) vs Control (-T); +7% (*) vs WE (-T) 
WE-4 0.679 ± 0.032   |   -3% (NS) vs Control (-T); +12% (**) vs WE (-T) 
WE-5 0.605 ± 0.017   |   -13% (***) vs Control (-T); +0% (NS) vs WE (-T) 
WE-6 0.666 ± 0.033   |   -5% (NS) vs Control (-T); +10% (**) vs WE (-T) 
  
 
Note: the WE (+T) AChE activity is +4% (NS) vs Control (+T). For more details concerning the experimental groups 
and the abbreviations used, refer to Table A.15. Each value indicates the mean ± SD of five independent experi-
ments (five rats, n = 5). The average of each experiment arose from three evaluations of the homogenised brain 
tissue of each animal. NS: non-statistically-significant; ***: p<0.001; **: p<0.01; *: p<0.05. 
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Table A.17: Effects of in vitro (3 h at 37oC) incubation of pure (eel E. electricus-derived) AChE 
with T (1 mM) or Carn (5 mM), on the pure enzyme’s activity. 
 
  
Incubation group AChE activity (ΔOD / min x μg protein) 
  
  
Control 1.161 ± 0.050   |   --- 
Control + [T] 0.767 ± 0.042   |   -34% (***) vs Control 
Control + [Carn] 1.188 ± 0.049   |   +2% (NS) vs Control 
  
 
Note: each value indicates the mean ± SD of four independent experiments. NS: non-statistically-significant; ***: 
p<0.001. 
 
 
Table A.18: Effects of experimentally-induced WE on adult rat brain Na+,K+-ATPase activity, 
and the role of in vivo T administration. 
 
  
Treatment Na+,K+-ATPase activity (μmol Pi / h x mg protein) 
  
  
Control (-T) 2.77 ± 0.19   |   --- 
WE (-T) 5.32 ± 0.17   |   +92% (***) vs Control (-T) 
Control (+T) 2.55 ± 0.21   |   -8% (NS) vs Control (-T) 
WE (+T) 2.38 ± 0.23   |   -14% (*) vs Control (-T); -55% (***) vs WE (-T) 
  
WE-1 2.69 ± 0.22   |   -3% (NS) vs Control (-T); -49% (***) vs WE (-T) 
WE-2 2.54 ± 0.19   |   -8% (NS) vs Control (-T); -52% (***) vs WE (-T) 
WE-3 2.84 ± 0.21   |   +3% (NS) vs Control (-T); -47% (***) vs WE (-T) 
WE-4 4.27 ± 0.23   |   +54% (***) vs Control (-T); -20% (***) vs WE (-T) 
WE-5 4.69 ± 0.26   |   +69% (***) vs Control (-T); -12% (**) vs WE (-T) 
WE-6 4.54 ± 0.29   |   +64% (***) vs Control (-T); -15% (***) vs WE (-T) 
  
 
Note: the WE (+T) Na+,K+-ATPase activity is -7% (NS) vs Control (+T). For more details concerning the experi-
mental groups and the abbreviations used, refer to Table A.15. Each value indicates the mean ± SD of five inde-
pendent experiments (five rats, n = 5). The average of each experiment arose from three evaluations of the ho-
mogenised brain tissue of each animal. NS: non-statistically-significant; ***: p<0.001; **: p<0.01; *: p<0.05. 
 
 
Table A.19: Effects of in vitro (3 h at 37oC) incubation of pure (porcine cerebral cortex-
derived) Na+,K+-ATPase with T (1 mM), Carn (5 mM) or Cys (0.83 mM), on the pure enzyme’s 
activity.  
 
  
Incubation group Na+,K+-ATPase activity (μmol Pi / h x mg protein) 
  
  
Control 14.83 ± 1.51   |   --- 
Control + [T] 09.61 ± 0.70   |   -35% (***) vs Control 
Control + [Carn] 10.13 ± 0.64   |   -32% (**) vs Control 
Control + [Cys] 08.96 ± 0.83   |   -40% (***) vs Control 
  
 
Note: each value indicates the mean ± SD of four independent experiments. ***: p<0.001; **: p<0.01. 
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Table A.20: Effects of experimentally-induced WE on adult rat brain Mg2+-ATPase activity, 
and the role of in vivo T administration.  
 
  
Treatment Mg2+-ATPase activity (μmol Pi / h x mg protein) 
  
  
Control (-T) 5.68 ± 0.41   |   --- 
WE (-T) 6.04 ± 0.52   |   +6% (NS) vs Control (-T) 
Control (+T) 5.75 ± 0.48   |   +1% (NS) vs Control (-T) 
WE (+T) 5.27 ± 0.56   |   -7% (NS) vs Control (-T); -13% (NS) vs WE (-T) 
  
WE-1 4.90 ± 0.50   |   -14% (*) vs Control (-T); -19% (**) vs WE (-T) 
WE-2 5.35 ± 0.45   |   -6% (NS) vs Control (-T); -11% (NS) vs WE (-T) 
WE-3 5.99 ± 0.57   |   +6% (NS) vs Control (-T); -1% (NS) vs WE (-T) 
WE-4 6.26 ± 0.53   |   +10% (NS) vs Control (-T); +4% (NS) vs WE (-T) 
WE-5 6.17 ± 0.46   |   +9% (NS) vs Control (-T); +2% (NS) vs WE (-T) 
WE-6 6.41 ± 0.59   |   +13% (NS) vs Control (-T); +6% (NS) vs WE (-T) 
  
 
Note: the WE (+T) Mg2+-ATPase activity is -8% (NS) vs Control (+T). For more details concerning the experimental 
groups and the abbreviations used, refer to Table A.15. Each value indicates the mean ± SD of five independent 
experiments (five rats, n = 5). The average of each experiment arose from three evaluations of the homogenised 
brain tissue of each animal. NS: non-statistically-significant; **: p<0.01; *: p<0.05. 
 
 
Figure A.8.a: Chemical structure of T, the vitamin that TDD does not include. 
 
 
 
 
 
Note: the TDD used in the described experiments was purchased from Mucedola (Italy) and contained: corn 
starch, casein vitamin free, sucrose, corn oil, cellulose powder, dicalcium phosphate, potassium citrate, calcium 
carbonate, D,L-methionine, ethoxyquin, vitamin A, vitamin D3, vitamin E, copper and selenium. 
 
Figure A.8.b: Chemical structure of PT, used in the experiments described. 
 
 
 
 
 
Note: PT is an inhibitor of T-pyrophosphokinase, the enzyme that converts T to its active form. 
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Figure A.9: Effects of experimentally-induced WE on adult rat brain TAS and the role of in 
vivo T administration. 
 
 
 
 
 
Note: for more details concerning the experimental groups and the abbreviations used, refer to Table A.15. Each 
value indicates the mean ± SD of five independent experiments (five rats, n = 5). The average of each experiment 
arose from three evaluations of the homogenised brain tissue of each animal. NS: non-statistically-significant 
(when compared with the “WE (-T)” group); ***: p<0.001 (when compared with the “Control (-T)” group); **: 
p<0.01 (when compared with the “Control (-T)” group); *: p<0.05 (when compared with the “Control (-T)” group); 
###: p<0.001 (when compared with the “WE (-T)” group); ##: p<0.01 (when compared with the “WE (-T)” group). 
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Figure A.10: Effects of in vitro (3 h at 37oC) incubation with T (1 mM) or Carn (5 mM) on the 
AChE activity of homogenised adult rat whole brains.  
 
 
 
 
 
Note: each value indicates the mean ± SD of four independent experiments. NS: non-statistically-significant (as 
compared with the “Control (-T)” or the “WE (-T)” group, where not differently stated); ***: p<0.001 (when com-
pared with the “Control (-T)” group); *: p<0.05 (when compared with the “Control (-T)” group); ###: p<0.001 
(when compared with the “WE (-T)” group).  
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Figure A.11: Effects of in vitro (3 h at 37oC) incubation with T (1 mM), Carn (5 mM) or Cys 
(0.83 mM) on the Na+,K+-ATPase activity of homogenised adult rat whole brains. 
 
 
 
 
 
Note: each value indicates the mean ± SD of four independent experiments. NS: non-statistically-significant (when 
compared with the “Control (-T)” or the “WE (-T)” group, where not differently stated); ***: p<0.001 (when com-
pared with the “Control (-T)” group); ###: p<0.001 (when compared with the “WE (-T)” group). 
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Figure A.12: Effects of in vitro (3 h at 37oC) incubation with T (1 mM), Carn (5 mM) or Cys 
(0.83 mM) on the Mg2+-ATPase activity of homogenised adult rat whole brains. 
 
 
 
 
 
Note: each value indicates the mean ± SD of four independent experiments. NS: non-statistically-significant (when 
compared with the “Control (-T)” or the “WE (-T)” group). 
 
 
 
 
  
CHAPTER V 
 
Contribution to the study of manganese-induced  
neurotoxicity* 
 
Most trace metals (specifically, metal ions) exert an influence on the CNS function in a com-
plex and dose-dependent manner (International Life Sciences Institute, 1994). Manganese 
(Mn) ions (Mn2+) represent an essential metalloenzyme component (Keen et al., 1999) that 
falls within this rule and can exert serious neurotoxic effects on both human beings and ex-
perimental animals at higher concentrations (Dobson et al., 2004). “Manganism” is a serious 
CNS disease that is caused by exposure to high concentrations of Mn oxides, often diagnosed 
in miners or workers engaged in the ferromanganese-alloy industry and the manufacturing of 
dry cell batteries (Inoue, 2007). Manganism is usually accompanied by locura manganica (Mn 
madness), thus leading to the development of a neuropsychiatric syndrome: patients in the 
early stages may complain of anorexia, lassitude, excessive tiredness, apathy, joint pains and 
muscular cramps, but later develop symptoms of organic psychosis (disorientation, impair-
ment of memory and judgment, acute anxiety, emotional lability, compulsive behaviour, flight 
of ideas, hallucinations, illusions and delusions) followed by psychomotor slowing, cognitive 
decline and manifestations of an extrapyramidal syndrome that clinically resembles Parkin-
son’s disease (Archibald and Tyree, 1987; Finkelstein et al., 2007; McMillan, 1999). 
This Mn-induced neuropsychiatric syndrome is usually the outcome of low-level long-
term occupational exposure to Mn (Finkelstein et al., 2007). The cellular, intracellular and 
molecular mechanisms underlying the Mn-induced neurotoxicity are both dose- and time-
dependent (Dobson et al., 2004; Villalobos et al., 1994), although they are also numerous and 
not well understood. Most mechanisms involve Mn2+-induced free radical production (Villa-
lobos et al., 2001), and changes in the function of nearly all systems of neurotransmission 
(Bonilla and Diez-Ewald, 1974; Eriksson et al., 1992; Lai et al., 1980; Mustafa and Chandra, 
1971). In view of the above, a high-level, short-term exposure to Mn might provide a suitable 
experimental basis for the evaluation of possible primary targets of Mn neurotoxicity, and 
                                                 
* modified-version of the article by Liapi et al., entitled: “Effects of short-term exposure to manganese 
on the adult rat brain antioxidant status and the activities of acetylcholinesterase, (Na+,K+)-ATPase and 
Mg2+-ATPase: modulation by L-cysteine”, published in Basic & Clinical Pharmacology & Toxicology 
2008; 103(2): 171-175. 
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contribute to the uncovering of mechanisms involved in the induction of clinical neuropsy-
chiatric manifestations. 
The aim of the work described and discussed in this chapter was to shed more light on 
the effects of Mn-induced neurotoxicity on: (a) the adult rat brain TAS, and (b) the activities 
of AChE and two important adenosine triphosphatases (Na+,K+-ATPase and Mg2+-ATPase). 
Moreover, in view of the fact that Cys is a well-known antioxidant and chelating agent (Car-
ageorgiou et al., 2004; Patrick, 2003), it was co-administered with Mn in order to evaluate its 
efficacy in protecting the rat brain against the Mn-induced toxic effects, specifically on the 
above parameters. 
Albino Wistar adult male rats (four-month-old, weighting 263 ± 18 g) were used in all 
experiments. The rats were housed at a maximum of four in a cage, at a constant room tem-
perature (22 ± 1oC) under a 12 h light : 12 h dark (light 08:00 - 20:00 h) cycle. Food and water 
were provided ad libitum. Animals were cared for in accordance with the principles for the 
care, use and protection of experimental animals as set by the EEC Council Directive 
86/609/EEC (EEC Council, 1986), and aligned according to the EU Recommendation 
2007/526/EU. 
Rats were divided into four groups (n = 7 at each group), as follows: (a) Control (sa-
line-treated), (b) Mn (50 mg / kg of body weight, as manganese chloride tetrahydrate - 
MnCl2·4H2O), (c) Cys (7 mg / kg of body weight), and (d) Mn+Cys (at the aforementioned dos-
es). All rats received intraperitoneal daily injections for 7 days. No behavioural or physiologi-
cal effects were observed over this period of administration. 
The animals were killed by decapitation 1 h after the last injection, and their brains 
were rapidly removed. The tissue was homogenised in 10 volumes of ice-cold (0-4oC) medi-
um containing 50 mM Tris-HCl, pH 7.4 and 300 mM sucrose, using an ice-chilled glass-
homogenising vessel at 900 rpm (4-5 strokes). Subsequently, the homogenate was centri-
fuged at 1,000 × g for 10 min in order to remove nuclei and debris (Tsakiris, 2001; Tsakiris et 
al., 2000). In the resulting supernatant, the protein content was determined according to the 
method of Lowry et al. (1951), and then the enzyme activities as well as the TAS were meas-
ured (following the same methodology described in Chapter I). 
Obtained data were analysed by ANOVA for repeated measurements, and this method 
was used for the comparison of the studied parameters. In addition, Student’s t-test followed 
by Bonferroni’s post-hoc test was used for the analysis of our findings after Cys administra-
tion, since data did not have a Gaussian distribution; p values of <0.05 were considered statis-
tically significant. All analyses were performed by SPSS for Windows Software. 
Figure A.13 illustrates the effects of administered Mn and / or Cys on the adult rat 
brain TAS. A Mn-induced statistically-significant decrease in TAS was recorded (-39%, 
p<0.001, when compared with Control), that was partially limited by the co-administration of 
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Cys (-13%, p<0.01, when compared with Control). The rat brain AChE activity was found sig-
nificantly increased by both Mn (+21%, p<0.001) and Cys (+61%, p<0.001) when compared 
with Control, while it was modified back to the control levels by the co-administration of Mn 
and Cys (Table A.21). The activity of rat brain Na+,K+-ATPase was not affected by Mn admin-
istration (Table A.22), whilst Mg2+-ATPase exhibited a slight but statistically-significant re-
duction in its activity (-9%, p<0.01, when compared with Control) attributable to Mn, which 
was further reduced by Cys co-administration (Table A.23). 
Although Mn is considered as an essential element, exposure to excessive levels of it 
can cause a variety of neurotoxic effects that involve (amongst others) alterations in oxidative 
stress biomarkers (Erikson et al., 2007; Villalobos et al., 2001). Our data revealed a statistical-
ly-significant Mn-induced reduction of whole rat brain TAS (Figure A.13), and an antioxidant 
role for Cys when co-administered with this metal ion. Because Cys did not cause a significant 
increase in the rat brain TAS by itself, the partially corrected Mn-induced TAS decrease by the 
co-administration of Mn and Cys could be attributable to the chelating properties of Cys (as-
sisting to the biological inactivation and / or excretion of Mn2+). It should be noted that Mn 
brain concentrations have not been related to the extent of lipid peroxidation (Chen et al., 
2006) or to alterations in the levels of oxidative stress biomarkers observed in certain animal 
brain regions after exposure to Mn (Erikson et al., 2007), and that such alterations might be 
(to some extent) reversible (Erikson et al., 2006). However, Cys (at least under the examined 
experimental conditions) was not proved sufficiently efficient to neutralise the Mn-induced 
oxidative stress. 
The co-administration of Mn and Cys was, on the other hand, sufficiently efficient in 
order to maintain AChE back to its control levels (Table A.21). This finding is of importance, 
since the observed Mn-induced increase of AChE activity has been associated with high brain 
Mn accumulation, as observed in a previous chronic study (Lai et al., 1992) conducted on rat 
striatum and cerebellum. Could this finding support the view that Cys exerts its neuroprotec-
tive effect towards Mn through a chelator / metal ion interaction that limits intracellular and 
extracellular free Mn2+ levels in the brain? The answer requires further research, since: (a) 
the Mn / Cys interaction is not of a simple nature (since Mn has been reported to catalyse the 
autoxidation of dopamine in the presence of Cys) (Shen and Dryhurst, 1998) and (b) Mn has 
been shown to exert different effects on AChE activity at different stages of the life circle 
(Finkelstein et al., 2007). 
The activity of Na+,K+-ATPase (Table A.22) was not affected by Mn in our study, whilst 
the Cys-induced decrease in Na+,K+-ATPase activity has already been reported by Carageor-
giou et al. (2004). Some studies (Atkinson et al., 1968; Shukla et al., 1983) have reported that 
Mn can inhibit Na+,K+-ATPase at high concentrations (over 1 mM), but it can also activate 
Na+,K+-ATPase at lower concentrations. Shukla et al. (1983) have demonstrated a concentra-
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tion-dependent effect of Mn on the brain microsomal Mg2+-Na+,K+-ATPase activity, by both in 
vivo and in vitro studies. These studies (Atkinson et al., 1968; Shukla et al., 1983) have also 
shown that Mn2+ could replace the Mg2+ of the Mg2+-ATPase, at certain Mn concentrations. 
This chemical property of Mn might result in a (slight but significant) decrease of Mg2+-
ATPase activity; a fact that was also observed in our experiments (Table A.23). Since Mg2+-
ATPase is an enzyme functioning in order to maintain high brain intracellular Mg2+, and 
hence possibly controlling the rate of protein synthesis and cell growth (Sanui and Rubin, 
1982), the high intracellular Mn2+ levels might be the reason for the observed inhibition. On 
the other hand, the co-administration of Cys could not circumvent this inhibition, because Cys 
seems to also cause a significant inhibition of Mg2+-ATPase by itself. 
In conclusion, our findings suggest that short-term in vivo administration of Mn causes 
a significant decrease in the rat brain TAS and a significant increase in AChE activity. Both 
effects can, either partially or totally, be reversed back to those of control levels by Cys co-
administration (which could hence be considered for future applications as a neuroprotective 
agent against chronic exposure to Mn and the treatment of manganism). The activity of 
Na+,K+-ATPase is not affected by Mn, whilst Mg2+-ATPase activity is slightly (but significantly) 
inhibited by Mn. These findings suggest that Mn (at least under the experimental conditions 
employed) may not primarily interfere with neuronal excitability, metabolic energy produc-
tion, as well as with the uptake and release of catecholamines, 5-HT and glutamate (Bogdan-
ski et al., 1968; Hernández, 1987; Lees et al., 1990; Mata et al., 1980; Sastry and Phillis, 1977; 
Swann, 1984). It may, however, cause oxidative stress, cholinergic dysfunction and other in-
tracellular deregulating phenomena associated with its antagonistic interaction with other 
essential elements such as Mg2+. 
 
>> Tables A.21, A.22 and A.23: page 49 
>> Figure A.13: page 50 
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Table A.21: Effects of Mn on the adult rat brain AChE activity and modulation by in vivo Cys 
co-administration. 
 
  
Treatment AChE activity (ΔOD / min x mg protein) 
  
  
Control  0.736 ± 0.045   |   --- 
Mn 0.893 ± 0.019   |   +21% (***) vs Control 
Cys 1.187 ± 0.028   |   +61% (***) vs Control 
Mn+Cys 0.719 ± 0.030   |   -2% (NS) vs Control; -19% (***) vs Mn 
  
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-
statistically-significant; ***: p<0.001. 
 
 
Table A.22: Effects of Mn on the adult rat brain Na+,K+-ATPase activity and modulation by in 
vivo Cys co-administration. 
 
  
Treatment Na+,K+-ATPase activity (μmol Pi / h x mg protein) 
  
  
Control  2.69 ± 0.24   |   --- 
Mn 2.59 ± 0.22   |   -4% (NS) vs Control 
Cys 1.57 ± 0.14   |   -42% (***) vs Control 
Mn+Cys 1.93 ± 0.11   |   -28% (***) vs Control; -25% (***) vs Mn 
  
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-
statistically-significant; ***: p<0.001. 
 
 
Table A.23: Effects of Mn on the adult rat brain Mg2+-ATPase activity and modulation by in 
vivo Cys co-administration. 
 
  
Treatment Mg2+-ATPase activity (μmol Pi / h x mg protein) 
  
  
Control  7.12 ± 0.26   |   --- 
Mn 6.50 ± 0.38   |   -9% (**) vs Control 
Cys 5.99 ± 0.21   |   -16% (***) vs Control 
Mn+Cys 6.08 ± 0.16   |   -15% (***) vs Control; -6% (*) vs Mn 
  
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. ***: p<0.001; **: 
p<0.01; *: p<0.05. 
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Figure A.13: Effects of Mn on the adult rat brain TAS and modulation by in vivo Cys co-
administration. 
 
 
 
 
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-
statistically-significant (when compared with Control); ***: p<0.001 (when compared with Control); **: p<0.01 
(when compared with Control); ###: p<0.001 (when compared with Mn). 
 
 
 
 
 
  
CHAPTER VI 
 
Contribution to the study of lanthanum-induced  
neurotoxicity* 
 
The rare earth elements (REEs) comprise a group of metallic elements that have similar 
chemical and physiological properties (Das et al., 1988; Evans, 1983). Lanthanum (La) is a 
REE used for medical (as a treatment of hyperphosphatemia ascribable to chronic renal fail-
ure) (Hutchison et al., 2004) and agricultural (as a trace fertiliser) (Guo et al., 1990) purpos-
es. Moreover, La is also released into the aquatic environment through industrial (electronic-
manufacturing), mining (of gold and uranium) and energy-producing (through coal-fired 
power plants) activities (Goetz et al., 1982; Noller, 1991; 1994). In fact, it has been suggested 
that lanthanides (the series of elements relevant to La) are released into the environment in 
amounts that largely exceed the environmental release of mercury or cadmium by up to 50 
times, of selenium, uranium or tin by up to 10 times, and of arsenic or lead by 2-3 times (Sab-
bioni et al., 1982). Hence, the amounts of La that reach the human body, either through the 
food chain, medical applications or via atmospheric particles, are high (Zhu et al., 1997). 
The REEs are not considered as highly toxic to mammals (Haley, 1965). However, stud-
ies have shown that children living near lanthanide ore areas tend to have lower IQ levels 
than those from other regions (Fan et al., 2004; Zhu et al., 1996). A number of experimental 
studies have focused on the La-induced neurotoxicity, and have revealed some very interest-
ing findings (Basu et al., 1982; 1984; Feng et al., 2006; Gundersen and Miledi, 1983). Indeed, 
it has been recently suggested that La could possibly impair learning ability via a disturbance 
of the homeostasis between trace elements, enzymes and neurotransmitter systems in the rat 
brain (Feng et al., 2006). However, this hypothesis has been questioned on the ground of La 
being an element that cannot readily cross the blood-brain barrier, and has questionable con-
centration-dependent biological effects (Damment et al., 2007). 
It should be noted that La has many chemical and physical characteristics in common 
with calcium (Ca) (Evans, 1983), and that its biological actions are mainly mediated through 
the displacement or replacement of Ca2+ at certain Ca2+-binding sites (Das et al., 1988), as well 
                                                 
* modified-version of the article by Liapi et al., entitled: “The neuroprotective role of L-cysteine towards 
the effects of short-term exposure to lanthanum on the adult rat brain antioxidant status and the activ-
ities of acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase”, published in BioMetals 2009; 22(2): 329-335. 
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as through its high affinity for the phosphate groups of certain macromolecules (Howells and 
Coult, 1971). Moreover, since REEs are believed to be excluded by the plasma membrane and 
cannot enter the cytoplasm, plasma membrane molecules are considered as their primary 
targets (Gao et al., 1998). 
The aim of the work described and discussed in this chapter was to shed more light on 
the effects of La-induced neurotoxicity, with regard to: (a) the adult rat brain TAS and (b) the 
activities of AChE and two important adenosine triphosphatases (Na+,K+-ATPase and Mg2+-
ATPase). Moreover, in view of the fact that Cys is a well-known antioxidant and chelating 
agent (Carageorgiou et al., 2004; Patrick, 2003), it was co-administered with La in order to 
evaluate its efficacy on protecting the rat brain against La-induced toxic effects on the above 
parameters. 
Albino Wistar adult male rats (four-month-old, weighting 279 ± 25 g) were used in all 
experiments. The rats were housed at a maximum of four in a cage, at a constant room tem-
perature (22 ± 1oC) under a 12 h light : 12 h dark (light 08:00 - 20:00 h) cycle. Food and water 
were provided ad libitum. Animals were cared for in accordance with the principles for the 
care, use and protection of experimental animals as set by the EEC Council Directive 
86/609/EEC (EEC Council, 1986), and aligned according to the EU Recommendation 
2007/526/EU. 
Rats were divided into four groups (n = 7 in each group), as follows: (a) Control (sa-
line-treated), (b) La (53 mg / kg of body weight, as lanthanum chloride heptahydrate - 
LaCl3·7H2O, which is equivalent to 1/2 of its median lethal dose; LD50), (c) Cys (7 mg / kg of 
body weight), and (d) La+Cys (on the aforementioned doses). All rats received intraperitone-
al daily injections for 7 days. No behavioural or physiological effects were observed during 
this period of administration. 
The animals were killed by decapitation 1 h after the last injection, and their brains 
were rapidly removed. The tissue was homogenised in 10 volumes of ice-cold (0-4oC) medi-
um containing 50 mM Tris-HCl, pH 7.4 and 300 mM sucrose, using an ice-chilled glass-
homogenising vessel at 900 rpm (4-5 strokes). Subsequently, the homogenate was centri-
fuged at 1,000 × g for 10 min in order to remove nuclei and debris (Tsakiris, 2001; Tsakiris et 
al., 2000). In the resulting supernatant, the protein content was determined according to the 
method of Lowry et al. (1951), and then the enzyme activities as well as the TAS were meas-
ured (following the same methodology described in Chapter I). 
Obtained data were analyzed by Student’s t-test followed by Bonferroni’s post-hoc test 
when needed; p values of <0.05 were considered statistically significant. All analyses were 
performed by SPSS for Windows Software. 
The effects of La and / or Cys on the adult rat brain TAS are presented in Figure A.14. A 
La-induced statistically-significant decrease in TAS was recorded (-36%, p<0.001, when com-
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pared with Control), that was partially limited by the co-administration of Cys (-13%, p<0.01, 
when compared with Control) (Figure A.14). The rat brain AChE activity was found signifi-
cantly increased by both La (+23%, p<0.001, when compared with Control) and Cys (+59%, 
p<0.001, when compared with Control), whilst it was adjusted back to control levels by the 
co-administration of La and Cys (Table A.24). The activity of rat brain Na+,K+-ATPase was sig-
nificantly decreased by La-administration (-28%, p<0.001, when compared with Control), 
whilst Cys co-administration could not reverse this decrease (Table A.25). The activity of 
Mg2+-ATPase exhibited a slight but statistically-significant reduction in its activity (-8%, 
p<0.01) attributable to La (when compared with Control), that was further reduced by Cys 
co-administration (Table A.26). 
Exposure to La is known to cause a variety of biological effects in a time- and dose-
dependent manner (Zheng et al., 2000). Lipid peroxidation of plasma membranes is de-
pressed by low and enhanced by high La concentrations, whilst the reduction rate of ferricy-
anide [Fe(CN)63-; a redox system activity marker] is increased by low and decreased by high 
La concentrations (Zheng et al., 2000). Our data revealed a statistically-significant La-induced 
reduction of whole rat brain TAS (Figure A.14), following its high-dose short-term in vivo ad-
ministration. The co-administration of Cys was able to partially correct the La-induced TAS-
decrease, an observation possibly attributable to the chelating properties of Cys (assisting to 
the biological inactivation and / or excretion of La ions; La3+) and / or to the possible elimina-
tion of La-induced free radical production. However, Cys (at least under the employed exper-
imental conditions) was not proved efficient enough to neutralise the La-induced oxidative 
stress. 
The co-administration of La and Cys was, on the other hand, efficient enough in order 
to maintain AChE at its control levels (Table A.24) and reverse the La-induced AChE activa-
tion. This finding is of much importance, since most in vitro studies have reported a La-
induced decrease in AChE activity (Ghosh et al., 1991; Gundersen and Miledi, 1983; Marquis 
and Black, 1985). Could this finding support the view of Damment et al. (2007), that La can 
actually cross the blood-brain barrier? Could this support the postulate that the observed 
AChE activation is an indirect effect of La? If so, what is the reason for this in vivo AChE acti-
vation, and how does Cys manage to reverse it? 
Recent studies (Feng et al., 2006; Xiao et al., 2005) have suggested that lanthanides can 
penetrate the blood-brain barrier when administered in high concentrations, and can accu-
mulate in certain crucial rat brain regions (such as those of the cerebral cortex, the hippo-
campus and the cerebellum). Moreover, La has been shown to inhibit the Ca2+-dependent 
neurotransmitter release (Przywara et al., 1992) and modulate ion homeostasis within the 
CNS (Feng et al., 2006). Since Cys also activates the rat brain AChE, the mechanism by which 
Cys exerts its neuroprotective effect towards La cannot be directly related to the enzyme, but 
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is possibly taking place through a chelator / metal ion interaction that limits extracellular free 
La3+ levels within the CNS and / or restricts the indirect (oxidative or deregulating) effects of 
this metal ion (towards other enzymes and mechanisms of neurotransmission) within the 
body and / or the CNS. However, this hypothesis requires further investigation, since: (a) it is 
not clear whether La is directly affecting AChE activity through its physical presence within 
the CNS (Damment et al., 2007), (b) little is known about the consequences of the reported 
ion homeostasis deregulation (Feng et al., 2006), whilst (c) the mechanisms by which the La-
induced cognitive decline is postulated to develop do not implicate any modifications in ACh 
levels (Feng et al., 2006). 
The La-induced decrease of the whole rat brain Na+,K+-ATPase activity (Table A.25) 
was expected (Li et al., 1998), whilst the Cys-induced decrease in Na+,K+-ATPase activity has 
already been reported by Carageorgiou et al. (2004). In contrast to the above parameters 
(TAS and AChE activity), Cys was not able to reverse this La-induced inhibition of Na+,K+-
ATPase. This finding suggests that La might interfere with neuronal excitability, metabolic 
energy production, as well as with the uptake and release of catecholamines, 5-HT and glu-
tamate (Bogdanski et al., 1968; Hernández, 1987; Lees et al., 1990; Mata et al., 1980; Sastry 
and Phillis, 1977; Swann, 1984), in a manner that cannot be reversed by the administration of 
an antioxidant / chelating-agent, such as Cys. This finding appears of much importantance: 
previous studies have implicated La-administration in glutamatergic, serotoninergic and do-
paminergic dysfunction (Basu et al., 1984; Feng et al., 2006). Moreover, the ability of La to 
cause a (slight but significant) decrease of Mg2+-ATPase activity, that could also not be re-
versed by Cys co-administration (Table A.26), leads to the conclusion that this metal ion also 
affects cellular mechanisms that function in order to maintain high brain intracellular Mg2+, 
and thus possibly controlling the rate of protein synthesis and cell growth (Sanui and Rubin, 
1982). The observed effects of La on the examined adenotriphosphatases could arise from the 
calcium adenosine triphosphatase (Ca2+-ATPase) inhibition (Basu et al., 1982; Zheng et al., 
2000), resulting in Ca2+-homeostasis deregulation, membrane signaling dysfunction, ATP 
consumption and / or ion redistribution. 
In conclusion, our findings suggest that short-term in vivo La-administration causes a 
significant decrease in rat brain TAS, and a significant increase in AChE activity. Both effects 
can, partially or totally, be reversed back to control levels by the co-administration of Cys, 
which could hence be considered for future application as a neuroprotective agent against 
poisoning and / or chronic exposure to La. The activities of Na+,K+-ATPase and Mg2+-ATPase 
were inhibited by La, in a manner which was irreversible by Cys. These findings suggest that 
La, at least under the examined experimental conditions, might interfere with neuronal excit-
ability, metabolic energy production, in addition to the uptake and release of catecholamines, 
5-HT and glutamate. Some of these phenomena might arise from oxidative stress, cholinergic 
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dysfunction and / or further intracellular deregulating phenomena associated with its chemi-
cal resemblance to other ions such as Ca2+. However, this matter requires further research in 
order to elucidate the exact mechanisms that lead (or at least have the potential to lead) to 
the (reported in the literature) La-induced cognitive impairment. 
 
>> Tables A.24, A.25 and A.26: page 56 
>> Figure A.14: page 57 
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Table A.24: Effects of La on the adult rat brain AChE activity and modulation by in vivo Cys 
co-administration. 
 
  
Treatment AChE activity (ΔOD / min x mg protein) 
  
  
Control  0.721 ± 0.054   |   --- 
La 0.890 ± 0.035   |   +23% (***) vs Control 
Cys 1.146 ± 0.031   |   +59% (***) vs Control 
La+Cys 0.750 ± 0.041   |   +4% (NS) vs Control; -16% (***) vs La 
  
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-
statistically-significant; ***: p<0.001. 
 
 
Table A.25: Effects of La on the adult rat brain Na+,K+-ATPase activity and modulation by in 
vivo Cys co-administration. 
 
  
Treatment Na+,K+-ATPase activity (μmol Pi / h x mg protein) 
  
  
Control  2.56 ± 0.28   |   --- 
La 1.85 ± 0.19   |   -28% (***) vs Control 
Cys 1.47 ± 0.31   |   -43% (***) vs Control 
La+Cys 1.86 ± 0.23   |   -27% (***) vs Control; +1% (NS) vs La 
  
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-
statistically-significant; ***: p<0.001. 
 
 
Table A.26: Effects of La on the adult rat brain Mg2+-ATPase activity and modulation by in 
vivo Cys co-administration. 
 
  
Treatment Mg2+-ATPase activity (μmol Pi / h x mg protein) 
  
  
Control  7.25 ± 0.31   |   --- 
La 6.66 ± 0.36   |   -8% (**) vs Control 
Cys 6.13 ± 0.18   |   -15% (***) vs Control 
La+Cys 5.46 ± 0.24   |   -25% (***) vs Control; -18% (***) vs La 
  
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. ***: p<0.001; **: 
p<0.01. 
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Figure A.14: Effects of La on the adult rat brain TAS and modulation by in vivo Cys co-
administration. 
 
 
 
 
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-
statistically-significant (when compared with Control); ***: p<0.001 (when compared with Control); **: p<0.01 
(when compared with Control); ###: p<0.001 (when compared with La). 
 
 
 
 
 
 
 
  
CHAPTER VII 
 
Contribution to the study of nickel-induced 
neurotoxicity* 
 
Nickel (Ni) is an environmental pollutant of wide distribution. Rock and soil dissolution, at-
mospheric fallout, industrial processing and waste disposal are the main pathways through 
which Ni enters groundwater and surface water (Obone et al., 1999). Industrial processing-
related anthropogenic activities provide a considerable amount of Ni in the environment as a 
consequence of mining, smelting, cement-production, combustion of fossil fuels, incineration 
of sewage sludge, electroplating, Ni-containing chemical manufacturing and / or use of water 
treatment plant-derived composted fertilizers (Zawisza-Raszka and Dolezych, 2008). As a 
result, human exposure to Ni is both occupational (mainly through inhalation) and dietary 
(through water and food chain-induced biomagnification) (Evans et al., 1995; Goyer, 1986). 
The rate and extent of Ni absorption is primarily dependent upon the solubility of the 
particular compound (Coogan et al., 1989): soluble compounds (such as chloride, sulfate, and 
nitrate salts) are thought to enter the cell by active transport rather than by diffusion (Furst, 
1984), whilst insoluble compounds can become more soluble in certain biological fluids (Cos-
ta et al., 1981). Inhalational exposure to Ni-compounds has been shown to produce respirato-
ry epithelial degeneration and olfactory epithelium atrophy (Benson et al., 1987; 1988), as 
well as olfactory impairment (Sunderman, 2001) and (in some cases) anosmia (Adams and 
Crabtree, 1961). Moreover, experimental exposure to the soluble Ni-63 chloride (63NiCl2) has 
been reported to provoke accumulation of Ni-63 (63Ni) in the olfactory peduncle, the olfactory 
tubercle, and even the cerebrum (Henriksson et al., 1997; Tallkvist et al., 1998). 
The current knowledge upon the neurotoxic effects of Ni is, however, limited. Dizzi-
ness, weakness, headache, sleeplessness, dysphoria and blurred vision are some of the non-
specific clinical symptoms reported to be related to Ni-compound occupational exposure (Shi, 
1994). However, several experimental studies have revealed a significant neuromodulatory 
role for Ni, since the latter has been suggested to interfere with ACh release from peripheral 
nerve terminals in vitro (Kita and Van der Kloot, 1973) and has been reported to decrease the 
                                                 
* modified-version of the article by Liapi et al., entitled: “Short-term exposure to nickel alters the adult 
rat brain antioxidant status and the activities of crucial membrane-bound enzymes: neuroprotection 
by L-cysteine”, published in Biological Trace Element Research 2011; 143(3): 1673-1681. 
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levels of dopamine, norepinephrine, and 5-HT in certain rat brain regions (Fatehyab et al., 
1980). 
The aim of the work described and discussed in this chapter was to shed more light on 
the effects of Ni-induced neurotoxicity on: (a) the adult rat brain TAS and (b) the activities of 
AChE and two important adenosine triphosphatases (Na+,K+-ATPase and Mg2+-ATPase). 
Moreover, in view of the fact that Cys is a well-known antioxidant and chelating agent (Car-
ageorgiou et al., 2004; Patrick, 2003), it was co-administered with Ni in order to evaluate its 
efficacy on protecting the rat brain against the Ni-induced toxic effects on the above parame-
ters. 
Albino Wistar adult male rats (four-month-old, weighting 283 ± 19 g) were used in all 
experiments. The rats were housed at a maximum of four in a cage, at a constant room tem-
perature (22 ± 1oC) under a 12 h light : 12 h dark (light 08:00 - 20:00 h) cycle. Food and water 
were provided ad libitum. Animals were cared for in accordance with the principles for the 
care, use and protection of experimental animals as set by the EEC Council Directive 
86/609/EEC (EEC Council, 1986) and aligned according to the EU Recommendation 
2007/526/EU. 
Rats were divided into four groups, as follows: (a) Control (saline-treated) (n = 7), (b) 
Ni (13 mg / kg of body weight, as nickel chloride - NiCl2, which is equivalent to 1/3 of its LD50) 
(Yan et al., 1998) (n = 9), (c) Cys (7 mg / kg of body weight) (n = 7), and (d) Ni+Cys (at the 
aforementioned doses) (n = 9). All rats received intraperitoneal daily injections for a period 
of 7 days. Two rats from each of the Ni-treated groups were excluded in view of the develop-
ment of evident inflammation at the injection sites. 
The animals were killed by decapitation 1 h after the last injection, and their brains 
were rapidly removed. The tissue was homogenised in 10 volumes of ice-cold (0-4oC) medi-
um containing 50 mM Tris-HCl, pH 7.4 and 300 mM sucrose, using an ice-chilled glass-
homogenising vessel at 900 rpm (4-5 strokes). Subsequently, the homogenate was centri-
fuged at 1,000 × g for 10 min in order to remove nuclei and debris (Tsakiris, 2001; Tsakiris et 
al., 2000). In the resulting supernatant, the protein content was determined according to the 
method of Lowry et al. (1951), and then the enzyme activities as well as the TAS were meas-
ured (following the same methodology described in Chapter I). 
Obtained data were analyzed by Student’s t-test followed by Bonferroni’s post-hoc test 
when required; p values of <0.05 were considered statistically significant. All analyses were 
performed by SPSS for Windows Software. 
The effects of Ni and / or Cys on the adult rat brain TAS are presented in Figure A.15. A 
Ni-induced statistically-significant decrease in TAS was recorded (-47%, p<0.001, when com-
pared with Control), that was efficiently limited by the co-administration of Cys (-4%, p>0.05, 
when compared with Control). The rat brain AChE activity was found significantly increased 
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by both Ni (+30%, p<0.001, when compared with Control) and Cys (+62%, p<0.001, when 
compared with Control), whilst it tended to adjust back to the control levels by the co-
administration of Ni and Cys (+13%, p<0.001, when compared with Control) (Table A.27). 
The rat brain Na+,K+-ATPase activity was significantly decreased by Ni-administration (-49%, 
p<0.001, when compared with Control), whilst Cys supplementation could not reverse this 
decrease (-44%, p<0.001, when compared with Control) (Table A.28). The activity of Mg2+-
ATPase was not affected by Ni-administration, but was significantly reduced when Ni was co-
administered with Cys (-17%, p<0.001, when compared with Control) (Table A.29). 
Despite the fact that Ni is an element, the biological actions of which are not fully un-
derstood, it is known that chemical transformations of it within cells lead to the production of 
ROS (Kawanishi et al., 1994; Novelli et al., 1995). These ROS could be a significant source of 
oxidative stress-induced cellular dysfunction and / or damage. Our data revealed a statistical-
ly-significant Ni-induced reduction of whole rat brain TAS (Figure A.15), following high-dose 
short-term in vivo administration. The co-administration of Cys was able to neutralise this Ni-
induced TAS decrease, an observation possibly attributable to the chelating properties of Cys 
(assisting to the biological inactivation and / or excretion of nickel ions; Ni2+) and / or to the 
possible elimination of the Ni-induced free radical production. It is already known that Cys 
manages to eliminate the oxidative effects of heavy metal ions: previous studies of ours have 
demonstrated the antioxidant capacity for Cys against cadmium ions (Carageorgiou et al., 
2004; 2005b), Mn2+ (Liapi et al., 2008) and La3+ (Liapi et al., 2009c) in adult rats. 
The co-administration of Ni and Cys was, furthermore, efficient enough in order to lim-
it the Ni-induced AChE activity increase (Table A.27). Apart from the evident neuroprotective 
role of Cys, this is (according to our knowledge) the first in vivo experimental study that fo-
cuses on the effects of Ni on rat brain AChE activity (a crucial enzyme for the nervous system 
and a functional target of several xenobiotics) (Frasco et al., 2005). 
The background of findings concerning the role of Ni in AChE activity is contradictory. 
Rat erythrocyte and bone marrow AChE activities were both found increased after a single 
intrarenal injection of nickel subsulfide (Ni3S2; by approximately +47% and +67% towards 
their respective controls) (Miszta et al., 1986). In a more recent study, long-term (10 weeks) 
sludge-supplemented diet-fed rats (considered to be exposed to Ni, cadmium, and other met-
als) were found to have activated brain and muscle AChE (Bag et al., 1999); however, this 
study did not discriminate the effects of Ni from those derived from the exposure to all 
sludge-containing contaminants. This is more-or-less the same problem that one has to face 
when considering the findings of Tsangaris et al. (2007), in which AChE activity was meas-
ured in mussels (Mylitus galloprovincialis), both native and transplanted for 1 and 6 months 
at a bay polluted by a ferro-Ni smelting plant. The mussels exhibited a decrease in AChE activ-
ity arising from their exposure to the polluted bay water; this fact was, however, not re-
Zarros AC | PhD Thesis (by published work / retrospective) in Neuroscience  61
established under laboratory conditions following the exposure to a mixture of Ni, chromium 
and ferrum, since mussel AChE activities exhibited non-significant changes (Tsangaris et al., 
2007). In support of this finding is an older in vitro study of Repetto et al. (2001), in which 
NiCl2 was not able to modify the AChE activity of Neuro-2a mouse neuroblastoma cells, fol-
lowing a 24 h exposure to various concentrations of the toxic metal. This last finding is in 
agreement with those of Frasco et al. (2005), who have thoroughly studied the implementa-
tion of assay conditions for the use of AChE activity as a biomarker of in vitro metal toxicity 
and have underlined that “unmistakably [...] all metals significantly inhibit AChE with the ex-
ception of Ni2+”. 
All pre-mentioned studies indicate the contradictions that exist concerning the effects 
of Ni on AChE activity. Our study has shown an increase in rat brain AChE activity following a 
short-term high-dose intraperitoneal administration. Since Cys also activates the rat brain 
AChE, one could propose the hypothesis that the mechanism by which Cys exerts its neuro-
protective effect towards Ni is not directly related to the enzyme, but it might possibly be tak-
ing place through a chelator / metal ion interaction that limits free Ni2+ levels within the CNS 
and / or restricts the indirect (oxidative or deregulating) effects of Ni (towards other en-
zymes and mechanisms of neurotransmission) within the body and / or the CNS. 
The Ni-induced decrease of the whole rat brain Na+,K+-ATPase activity (Table A.28) is 
also a novel finding, whilst the Cys-induced decrease in Na+,K+-ATPase activity has already 
been reported (Carageorgiou et al., 2004; Liapi et al., 2008; 2009c). In contrast to the pre-
mentioned parameters (TAS and AChE activity), Cys was not able to reverse this Ni-induced 
inhibition of Na+,K+-ATPase. This finding suggests that Ni might interfere with neuronal excit-
ability, metabolic energy production, as well as with the uptake and release of catechola-
mines, 5-HT and glutamate (Bogdanski et al., 1968; Hernández, 1987; Lees et al., 1990; Mata 
et al., 1980; Sastry and Phillis, 1977; Swann, 1984), in a manner that cannot be reversed by 
the administration of an antioxidant and chelating agent such as Cys. 
Our data revealed that Ni (at least under the examined experimental conditions) does 
not cause any effect on the rat brain Mg2+-ATPase activity (Table A.29). This finding is not in 
agreement with those of Asthana et al. (1992), demonstrating a significant stimulation of 
both Mg2+-ATPase and Ca2+-ATPase of Nostoc muscorum, following an in vitro exposure of the 
cyanobacterium cells to various concentrations of Ni. 
In conclusion, our findings suggest that short-term in vivo Ni-administration causes a 
significant decrease in the rat brain TAS and a significant increase in AChE activity. Both ef-
fects can be, partially or totally, reversed into control levels by Cys co-administration, which 
could hence be considered for future applications as a neuroprotective agent against Ni-
induced neurotoxicity. The activity of Na+,K+-ATPase was inhibited by Ni, in a non-reversible 
(by Cys) manner, whilst Mg2+-ATPase was found to be unaffected by Ni-administration. These 
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findings suggest that Ni, at least under the examined experimental conditions, might interfere 
with neuronal excitability, metabolic energy production, as well as with the uptake and re-
lease of catecholamines, 5-HT and glutamate. Some of these phenomena may arise from oxi-
dative stress, cholinergic dysfunction, and / or other intracellular deregulating phenomena. 
However, the matter requires further research in order to fully elucidate the spectrum of the 
neurotoxic effects of Ni, to clarify the direct or indirect nature of the hereby reported Ni-
induced neurotoxicity, and to correlate the observed phenomena with the exact levels of Ni 
found in neural tissues. 
 
>> Tables A.27, A.28 and A.29: page 63 
>> Figure A.15: page 64 
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Table A.27: Effects of Ni on the adult rat brain AChE activity and modulation by in vivo Cys 
co-administration. 
 
  
Treatment AChE activity (ΔOD / min x mg protein) 
  
  
Control  0.743 ± 0.039   |   --- 
Ni 0.968 ± 0.025   |   +30% (***) vs Control 
Cys 1.206 ± 0.027   |   +62% (***) vs Control 
Ni+Cys 0.842 ± 0.018   |   +13% (***) vs Control; -13% (***) vs Ni 
  
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. ***: p<0.001. 
 
 
Table A.28: Effects of Ni on the adult rat brain Na+,K+-ATPase activity and modulation by in 
vivo Cys co-administration. 
 
  
Treatment Na+,K+-ATPase activity (μmol Pi / h x mg protein) 
  
  
Control  2.72 ± 0.31   |   --- 
Ni 1.40 ± 0.17   |   -49% (***) vs Control 
Cys 1.67 ± 0.30   |   -39% (***) vs Control 
Ni+Cys 1.51 ± 0.27   |   -44% (***) vs Control; +8% (NS) vs Ni 
  
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-
statistically-significant; ***: p<0.001. 
 
 
Table A.29: Effects of Ni on the adult rat brain Mg2+-ATPase activity and modulation by in 
vivo Cys co-administration. 
 
  
Treatment Mg2+-ATPase activity (μmol Pi / h x mg protein) 
  
  
Control  6.98 ± 0.24   |   --- 
Ni 6.76 ± 0.19   |   -3% (NS) vs Control 
Cys 5.77 ± 0.23   |   -17% (***) vs Control 
Ni+Cys 5.81 ± 0.28   |   -17% (***) vs Control; -14% (***) vs Ni 
  
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-
statistically-significant; ***: p<0.001. 
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Figure A.15: Effects of Ni on the adult rat brain TAS and modulation by in vivo Cys co-
administration. 
 
 
 
 
 
Note: each value indicates the mean ± SD of seven independent experiments (seven rats, n = 7). The average of 
each experiment arose from three evaluations in the homogenised brain tissue of each animal. NS: non-
statistically-significant (when compared with Control); ***: p<0.001 (when compared with Control); ###: p<0.001 
(when compared with Ni). 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
PART B 
 
Critical appraisal of the published work  
 
 
 
 
 
 
  
CHAPTER VIII 
 
Novelty, importance and perspectives  
of the published work* 
 
The current PhD Thesis incorporates and presents performed studies of three crucial brain 
enzyme activities under seven categories of experimentally-simulated toxic and metabolic 
encephalopathies. The studied enzymes were: (a) AChE (EC 3.1.1.7), (b) Na+,K+-ATPase (EC 
3.6.3.9, formerly EC 3.6.1.3), and (c) Mg2+-ATPase (EC 3.6.3.2, formerly EC 3.6.1.3). On the 
other end, the studied experimentally-simulated toxic and metabolic encephalopathies were: 
(a) TH-related brain dysfunctions (as a result of HyperT or HypoT), (b) TAA-induced fulmi-
nant hepatic encephalopathy, (c) STZ-induced diabetic encephalopathy, (d) experimentally-
simulated WE (arising from chronic EtOH consumption, dietary TD and PT-administration), 
(e) Mn-induced neurotoxicity, (f) La-induced neurotoxicity, and (g) Ni-induced neurotoxicity. 
Within these studies, enzymatic activities were determined spectrophotometrically on albino 
Wistar rat brain homogenates, while assessments of brain homogenates’ antioxidant status, 
in vivo antioxidant administrations, in vitro experiments, brain homogenates’ enzymatic ac-
tivity determinations, as well as pure enzyme activity determinations (under various condi-
tions) were performed (wherever required) in order to: (a) elucidate the nature of some of 
the observed in vivo findings, (b) evaluate the potential limitations of the experimental-
simulation techniques and / or (c) study the potential use of known antioxidants as neuro-
protective agents. It should be noted that all experiments were performed at the laboratories 
of the Medical School of the National and Kapodistrian University of Athens.  
An organized synopsis of the novelty, the importance and the perspectives of the pub-
lished work that form the basis of this PhD Thesis is provided in this chapter. However, this 
synopsis should also be considered as a supplement to the discussion presented in Part A 
(Chapters I-VII) of the current PhD Thesis. 
 
Contribution to the study of TH-related brain dysfunctions: 
 
The published work on the study of TH-related brain dysfunctions (Carageorgiou et al., 
2005a) that is incorporated in this PhD Thesis (Chapter I) has reported that experimentally-
                                                 
* this chapter is the first part of the required by the PhD (by published work / retrospective) regula-
tions of the University of Bolton “critical appraisal”. 
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induced adult-onset long-term moderate HyperT (provoked through daily subcutaneous in-
jections of T4 at a dose of 25 μg / 100 g of body weight, for 14 days) (Pantos et al., 1999) does 
not affect the rat brain TAS and Mg2+-ATPase activity, but exerts a significant inhibition of 
both rat brain AChE and Na+,K+-ATPase. These findings are not in total agreement with the 
findings of others (Almeida and Santos, 1993; Smith et al., 2002; Virgili et al., 1991) possibly 
due to methodological and timeframe-dependent variations in the experimental approaches 
employed, but have provided a basis for further brain region-specific studies performed by 
the host laboratories (Carageorgiou et al., 2007a; 2007b). The latter have revealed a brain 
region-specific vulnerability of the studied enzyme activities to experimentally-induced 
adult-onset long-term moderate HyperT (Carageorgiou et al., 2007a; 2007b), and have pro-
vided a better view of their potential association to the clinically-well-characterized HyperT-
accompanying neuropsychiatric symptomatology.  
The same published work (Chapter I; Carageorgiou et al., 2005a) has also reported that 
experimentally-induced HypoT (provoked through the administration of PTU in the drinking 
water at a concentration of 0.05%, for 21 days) (Pantos et al., 2003) increases rat brain TAS 
as well as Na+,K+- and Mg2+-ATPase activities (as compared to their respective control levels), 
and significantly-inhibits rat brain AChE. These changes are considered to accurately reflect 
the metabolic effects that the employed experimental approach to HypoT exerts on the rat 
brain, and were accompanied by a marked (and rarely observed by us in other experimental 
settings) decrease of the rat brain homogenate protein concentration. Although the latter 
could be attributed to the inhibited brain Mg2+-ATPase (an ATP-consuming enzyme that func-
tions in order to maintain high intracellular Mg2+ levels and that is known to control through 
them major cellular functions such as protein synthesis and cell growth) (Sanui and Rubin, 
1982), little could be said in order to explain the observed significant decrease of rat body 
weight due to HypoT. In a similar experimental setting employing a lower PTU concentration 
(0.005%) in the drinking water, Ahmed et al. (1993) did not observe any significant change in 
the body weight of male Sprague-Dawley rats undergoing experimentally-induced adult-
onset HypoT (as compared to their controls). However, a significant body weight loss was 
observed in rats undergoing neonatal thyroidectomy even by the time they reached adult-
hood (Hrdina et al., 1975). A possible reason for the observed, by us, weight loss accompany-
ing the employed PTU-induced adult-onset HypoT could be the fact that no action has been 
taken in order to ensure that the dilution of PTU into the drinking water would not cause a 
bitter taste to the receiving rats (Turnbull and Matisoo-Smith, 2002), nor have we systemati-
cally monitored food and water consumption in the specific (Carageorgiou et al., 2005a) or 
the subsequent brain region-specific studies of ours (Carageorgiou et al., 2007a; 2007b). The 
latter, as in the case of HyperT, have provided us with a more accurate view of the potential 
association of the observed brain region-dependent neurochemical changes (as reflected by 
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the study of the activities of AChE, Na+,K+-ATPase and Mg2+-ATPase in crucial brain regions 
such as the frontal cortex, the hippocampus, the hypothalamus and the cerebellum) (Car-
ageorgiou et al., 2007a; 2007b) with the clinically-serious HypoT-accompanying neuropsy-
chiatric symptomatology. 
It should be noted that the work presented and discussed in Chapter I (Carageorgiou et 
al., 2005a) of the current PhD Thesis has also formed the basis for a recently undertaken and 
published study of ours on the effects of gestational and / or lactational maternal exposure to 
PTU-induced experimental HypoT on the same crucial brain enzyme activities of Wistar rat 
offspring, at two time-points of their lives: at birth (day 1) and at 21 days of age (end of lacta-
tion) (Koromilas et al., 2014). The findings of the latter study have provided the basis for a 
debate on the need of a more consistent experimental approach to HypoT during neurode-
velopment as well as for a further evaluation of the reported neurochemical (and, ultimately, 
neurodevelopmental) effects of experimentally-induced maternal HypoT, in a brain region-
specific manner. 
 
Contribution to the study of TAA-induced fulminant hepatic encephalopathy: 
 
The published work on the study of TAA-induced fulminant hepatic encephalopathy 
(Zarros et al., 2008) that forms part of this PhD Thesis (Chapter II) has aimed to shed more 
light on the mechanisms involved in this rapid-onset brain disease by assessing the changes 
occurring in the adult rat brain TAS and the activities of AChE, Na+,K+-ATPase and Mg2+-
ATPase. The induction of fulminant hepatic encephalopathy was performed through the ad-
ministration of TAA (intraperitoneally, at a dosage of 400 mg / kg of body weight at three 
consecutive time intervals of 24 h) and has resulted into a significant decrease of the rat brain 
TAS and the activity of Na+,K+-ATPase, but exerted no significant changes in brain AChE and 
Mg2+-ATPase activities. Moreover, in vitro experiments that were conducted in order to eval-
uate the possible role of ammonia in the observed effects of TAA-induced fulminant hepatic 
encephalopathy on the examined adult rat brain enzyme activities, showed no significant al-
terations in any of the examined parameters. Our in vitro and in vivo findings suggest that al-
terations in AChE and Mg2+-ATPase activities are not involved in the pathophysiology of the 
adult-onset fulminant hepatic encephalopathy (to the extent that this can be securely stated if 
one considers the neurochemical changes observed in whole brain homogenates), while the 
observed Na+,K+-ATPase inhibition could be a result of the oxidative stress, neurotransmis-
sion deregulation and / or of the presence of other toxic substances (that appear to act as di-
rect or indirect inhibitors of the enzyme), and not due to the excess accumulation of ammonia 
in the brain (Zarros et al., 2008). These findings have formed the basis of further research 
into the field of hepatic injury-associated brain dysfunction by the host laboratories (Liapi et 
al., 2009a), while the ones referring to the activity of AChE have recently been critically-
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evaluated by the author (Zarros et al., 2013a) along with those of others (Dhanda et al., 2013; 
Faff-Michalak and Albrecht, 1991; García-Ayllón et al., 2008; Méndez et al., 2011; Rao et al., 
1994; Swapna et al., 2007). However, the need to further study / confirm the effects of the 
TAA-induced fulminant hepatic encephalopathy on the above-mentioned neurochemical pa-
rameters at a brain region-focusing level has not been met yet. 
 
Contribution to the study of STZ-induced diabetic encephalopathy: 
 
The published work on the study of STZ-induced diabetic encephalopathy (Zarros et 
al., 2009) that is included in this PhD Thesis (Chapter III) has aimed to clarify the effect of 
Cys-administration on the changes caused by untreated / uncontrolled adult-onset diabetes 
on the rat brain TAS and the activities of AChE, Na+,K+- and Mg2+-ATPase. For this reason, dia-
betic rats were generated with an intraperitoneal STZ injection (50 mg/kg of body weight, 
diluted in a 0.1 mol / L citrate solution, pH 4.5) and where systematically confirmed to be di-
abetic through regular monitoring of their urine volume and glucose levels as well as through 
monitoring of their food and water consumption. It should be noted that the herein employed 
method of diabetes-induction is widely-used in rats (Arrick et al., 2007; Bilginoglu et al., 
2007; Khan et al., 2013; Ramanathan et al., 1998; Trauernicht et al., 2003; Tripathi and Kohli, 
2014; Valencia-Torres et al., 2014), although variations of this dose-scheme are also in use in 
both rats and mice (Chatzigeorgiou et al., 2009; Chaudhry et al., 2013; Dang et al., 2014; Lukić 
et al., 1998).  
In this study (Chapter III; Zarros et al., 2009), diabetic rats: (a) exhibited a statistically-
significant reduction in their brain TAS (that was reversed after a 7-day Cys-administration 
into control levels), (b) were found to bear a significantly-stimulated brain AChE (that was 
further enhanced by Cys-administration), and (c) suffered from a significant reduction in the 
activity of brain Na+,K+-ATPase (that was not reversed after 1 week of Cys-administration). 
The conducted in vitro experiments demonstrated a partial but significant reversal of the dia-
betes-induced Na+,K+-ATPase inhibition following an incubation of diabetic rat brain homog-
enates with Cys; a fact indicating that, to an extent, the observed diabetes-induced brain 
Na+,K+-ATPase inhibition could be attributed to the generation of oxidative stress. Moreover, 
in vitro incubation of non-diabetic rat brain homogenates with STZ had no effect on the stud-
ied enzymes, while in vivo experiments showed that Mg2+-ATPase activity is not affected by 
STZ-induced diabetes (a finding confirmed by later experiments of ours; Liapi et al., 2010).  
The herein demonstrated inhibition of brain Na+,K+-ATPase reflects a possible mecha-
nism through which untreated diabetes could affect neuronal excitability, metabolic energy 
production and certain systems of neurotransmission, and is certainly, now, an established 
finding (Franzon et al., 2005; Leong and Leung, 1991) that has also been shown by us to be 
time-dependent (Liapi et al., 2010). On the other hand, with regards to the use of Cys as a 
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neuroprotective agent against diabetes, our in vitro findings could be indicative of a possible 
protective role of Cys under different in vivo experimental conditions; an issue that requires 
the undertaking of further research. 
 
Contribution to the study of experimentally-induced WE: 
 
The published work on the study of experimentally-induced WE (Zarros et al., 2013d) 
that is incorporated in this PhD Thesis (Chapter IV) has shed more light on the pathophysiol-
ogy of WE, by introducing a modified in vivo experimental approach to WE and by focusing on 
changes provoked in brain TAS and the above-mentioned three crucial brain enzyme activi-
ties of adult rats. Briefly, in this study, rats were placed on EtOH consumption for a total of 5 
weeks, and by the end of the 3rd week, rats were fed a TDD and were treated with PT for the 
remaining 2 weeks. Following the induction of WE symptomatology, rats were treated with 
three consecutive (every 8 h) injections of saline or T and were killed by decapitation; brain 
homogenates were generated and used for spectrophotometrical evaluation of TAS and en-
zymatic activities, while in vitro experiments were also conducted on brain homogenates or 
pure enzymes incubated with T or neuromodulatory antioxidants.  
The study (Chapter IV; Zarros et al., 2013d) revealed that: (a) pre-exposure to EtOH 
can provide a successful protocol modification that does not affect the expected time of WE 
symptomatology onset, (b) the administration of T can ameliorate this symptomatology, as 
well as (c) WE provokes oxidative stress that can be partially limited by T administration 
(while T itself also causes oxidative stress to a smaller extent). On the other hand, rat brain 
AChE was found to be significantly-inhibited by WE and was further inhibited by T admin-
istration; an inhibition against which in vitro experiments revealed a potential neuroprotec-
tive role for Carn. 
Brain Mg2+-ATPase activity was found decreased by prolonged exposure to EtOH, but 
was not significantly affected by the experimental induction of WE. However, the most inter-
esting finding of the study is, undoubtedly, the stimulated by experimentally-induced WE 
brain Na+,K+-ATPase. The latter was returned to control levels by in vivo T administration, 
while this increase in Na+,K+-ATPase activity was also evident in groups exposed to PT or to 
TDD, but not to EtOH. Moreover, the in vitro experiments performed within this study have 
demonstrated a potential neuroprotective role for this Na+,K+-ATPase stimulation through T 
or Cys administration. These data (Chapter IV; Zarros et al., 2013d) suggest that increased 
brain Na+,K+-ATPase activity could be a marker of T deficiency in WE (and, probably, a major 
contributor to the WE-associated neuronal injury / death), while combined T and antioxidant 
co-supplementation of Cys and / or Carn could be neuroprotective in terms of restoring the 
examined crucial brain enzyme activities to control levels. These findings must be subject to 
further experimentation under both in vivo and in vitro conditions, as they are likely to play a 
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major role in clarifying a (potentially) significant aspect of the neuropathology of WE and 
other TD-related clinical conditions. 
 
Contribution to the study of Mn-induced neurotoxicity: 
 
The published work on the study of Mn-induced neurotoxicity (Liapi et al., 2008) that 
is incorporated in this PhD Thesis (Chapter V) has reported that adult-onset high-dose short-
term Mn-administration causes a significant decrease in rat brain TAS, a significant increase 
in AChE activity and a significant inhibition of Mg2+-ATPase. Interestingly, Mn-administration 
did not alter the rat brain Na+,K+-ATPase activity. Within this context, both the observed Mn-
induced rat brain TAS lowering and AChE stimulation were reversed to approximate control 
levels by Cys co-administration (Chapter V; Liapi et al., 2008).  
The study of Mn-induced neurotoxicity is a field of increasing interest due to its close 
clinical association with the extrapyramidal symptomatology resembling idiopathic Parkin-
son’s disease and the neuropsychiatric manifestations associated with manganism and locura 
manganica (Martinez-Finley et al., 2013; McMillan, 1999; Michalke and Fernsebner, 2014). 
Dopaminergic neurodegeneration seems to be a central aspect of Mn-induced neurotoxicity 
(Martinez-Finley et al., 2013), while a recent review article has discussed the link between 
Mn and Huntington’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis and, even 
prion disease (Bowman et al., 2011). Our study has contributed to the current understanding 
of the mechanisms involved in the exerting of Mn-induced neurotoxicity: (a) by confirming 
the important role of oxidative stress in it (Fernsebner et al., 2014), (b) by revealing an effect 
on AChE activity that seems to be dependent upon the extent of the in vivo exposure 
timeframe applied (Chtourou et al., 2012; Fernsebner et al., 2014; Lebda et al., 2012; Mar-
tínez and Bonilla, 1981; Michalke and Fernsebner, 2014; Santos et al., 2012) as well as upon 
the mode of killing employed (Zarros et al., 2012), and (c) by demonstrating a slight but sig-
nificant Mn-induced inhibition of the brain Mg2+-ATPase, that could be a direct effect of the 
displacement of Mg2+ by Mn2+ (Atkinson et al., 1968; Shukla et al., 1983) taking place in the 
CNS. 
 
Contribution to the study of La-induced neurotoxicity: 
 
The published work on the study of La-induced neurotoxicity (Liapi et al., 2009c) that 
forms part of this PhD Thesis (Chapter VI) has reported that adult-onset high-dose short-
term La-administration causes a significant decrease in rat brain TAS, a significant increase in 
AChE activity and a significant inhibition of both Na+,K+- and Mg2+-ATPase. Although per-
formed under specific (and, as one might argue, indicative) experimental conditions, these 
findings have allowed us to suggest that La might interfere with neuronal excitability and 
metabolic energy production, as well as that some of these phenomena might arise from oxi-
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dative stress, cholinergic dysfunction and / or further intracellular deregulating phenomena 
associated with its chemical resemblance to other ions such as Ca2+ (Liapi et al., 2009c). 
Moreover, both the observed La-induced rat brain TAS lowering and AChE stimulation were, 
partially or totally, reversed to control levels by Cys co-administration (Chapter VI; Liapi et 
al., 2009c); a fact suggesting that Cys could be considered for future applications as part of a 
neuroprotective approach against poisoning and / or chronic exposure to La.    
We have, recently, been given the opportunity to interpret our results with those of 
Zheng et al. (2013) and others (Feng et al., 2006; Gramowski et al., 2011; He et al., 2008; Wu 
et al., 2013; Yang et al., 2009; 2011a; 2011b; 2013), resulting in a very interesting Letter-to-
the-Editor (Zarros et al., 2013b) that highlighted potential targets for further study into the 
mechanisms which underpin La-induced neurotoxicity, with a focus on the crucial role of the 
hippocampus. Within this context, a central role for the cyclic-adenosine monophosphate sig-
nalling pathway has been proposed (Zarros et al., 2013b) that remains to be experimentally-
challenged both in vivo and in vitro. The confirmation of this proposal / hypothesis would, 
hopefully, solve the riddle of La-induced neurotoxicity and its related (and well established) 
contribution to cognitive impairment. 
 
Contribution to the study of Ni-induced neurotoxicity: 
 
The published work on the study of Ni-induced neurotoxicity (Liapi et al., 2011) that is 
included in this PhD Thesis (Chapter VII) has reported that adult-onset high-dose short-term 
Ni-administration causes a significant decrease in rat brain TAS, a significant increase in 
AChE activity and a significant inhibition of Na+,K+-ATPase. Interestingly, Ni-administration 
did not alter the rat brain Mg2+-ATPase activity. Within this context, both the observed Ni-
induced rat brain TAS lowering and AChE stimulation were (as in the respective cases of Mn 
and La) reversed to approximate control levels by Cys co-administration (Chapter VII; Liapi 
et al., 2011).   
To-date, there has not been any study citing / discussing these findings with the excep-
tion of that of He et al. (2013) who have reported the effects of acute high-dose oral admin-
istration of NiCl2 on neurobehavioral performance and parameters of neuroenergetic interest 
in the cerebral cortexes of mice; an experimental setting that although being significantly dif-
ferent from that of ours, has suggested: (a) that Ni-administration causes deficits in spatial 
memory performance and exploring activity in mice, (b) that Ni can easily be deposited in 
their cerebral cortex (even after acute dose-schemes), and (c) that a major neurochemical 
effect of acute poisoning with Ni is the establishment of a deficient aerobic metabolism mani-
fested as decreased oxygen consumption, low ATP availability, lactate accumulation and, ul-
timately, the development of oxidative stress. These findings are in agreement with those of 
ours (Chapter VII; Liapi et al., 2011) in terms of their suitability in justifying the observed Ni-
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induced Na+,K+-ATPase inhibition, if a similar methodological approach was to be applied un-
der the examined (by us) experimental conditions. 
 
Account of the importance of the studied neurochemical parameters: 
 
The importance of the herein studied neurochemical parameters has been extensively 
highlighted in the chapters that form Part A of this PhD Thesis. What might not have been suf-
ficiently underlined is the fact that the studied rat brain enzyme (AChE, Na+,K+-ATPase and 
Mg2+-ATPase) activities represent the functional capacity of the specific enzymes under 
standard assessment conditions (Bowler and Tirri, 1974; Ellman et al., 1961; Tsakiris, 2001) 
and constitute, probably, the most reliable parameter for the characterization of these en-
zymes that one could seek for the study of neurochemical changes under the examined exper-
imental settings. Neither the comparative gene expression nor the actual protein expression 
or the extent of the post-translational modification of these enzymes, are parameters that can 
reliably predict the dynamic of their functional capacity; thus, the accurate measurement of 
their activity (although being a rather “old” technical approach) is still considered as a major 
and irreplaceable neurochemical method of research.  
 
Account of the use of Cys as a neuroprotectant against toxic element-induced neurotoxicity: 
 
It should be noted that the use of Cys as a potential neuroprotective agent against the 
herein presented adult-onset toxic element-induced neurotoxicity (Chapters V, VI and VII; 
Liapi et al., 2008; 2009c; 2011) is indicative of the molecule’s capacity: the drug is adminis-
tered at a specific dosage (administered intraperitoneally at a dose of 7 mg / kg of body 
weight) as suggested by a previous study of ours (Carageorgiou et al., 2005b), within a specif-
ic time-frame (7 days, alone or in parallel to Mn-, La- or Ni-administration), and one cannot 
exclude the possibility of a different dose-scheme of the same compound being more efficient 
in exerting the required neuroprotection (to the extent, of course, that this can be reliably 
assessed through the studied parameters). In view of the fact that Cys is a well-known antiox-
idant and chelating agent (Carageorgiou et al., 2004; Patrick, 2003) and, thus, could be con-
sidered as an ideal candidate for the neutralization of the studied toxic element-induced neu-
rotoxicity, one should keep in mind that: (a) Cys has been found to significantly stimulate 
AChE and inhibit Na+,K+- and Mg2+-ATPase in all three experimental studies (Liapi et al., 2008; 
2009c; 2011), and (b) Cys has been reported to exert neuromodulatory activity and devel-
opmental neurotoxicity on its own (Janáky et al., 2000) and, thus, its use should be well moni-
tored even when applied against adult-onset neurotoxicity settings. However, due to the fact 
that Cys is a rate-limiting precursor for neuronal GSH synthesis (Kranich et al., 1996) and has 
also been reported to protect brain cells by forestalling the entry of heavy metal ions into the 
CNS across the blood-brain barrier (Bradbury and Deane, 1993), its use as a potential neuro-
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protective agent in our adult-onset neurotoxicological studies is reasonable and in agreement 
with the recent trend of testing relevant compounds (such as N-acetyl-L-cysteine; a widely-
used derivative of Cys) within similar experimental contexts, for the same reasons (Gonçalves 
et al., 2010; Nehru and Kanwar, 2004; Ozcelik et al., 2012). 
 
Summarizing the work described in the current PhD Thesis: 
 
As already underlined in the Preface of the current PhD Thesis, encephalopathies com-
promise a large chapter in human brain pathology, and their study maintains a high-priority 
research objective for Neuroscience, since a better understanding of their pathophysiology 
might reveal sites of potential neuroprotective and eventually therapeutic intervention. With-
in this context, the current PhD Thesis (by published work / retrospective) condenses and 
presents the significance of a part of the author’s contribution to the study of experimentally-
simulated toxic and metabolic encephalopathies, based on seven published works. This Chap-
ter has provided an account of the novelty, perspectives and importance of each of the stud-
ied encephalopathies, but cannot - of course - easily provide a global account of the works 
described. The latter is difficult to perform as: (a) it is obvious that there is limited patho-
physiological relevance between the encephalopathies described, (b) their (herein described) 
experimental simulation aimed to address the clinical “natural” history of each encephalopa-
thy in a distinctive and unique (for each case) way, while (c) with the exception of the use of 
Cys as a common neuroprotectant against the studied toxic element-induced neurotoxicity 
cases, there is no other common in vivo methodological approach that could allow for a 
ground for comparison among the seven studies. However, all of the studies that form the 
basis of the current PhD Thesis are linked through a common aim: the characterization of 
three crucial brain enzyme activities (those of AChE, Na+,K+-ATPase and Mg2+-ATPase) under 
the different experimentally-simulated toxic and metabolic encephalopathies. Based on this 
common aim, a summarizing approach could be fulfilled with the assistance of the overview 
provided in Table B.1. 
The overview of the changes observed in the neurochemical parameters studied due to 
each of the attempted experimental encephalopathies (Table B.1) could support the author’s 
belief that the following five summarizing statements can be safely drawn as a supplement to 
the already provided studies’ conclusions: (a) a change in the activity of brain AChE could 
represent a major neurochemical event in the pathophysiology of almost all studied encepha-
lopathies that could play a significant role in the manifestation of the clinically-associated 
neuropsychiatric symptomatology of these disorders, (b) more specifically, the inhibition of 
rat brain AChE could be a reliable indicator (if not a major “biomarker”) of (at least) the 
(herein) studied toxic element-induced neurotoxicity settings, (c) the inhibition of Na+,K+-
ATPase could be a neurotoxic effect of most of the studied encephalopathies, but might reflect 
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either generic (e.g. oxidative stress-induced) and / or complex neurochemical phenomena, 
(d) an increase in rat brain Na+,K+-ATPase activity is a rare finding that has only been encoun-
tered in the cases of HypoT and WE (the latter has been shown to bear this TD-induced neu-
rotoxic phenomenon in a reverse relationship to T availability; a finding of major significance 
to the author’s opinion) and, finally, (e) it is clear that although rat brain Mg2+-ATPase activity 
is a rarely affected neurochemical parameter within the context of the studied experimental 
settings, changes in its activity might represent major (metabolic) cellular events. 
Although these statements can be subject to extensive debate, the findings on which 
they are drawn can certainly provide a reliable and important background of evidence that 
must be subject to further experimentation under both in vivo and in vitro conditions, to-
wards the clarification of (hopefully) central aspects of the neuropathology of the simulated 
clinical conditions. Towards this direction, the readers should also consider the methodologi-
cal restrictions and unanswered questions within the published work (as indicatively pre-
sented in Chapter IX). 
 
>> Table B.1: page 76 
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Table B.1: Overview of the changes observed in the neurochemical parameters studied due 
to each of the attempted experimental setting aiming to mimic clinically-relevant encephalo-
pathies. 
 
    
 Rat brain homogenate activity 
    
    
Experimentally-simulated encephalopathies AChE Na+,K+-ATPase Mg2+-ATPase 
    
    
TH-related brain dysfunctions (HyperT / HypoT)  /   /  NS /  
TAA-induced fulminant hepatic encephalopathy NS  NS 
STZ-induced diabetic encephalopathy   NS 
experimentally-induced WE   NS 
Mn-induced neurotoxicity  NS  
La-induced neurotoxicity    
Ni-induced neurotoxicity   NS 
    
 
Note: the “” arrow indicates a statistically-significant increase in the activity of each enzyme, while the “” ar-
row indicates a statistically-significant inhibition, respectively. NS: non-statistically significant. 
 
 
  
CHAPTER IX 
 
Methodological restrictions and unanswered questions  
within the published work* 
 
The publications that form the basis of the current PhD Thesis are works employing a signifi-
cant number of scientific speculations in order to discuss the presented experimental find-
ings. The primary (but not the only) source of these speculations is the limited financial sup-
port available in order to undertake the described experiments; a problem that has resulted 
into significant methodological restrictions and the subsequent (unavoidable) generation of a 
number of unanswered questions. The author accepts that one can come up with dozens of 
arguments / suggestions / objections while reading this Thesis. Thus, in this final chapter, a 
choice of twelve important such arguments are presented and discussed; these arguments 
address major methodological restrictions applied to the published work included in this PhD 
Thesis, and highlight the importance of the questions that some of these restrictions have left 
unanswered.  
 
The measurement of TAS is a low-clarity tool for the evaluation of oxidative stress in the brain: 
 
In all works included in this Thesis, the measurement of TAS has been employed as an 
indicator of oxidative stress achieved under the examined in vivo experimental conditions. 
The commercially-available TAS kit (Randox Laboratories Ltd., Cat No NX2332) has been 
widely used in order to provide an overview of the samples’ total antioxidant capacity under 
specific conditions defined by the manufacturer (the samples must be appropriately handled, 
stored, diluted, and cannot be of more than 14 days old). What is actually measured through 
TAS is the samples’ (in our case, the rat brain homogenates’) capacity of free radical scaveng-
ing by the radical scavenging antioxidants contained in the test samples (Niki, 2010). 
Throughout recent years there have been concerns on whether the use of TAS is reliable and 
sufficient in order to provide an accurate evaluation of oxidative stress in both biological flu-
ids and tissues (Ghiselli et al., 2000; Lamont et al., 1997; Niki, 2010; Pinchuk et al., 2012; Pri-
or and Cao, 1999; Schofield and Braganza, 1996). The complexity of the issues involved in this 
methodological controversy were rigorously presented a few years ago by Niki (2010), who 
                                                 
* this chapter is the second and final part of the required by the PhD (by published work / retrospec-
tive) regulations of the University of Bolton “critical appraisal”. 
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concludes by stating that: “despite numerous studies, there is no general, reliable method for 
assessment of antioxidant capacity even in vitro […] antioxidants in vivo are far less understood 
[…] more studies are necessary to demonstrate the role and capacity of antioxidants in vivo”. 
The functional capacity of the brain antioxidant system (which is to-date largely uncharacter-
ized due to the fact that a number of factors not considered as “antioxidants” seem to affect 
the delicate balance between known oxidants and antioxidants) (Ghiselli et al., 2000) could 
have been, certainly, better assessed in our studies if one would have been able to measure: 
(a) specific antioxidant compound (vitamin) levels, (b) activities of specific antioxidant en-
zymes (such as SOD, CAT, GSH-Px and others), (c) the oxidation product levels of certain anti-
oxidants (such as allantoin, tocopheryl quinones, 5-nitro-gamma-tocopherol and others), as 
well as (d) the ratio of oxidized to reduced form of major antioxidants such as GSH (Niki, 
2010). However, this was not considered as necessary since our studies’ aims were not fo-
cused on the mechanisms underlying the rat brain antioxidant status alterations observed 
under the studied experimentally-simulated toxic and metabolic encephalopathies, but to use 
TAS: (a) as an indirect assessor of oxidative stress and its correlation with our neurochemical 
findings, as well as (b) as a confirmation of the efficacy of the undertaken antioxidant admin-
istration (in the case of Cys) aiming to act as a potential neuroprotectant in the studied in vivo 
experimental settings. Within this context, the employment of TAS served as a rapid and low-
cost oxidative stress indicator of sufficient clarity. 
 
The measurement of ChAT activity could provide a better overview of the cholinergic function: 
 
A major enzyme implicated in cholinergic neurotransmission is none other than ChAT, 
the synthesizing enzyme of ACh. Although ChAT expression is considered as a marker of cho-
linergic neurons (Strauss et al., 1991), its activity is not as widely employed as that of AChE 
for two reasons: (a) its measurement is more technically-demanding than that of AChE as it 
requires the use of radiochemicals (3H-acetyl CoA or 14C-acetyl CoA) (Engel et al., 1980; Shea 
and Aprison, 1973; Somani et al., 1991) or the employment of high-performance liquid chro-
matography (HPLC) along with electrochemical detection (Kaneda and Nagatsu, 1985), and 
(b) it is not as widely characterized in terms of its role as a “biomarker” of neurotoxicity as 
AChE activity is (Manzo et al., 2001; Zarros et al., 2013c). The latter could be attributed to the 
fact that AChE is also abundantly (compared to ChAT) present in the erythrocyte membrane 
(and thus, has allowed for its assessment as an easily accessed peripheral marker of neuro-
toxicity) (de Almeida and Saldanha, 2010; Eckernäs et al., 1979; Tsakiris et al., 2002; 2005; 
2006), as well as due to the fact that the presence of AChE is not restricted to cholinergic neu-
rons (Klegeris et al., 1995). Provided that the host laboratories had the capacity of measuring 
brain homogenate ChAT activity, the correlation of changes in ChAT activity with those ob-
served with regards to AChE activity would have provided a very important and reliable tool 
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for the assessment of the rat brain cholinergic function (Vathana et al., 2014) under the ex-
amined in vivo experimental settings. Moreover, the existence of commercially-available pure 
ChAT (obtained from human placentas) would have allowed for the conduction of in vitro ex-
periments to an equal extent to those already performed with the use of eel-deriving pure 
AChE (see Chapter IV; Zarros et al., 2013d). 
 
The measurement of brain ACh levels could reveal a potential cholinergic impairment: 
 
True. However, the measurement of ACh levels might not have provided an accurate 
and reliable neurochemical parameter under the employed experimental conditions, primari-
ly due to the fact that the herein described neurochemical analyses where performed on 
whole brain homogenates and not on specific brain regions (such as the hippocampus, the 
cerebellum, the frontal cortex or even sub-regional nuclei). Measuring ACh levels: (a) should 
be undertaken after isolating specific rat CNS regions in which its role is (to an extent) char-
acterized (Pepeu and Giovannini, 2004), (b) should be accompanied by a parallel measure-
ment of associated enzyme activities (preferably both ChAT and AChE), as well as (c) would 
require a significantly-higher number of experimental animals to be used / killed (since the 
permittable, for this analysis, mode of animal killing and tissue handling might require extra 
animals for the undertaking of the aforementioned parallel enzyme kinetics’ analyses).  
 
The protein and / or gene expression of the studied enzymes could have been performed: 
 
A major deficiency of the studies presented in this Thesis is the fact that the absence of 
any data on potential changes occurring with regards to the protein and / or gene expression 
of the studied enzymes does not allow for a deeper understanding of the mechanisms under-
lying the functional enzymatic alterations observed under the examined experimental condi-
tions. The undertaking of western blotting and / or of polymerase chain reaction (PCR) anal-
yses would have added significant value and impact to the herein presented studies, and 
would have restricted the number of hypotheses / speculations employed. 
 
Variations in the expression of Na+,K+-ATPase subunits are of neuropathological significance: 
 
The existence of multiple Na+,K+-ATPase subunits (alpha, beta and a gamma subunit or 
FXYD protein) (Geering, 2008; Mishra et al., 2011) reflects the mechanism through which na-
ture copes with the need for a tissue-specific ion regulation through this enzyme of para-
mount biological importance (Blanco, 2005). In fact, there are four isoforms of the catalytic 
alpha subunit (α1, α2, α3 and α4) and three isoforms of the membrane-anchoring beta subunit 
(β1, β2 and β3) which combined as αβ dimers produce a highly-regulated pattern of the mem-
brane-bound Na+,K+-ATPase expression that depends on cell type (Arystarkhova and Swead-
ner, 1997; Fink et al., 1996; Lingrel, 1992; Martín-Vasallo et al., 1997; 2000), cellular differen-
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tiation stage (Habiba et al., 2000), developmental stage / age (Chang et al., 2012; Chauhan 
and Siegel, 1997; Kawakami and Ikeda, 2006; Kim et al., 2011; Lingrel, 1992; Martín-Vasallo 
et al., 1997) as well as hormonal stimulation (Kim et al., 2011; Nakhoul et al., 2000). The mo-
lecular complexity of Na+,K+-ATPase goes beyond its αβ dimer structure and, in certain tis-
sues, other accessory small membrane-bound polypeptides (known as FXYD proteins: FXYD1 
or phospholemman, FXYD2 or gamma-subunit of Na+,K+-ATPase, FXYD3 or Mat-8, FXYD4 or 
CHIF, FXYD7) modulate Na+,K+-ATPase activity (Blanco, 2005; Geering, 2006). Changes in the 
expression of several Na+,K+-ATPase subunits seem to play a major cell-specific role in exper-
imentally-simulated ischaemic CNS injury (Kasai et al., 2003; Kim et al., 2013; Kwon et al., 
2003; Liu et al., 2013b) and CNS tumorigenesis (Lefranc et al., 2008; Sun et al., 2013), while 
experimental work has already associated Na+,K+-ATPase subunits’ expression with ammo-
nia-induced brain injury (Xue et al., 2010), chronic EtOH consumption-associated brain dys-
function (Chen et al., 1997) and STZ-induced diabetic encephalopathy (Vér et al., 1995). With-
in this context, the undertaking of western blotting and / or of PCR analyses would have been 
of high value towards the acquisition of a more accurate interpretation of the changes ob-
served in brain Na+K+-ATPase activity in all seven of the herein presented experimentally-
simulated encephalopathies. Moreover, given the high neuropathological importance of this 
enzyme, a deeper understanding of the molecular mechanisms orchestrated by the variation 
of Na+,K+-ATPase subunits’ expression within the context of the studied toxic and metabolic 
encephalopathies (as well as within any other experimentally-simulated CNS disease) could 
provide a whole new field of potential therapeutic targets (Aperia, 2007; Lefranc and Kiss, 
2008).  
 
Brain region-specific studies could have been attempted in all examined encephalopathies: 
 
The whole rat brain neurochemical analyses performed and described in Part A of this 
PhD Thesis are representative of the neurochemical changes that are, on average, taking 
place in the rat brain within the examined experimental contexts. Under the same experi-
mental conditions, the undertaking of further brain region-specific studies could definitely 
provide us with a wider spectrum of observations that would be of higher pathophysiological 
value and clinical relevance. The host laboratories have undertaken a number of such brain 
region-specific studies in recent years (Carageorgiou et al., 2007a; 2007b; Liapi et al., 2009b; 
Stolakis et al., 2013); these studies have revealed, as expected, several important region-
specific variations in the studied neurochemical parameters (when compared both to those of 
controls as well as to those observed following the analysis of whole brain homogenates) un-
der identical in vivo metabolic and toxic experimental settings. These changes could be at-
tributed to the varying neuroanatomical composition and neuronal networking of the studied 
rat brain regions: a major determinant of the abundance, quality and vulnerability of the 
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studied enzymes. However, the readers should keep in mind that the undertaking of brain 
region-specific studies should not be attempted as a first option, since the minimum number 
of rats needed for the performance of the required neurochemical analyses is approximately 
threefold than that needed for whole brain experimentation; on average, a brain region-
focusing study that would estimate the activities of AChE, Na+,K+-ATPase and Mg2+-ATPase in 
the frontal cortex, the hippocampus, the hypothalamus, the pons and the cerebellum of adult 
rats would require the sacrifice of approximately 15-21 rats per experimental group (com-
pared to the requirement of approximately 5-7 rats per experimental group in the case of 
similarly-performed whole brain-focusing studies).  
 
Decapitation is not the most acceptable way of laboratory animal killing: 
 
Unfortunately, decapitation is the most suitable (if not the only reliable) way of rat kill-
ing in our case, since the use of any form of anaesthesia would have caused a significant inhi-
bition of brain AChE activity under the majority of the herein studied experimental settings 
(Micic et al., 1978; Vernadakis and Rutledge, 1973). The use of anaesthesia in experimental 
studies involving the evaluation of AChE activity as a neurotoxicity marker is definitely a 
more “humane” approach, but is also a frequent mistake performed by scientists in the field 
and should be avoided, especially under experimental conditions that involve hepatic or renal 
damage of any nature or magnitude (Zarros et al., 2012; 2013a; 2013c). 
 
Behavioural experiments could have been performed: 
 
The undertaking of behavioural experiments would have been useful in the case of a 
brain region-focusing study, where neurochemical changes observed in the frontal cortex and 
the hippocampus could have been correlated to task performance. Such tasks would have not 
been useful in the case of TAA-induced fulminant hepatic encephalopathy (Chapter II; Zarros 
et al., 2008) or in the later phases of experimentally-induced WE (Chapter IV; Zarros et al., 
2013d), where an acute onset of symptomatology should be monitored instead. Moreover, 
tasks testing cognitive performance (such as the two-way active avoidance task) (Carageor-
giou et al., 2003) could have been useful in the case of the herein studied toxic encephalopa-
thies (Chapters V, VI and VII; Liapi et al., 2008; 2009c; 2011), provided that the treatment 
scheme would have been longer. 
 
A wider range of dose- and treatment-schemes could have been applied in some cases: 
 
True. For instance, the employment of an additional wider timeframe for the studied 
TH-related brain dysfunctions (Chapter I; Carageorgiou et al., 2005a) would have allowed for 
an estimation / validation of the already reported in the literature time-dependent changes in 
the activities of AChE (Kundu et al., 2006; 2007; Sarkar and Ray, 2001) and Na+,K+-ATPase 
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(Kundu et al., 2006; 2007; Sarkar and Ray, 1993; 2001), while a different (shorter) treatment-
scheme in the case of experimentally-induced WE (Chapter IV; Zarros et al., 2013d) would 
have allowed for an evaluation of a “pre-clinical” and milder TD-induced brain injury (as the 
one recently attempted by Oliveira-Silva et al., 2014). However, in both cases, such an under-
taking could have been characterized as of lower priority. On the other hand, the herein pre-
sented experimentally-simulated toxic encephalopathies due to Mn, La and Ni (Chapters V, VI 
and VII; Liapi et al., 2008; 2009c; 2011) would certainly benefit from a wider range of dose- 
and treatment-scheme further study of their neurotoxic effects on crucial enzymatic parame-
ters such as the brain activities of AChE, Na+,K+-ATPase and Mg2+-ATPase. In all three of these 
experimentally-simulated encephalopathies, the undertaken in vivo studies could be consid-
ered as representative of a clinically short-term high-dose exposure / poisoning and, thus, as 
indicative of the neurotoxic potential of these toxic elements. A longer exposure timeframe 
along with a lower dosing of these elements could have allowed for a more realistic and clini-
cally-relevant simulation of chronic poisoning conditions. 
 
Brain levels of the studied toxic elements (Mn, La, Ni) could have been measured: 
 
The measurement of the levels of the studied toxic elements (Mn, La and Ni) could 
have provided crucial information on the mode of the reported in the studies described in 
Chapters V, VI and VII (Liapi et al., 2008; 2009c; 2011) Cys-induced neuroprotection. Such a 
measurement could have been performed through the use of atomic absorption spectroscopy, 
preferably in both rat brain tissues and blood samples (obtained immediately after decapita-
tion) so as to obtain important data concerning the distribution and clearance of these toxic 
elements under the examined experimental conditions. Moreover, the estimation of the 
achieved intracerebral levels of these elements would have allowed for the conduction of in 
vitro experiments aiming to shed more light on the potential direct interaction of these ele-
ments with AChE and Na+,K+-ATPase.  
 
Experimental simulation of the studied encephalopathies could have been achieved better: 
 
It is the author’s belief that, with the exception of the opinion expressed above with re-
gards to the need / reasoning for the employment of further different dose- and treatment-
scheme studies in certain cases, none of the herein presented experimentally-simulated toxic 
and metabolic encephalopathies could have been technically achieved in better ways than the 
ones already applied. In Chapter I (Carageorgiou et al., 2005a), the TH-related brain dysfunc-
tions are simulated following established and well-characterized experimental approaches 
(Pantos et al., 1999; 2003) that guarantee the establishment of proven long-term moderate 
HyperT and HypoT; moreover, the use of PTU (in the drinking water) as a mode of experi-
mentally-induced HypoT has major practical advantages over the use of thyroidectomy or 
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iodine-131 administration, while both HyperT and HypoT groups are allocated to suitable 
controls. In Chapter II (Zarros et al., 2008), the applied TAA-induced fulminant hepatic en-
cephalopathy is an established and simple experimental approach (Larsen et al., 1994; Zim-
mermann et al., 1989) that does not require the undertaking of any invasive procedure (such 
as an ischaemia-complicated partial hepatectomy) (Eguchi et al., 1996) with all the complica-
tions that such an approach might be accompanied by (trauma infections, use of anaesthesia, 
use of antibiotics, mortality). In Chapter III (Zarros et al., 2009), the STZ-induced diabetic en-
cephalopathy is one of the two most commonly employed methods of causing adult-onset 
diabetes in rodents (Bilginoglu et al., 2007); high-dose administration of the beta-cytotoxic 
AL is the other method (Szkudelski, 2001). The experimental protocol followed in the case of 
the STZ-induced diabetic encephalopathy aimed to estimate the effects of a 2-month-long ex-
posure to uncontrolled diabetes; this amount of time is considered as reasonable for the es-
tablishment of diabetes-induced cerebral dysfunction (Liu et al., 2013a; Xue et al., 2012). In 
Chapter IV (Zarros et al., 2013d), the study’s experimental design was based on previous ones 
(Langlais and Zhang, 1997; Pires et al., 2005) with the modification / addition of a prolonged 
pre-exposure to EtOH (for an extra period of 3 weeks prior to the co-administration of TDD 
and / or PT); this modification increased the simulatorial proximity to clinical reality of the 
employed in vivo experimental approach, and did not affect the onset of the WE-associated 
neurological symptomatology (the latter occurred at the 14th day of PT administration, as 
expected). Finally, in Chapters V, VI and VII (Liapi et al., 2008; 2009c; 2011), the administra-
tion of the studied toxic elements was performed daily (for 7 days) via intraperitoneal injec-
tions in order to ensure that all rats are exposed to the appropriate toxic element and / or Cys 
amounts (a result that would not have been achieved in the case of an ad libitum intake of el-
ement- and / or Cys-supplemented drinking water). Thus, a monitored parenteral admin-
istration was considered as the most appropriate approach to these experimentally-
simulated toxic encephalopathies.  
 
Additional important neurochemical parameters could have been studied: 
 
The examined neurochemical parameters where chosen due to the fact that the host 
laboratories had established (by the time of the experimental design and conduction) experi-
ence and published work on the significance / role of these parameters in a number of in vivo 
and in vitro experimental settings aiming to simulate accumulative metabolic or neurotoxic 
disorders. Although one could argue that there could have been unlimited options of similar 
parameters of neurochemical interest to be considered and studied within the context of the 
chosen experimentally-simulated toxic and metabolic encephalopathies, the author would 
like to underline the time-consuming and technically-demanding nature of the herein pre-
sented and discussed studies. 
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APPENDIX A 
 
List of biomedical abbreviations and  
symbolography used 
 
 
The following list of abbreviations and symbolography includes the majority of the abbrevia-
tions and symbols defined and used within the main corpus of the current PhD Thesis (Parts 
A and B). This list does not include (a) the abbreviations / symbols of many of the standard 
scientific units, (b) some abbreviations of animal subgroups or of in vitro treatments or (c) 
some of the well-established abbreviations of everyday use and brand names that are found 
within the current PhD Thesis (as this was considered unnecessary). However, every effort 
has been made in order to make sure that the readers will not find it difficult to cope with the 
use of abbreviations and symbols at certain crucial points of this PhD Thesis (such as at the 
Tables and the Figures used).  
 
† deceased 
* p<0.05; # 
** p<0.01; ## 
*** p<0.001; ### 
5-HT serotonin; 5-hydroxytryptamine 
63Ni nickel-63 
63NiCl2 nickel-63 chloride 
α-KGDH alpha-ketoglutarate-dehydrogenase 
ABTS 2,2’-azino-di-(3-ethylbenzthiazoline sulphonate) 
ACh acetylcholine 
AChE acetylcholinesterase 
AL alloxan  
ANOVA analysis of variance 
ATP adenosine triphosphate 
C control (group) 
Ca calcium 
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Ca2+ calcium ion 
Ca2+-ATPase calcium adenosine triphosphatase 
Carn L-carnitine 
CAT catalase 
Ch choline  
ChAT choline-acetyltransferase 
CNS central nervous system 
CoA coenzyme A 
Cys L-cysteine 
D diabetic (group) 
DTNB 5,5’-dithionitrobenzoic acid 
EEC European Economic Community 
EEG electroencephalography  
EtOH ethanol  
EU European Union 
Fe(CN)63- ferricyanide 
G-6-PD glucose-6-phosphate dehydrogenase 
GSH glutathione 
GSH-Px glutathione peroxidase 
H2O2 hydrogen peroxide 
H2SO4 sulphuric acid 
HPLC high-performance liquid chromatography 
HyperT hyperthyroidism; hyperthyroid (group) 
HypoT hypothyroidism; hypothyroid (group) 
K+ potassium ion 
K+-EDTA ethylenediamine tetraacetic acid dipotassium-salt 
KCl potassium chloride 
La lanthanum (-treated group) 
La3+ lanthanum ion 
LaCl3·7H2O lanthanum chloride heptahydrate 
LD50 median lethal dose; lethal dose 50% 
Mg2+ magnesium ion 
Mg2+-ATPase magnesium adenosine triphosphatase 
MgCl2 magnesium chloride 
Mn manganese (-treated group) 
Mn2+ manganese ion 
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MnCl2·4H2O manganese chloride tetrahydrate 
n number 
Na+ sodium ion 
NaCl sodium chloride 
Na+,K+-ATPase sodium-potassium adenosine triphosphatase 
NaOH sodium hydroxide 
NH4Cl ammonium chloride 
Ni nickel (-treated group) 
Ni2+ nickel ion 
Ni3S2 nickel subsulfide 
NiCl2 nickel chloride 
NO nitric oxide 
NS non-statistically-significant; p>0.05 
NTC controls without any treatment; non-treated controls 
PCR polymerase chain reaction 
PhD Doctor of Philosophy 
PT pyrithiamine  
PTU 6-n-propyl-2-thiouracil 
REE(s) rare earth element(s) 
ROS reactive oxygen species 
SC saline controls 
SD standard deviation 
SOD superoxide dismutase 
STZ streptozotocin  
T thiamine; vitamin B1 
T3 triiodothyronine  
T4 thyroxine; tetraiodothyronine 
TAA thioacetamide 
TAS total antioxidant status 
TD thiamine-deficiency; thiamine-deprivation 
TDD thiamine-deficient diet 
TH(s) thyroid hormone(s) 
Tris-HCl Tris (hydroxymethyl) aminomethane-hydrochloride 
vs versus 
v / v volume / volume (concentration) 
WE Wernicke’s encephalopathy; Wernicke encephalopathy 
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w / v weigth / volume (concentration) 
 
 
APPENDIX Β 
 
Notes and list of publications that form the basis  
of the current PhD Thesis 
 
 
The readers of the current PhD Thesis should consider the following notes concerning cetrain 
points within the text: 
 
 Note 1: within this PhD Thesis, the reaction for the estimation of AChE activity was fol-
lowed spectrophotometrically by the increase of absorbance (ΔOD) at 412 nm, where 
ΔOD accounts for the mean of the difference in the optical density measured. 
 Note 2: all mentions of 0.9% NaCl refer to a 0.9% weight / volume (w / v) concentration 
solution of NaCl (also known as “saline”); within this PhD Thesis, all concentrations pre-
sented as % should be considered to refer to w / v, unless differently stated. 
 Note 3: in Chapters V, VI and VII of this PhD Thesis, the accurate forms (oxidation states) 
of the ions used in the employed experiments were those of Mn(II), La(III) and Ni(II), re-
spectively. 
 Note 4: the estimation of a CNS-related enzymatic activity is a basic neurochemical ap-
proach that reflects the functional capacity of a given tissue or sample to perform a specif-
ic assay (biochemical reaction); the author believes that this technically-limited, old and 
sensitive approach is not adequate for the shapping of solid conclusions and the study of 
disease-related mechanisms, but it could be considered as a crucial and low-cost tool for 
the acquiring of important neurochemical observations. 
 Note 5: the author believes that the experimental findings described in Chapters IV, V and 
VI are of higher significance (when compared with the other works described in this PhD 
Thesis), and provide an important basis for further research within the field of experi-
mentally-simulated toxic and metabolic encephalopathies.  
 Note 6: the co-supervisor of the current PhD Thesis, Prof. Martin Grootveld, moved to “De 
Montfort University” whilst this Thesis was under preparation. 
 
The publications that form the basis of the current PhD Thesis are the following seven (7) ar-
ticles: 
Zarros AC | PhD Thesis (by published work / retrospective) in Neuroscience 117 
 
 
 
 Chapter I: Carageorgiou H, Pantos C, Zarros A, Mourouzis I, Varonos D, Cokkinos D, Tsa-
kiris S. Changes in antioxidant status, protein concentration, acetylcholinesterase, 
(Na+,K+)-, and Mg2+-ATPase activities in the brain of hyper- and hypothyroid adult rats. 
Metabolic Brain Disease 2005; 20(2): 129-139, 
 Chapter II: Zarros A, Theocharis S, Skandali N, Tsakiris S. Effects of fulminant hepatic en-
cephalopathy on the adult rat brain antioxidant status and the activities of acetylcholines-
terase, (Na+,K+)- and Mg2+-ATPase: comparison of the enzymes’ response to in vitro 
treatment with ammonia. Metabolic Brain Disease 2008; 23(3): 255-264, 
 Chapter III: Zarros A, Liapi C, Galanopoulou P, Marinou K, Mellios Z, Skandali N, Al-
Humadi H, Anifantaki F, Gkrouzman E, Tsakiris S. Effects of adult-onset streptozotocin-
induced diabetes on the rat brain antioxidant status and the activities of acetylcholines-
terase, (Na+,K+)- and Mg2+-ATPase: modulation by L-cysteine. Metabolic Brain Disease 
2009; 24(2): 337-348, 
 Chapter IV: Zarros A, Liapi C, Al-Humadi H, Almpani M, Stolakis V, Skandali N, 
Voumvourakis K, Katsouni E, Tsakiris S. Experimentally-induced Wernicke’s encephalo-
pathy modifies crucial rat brain parameters: the importance of Na+,K+-ATPase and a po-
tentially neuroprotective role for antioxidant supplementation. Metabolic Brain Disease 
2013; 28(3): 387-396, 
 Chapter V: Liapi C, Zarros A, Galanopoulou P, Theocharis S, Skandali N, Al-Humadi H, Ani-
fantaki F, Gkrouzman E, Mellios Z, Tsakiris S. Effects of short-term exposure to manganese 
on the adult rat brain antioxidant status and the activities of acetylcholinesterase, 
(Na+,K+)-ATPase and Mg2+-ATPase: modulation by L-cysteine. Basic & Clinical Pharmacol-
ogy & Toxicology 2008; 103(2): 171-175, 
 Chapter VI: Liapi C, Zarros A, Theocharis S, Al-Humadi H, Anifantaki F, Gkrouzman E, 
Mellios Z, Skandali N, Tsakiris S. The neuroprotective role of L-cysteine towards the ef-
fects of short-term exposure to lanthanum on the adult rat brain antioxidant status and 
the activities of acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase. BioMetals 2009; 22(2): 
329-335, and 
 Chapter VII: Liapi C, Zarros A, Theocharis S, Voumvourakis K, Anifantaki F, Gkrouzman E, 
Mellios Z, Skandali N, Al-Humadi H, Tsakiris S. Short-term exposure to nickel alters the 
adult rat brain antioxidant status and the activities of crucial membrane-bound enzymes: 
neuroprotection by L-cysteine. Biological Trace Element Research 2011; 143(3): 1673-
1681. 
 
Scanned copies of the seven published articles that form the basis of the current PhD Thesis 
are provided in Appendix C. 
 
APPENDIX C 
 
Scanned copies of publications that form the basis  
of the current PhD Thesis 
 
 
Scanned copies of the seven published articles that form the basis of the current PhD Thesis 
are provided within the next pages in the following order:  
 
 Carageorgiou et al. Metabolic Brain Disease 2005; 20(2): 129-139, 
 Zarros et al. Metabolic Brain Disease 2008; 23(3): 255-264, 
 Zarros et al. Metabolic Brain Disease 2009; 24(2): 337-348, 
 Zarros et al. Metabolic Brain Disease 2013; 28(3): 387-396, 
 Liapi et al. Basic & Clinical Pharmacology & Toxicology 2008; 103(2): 171-175, 
 Liapi et al. BioMetals 2009; 22(2): 329-335, and 
 Liapi et al. Biological Trace Element Research 2011; 143(3): 1673-1681. 
 
This order of the articles matches the order of their presentation within the current PhD The-
sis. 
 
 
  
 
 
Appendix C 
Pages 133 to 197 of this thesis have been removed from this 
electronic version as they contain Published material under 
copyright. 
 
 
 
APPENDIX D 
 
Scanned copies of letters certifying the author’s contribution  
to the work described 
 
 
Scanned copies of the statement of Dr Haris Carageorgiou (corresponding author of the work 
described in Chapter I) and the letter of Dr Stylianos Tsakiris (senior author of all works that 
form the basis of the current PhD Thesis and corresponding author of the works described in 
Chapters II-VII) that highlight the author’s contribution to the work described in Part A of the 
current PhD Thesis and his right to use this work towards a PhD. 
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